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1 Introduction 
 
During the last century, researchers have focused on the influence of certain 
chemicals involved in interactions between living organisms. The production or 
biosynthesis of such organic compounds and their distribution between the 
producers or between other organisms are important questions in chemical 
ecology. The response to signalling molecules, the effects of certain toxins and 
especially the interactions between different kingdoms, such as insect-plant 
interactions, fungi-plant interactions or plant-plant interactions, represent major 
research topics of this field. 
Over their entire lifetime, plants are exposed to a variety of stress factors. Such 
stress factors can be either abiotic or biotic. Abiotic stress is caused by 
environmental factors, such as water deficit, extreme temperature or light 
conditions. Biotic stress is caused by different living organisms, such as 
herbivores, pathogens or fungi. Stress affects plants in their development and 
reproduction processes. Since they are unable to move, they have evolved 
efficient strategies to cope with or to adapt to such stresses. 
Plants have developed a wide range of defensive mechanisms to survive and 
fight against attacking enemies. Recognition of enemies and the triggered answer 
cascade is part of the study of chemical ecology as well. 
 
 
1.1 Plant defence reactions 
 
During evolution, plants have developed efficient strategies against different 
natural stresses. Their defence can either be constitutively, providing general 
protection against infestion, since it is inherent to a specific host, or it is induced by 
certain effectors, such as pathogens or herbivore attack. The induced defence has 
certain advantages because natural resources are conserved and resistance is not 
minimised. Mechanical barriers, such as thorns, spikes or wax layers can be 
formed to protect the plant against first attacks. Beside this mechanical defence, 
the chemically induced defence is more interesting to researchers. By producing 
toxic substrates (direct chemical defence), e.g. nicotine from the tobacco plant 
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Nicotiana attenuata1 or morphine from the poppy plant Papaver somniferum2, 
plants protect themself against enemies, because the attacking enemies are either 
deterred by the smell of the released substances or they are killed directly. Plants 
are also able to defend themselves indirectly, as it can be found in the plant 
Acacia farnesiana.3 With the formation and secretion of extrafloral nectaries 
(EFN), this acacia is able to attract ants. Secretory nectar glands are found in 
flowers, but sometimes similar organs are also located in other vegetative parts of 
the plant and are therefore called extrafloral. EFN is mainly composed of a mixture 
of sugars and minor amino acids attracting certain ants that provide protection to 
the plant by stinging, spraying or swarming over insects landing on the plant. This 
effect is called mutualism, where the plant serves as a food source for ants, and 
the ants in turn defend their host against predators. 
Another phenomenon of indirect defence is the release of volatile organic 
compounds4 as an answer to mechanically wounding of the plant, herbivore attack 
or as a result of exposing plants to certain stimuli, such as heavy metal or 
hydroperoxide treatment. Plants emit a specific blend of volatiles, e.g. a mixture of 
methyl salicylate, different terpenoids, or green leaf alcohols. This so-called “cry 
for help” is often a first characteristic for indirect defence including higher trophic 
levels, which means that plants release such volatiles for attracting carnivorous 
insects or parasitoids, that reduce the feeding pressure by predation of the 
herbivore.5 This simple theory includes complicated recognition mechanisms 
within the plant. According to the nature of the attack, a specific response cascade 
is triggered (Figure 1). Recognition of stress factors allows plants to act in a 
specific way to defend themselves. A variety of signalling pathways are involved in 
the initiation of defence responses. After identificitaion via specific receptors, 
recognition triggers subsequent activation of intracellular signal transduction 
cascades, ranging from second messenger stimulation, such as calcium influx,6,7 
to induction of protein phosphorylation, including mitogen-activated protein kinases 
(MAP-kinases)8 or synthesis of reactive oxygen species (ROS),9 which in turn 
results in a characteristic expression of defensive genes, leading to phytoalexin 
accumulation or to the release of specific volatile blends. Of special importance in 
such early responses are certain signal molecules, the so-called plant- or 
phytohormones that are major players in plant defence regulation. 
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Figure 1. Interaction between plants, herbivores and parasitoids. Caused by certain stress factors, 
plants answer through a complex cascade of signal transduction pathways leading to 
defensive gene expression, accumulation of phytoalexins and the release of special 
volatiles that attract e.g. parasitic wasps to their prey. 
 
 
1.2 Phytohormones as regulators of plant 
development and defence 
 
Plants adapt to various environmental stimuli by using sophisticated defence 
strategies, according to the nature of the attack. A central role in such defensive 
mechanisms refers to plant- or phytohormones. They are not only regulators of 
plant development and reproduction, but are also involved in many other 
physiological processes of primary and secondary metabolism.10 In contrast to 
animal hormones, plant hormones are not produced in specific glandular cells, but 
in cells located all over the tissue. Such signal molecules, e.g. auxins, cytokinins, 
gibberellins, brassinosteroids, abscisic acid, ethylene and jasmonates, regulate 
plants growth, differentiation and the communication between different plant cells. 
Therefore, the name phyto- or plant hormone is applied for these regulating 
molecules. Phytohormones can interact synergistically or antagonistically (cross-
talk) to allow differentiated responses to various threats. Often not a single 
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hormone is responsible for a special response reaction, but the interaction 
between two or more hormones is involved. 
Plant hormones are devided into two groups, one for promoting and one for 
inhibiting plant growth.10  
Plant growth hormones are auxins, e.g. indol-3-acetic acid (1), cytokinins, e.g. 
kinetin (2), gibberellins, e.g. gibberellic acid (3) and brassinosteroids, e.g. 
































Figure 2. Auxins, cytokinins, gibberellins and brassinosteroids are plant growth hormones. 
 
Auxins can be found in all higher plants, especially in high doses in the 
developing seedling. In lower concentrations they induce root and shoot 
elongation, cell division in the cambium and root formation. They also influence the 
dropping of leaves, flowers and fruits. The most important auxin is indol-3-acetic 
acid (1). Navarro et al.11 demonstrated a link between auxin signalling in plants 
and resistance to bacterial pathogens. These results indicate that decreasing plant 
auxin signalling can increase resistance to bacterial pathogens. Some 
microorganisms, like E.coli, even use auxins as signalling molecules, although 
they are not able to produce them.12 According to Bianco et al., treatment with 1 
triggered an increased tolerance to several stress conditions (heat and cold shock, 
UV-irradiation, osmotic and acid shock and oxidative stress) and to different toxic 
compounds (antibiotics, detergents and dyes).  
Cytokinins are plant hormones that stimulate cell division and other growth- or 
differentiation processes. They reduce senescence and stimulate dark-germination 
of light-dependent seeds. Cytokinins, such as kinetin (2), are amino-substituted 
derivatives of adenine or adenosin. It has been found that cytokinins are able to 
inhibit the hypersensitive response and induce susceptibility in potato plants.13 
Gibberellins are another group of plant growth promoters that are found in young 
unripe fruits and seeds, in root tips and shoots. They are responsible for the 
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elongation of internodies, enhance seed germination and flower development. 
Gibberellins are pentacyclic diterpenoic acids. It is suggested that gibberellic acid 
(3) inhibits leaf senescence of Pelargonium by reducing levels of reactive oxygen 
species (ROS).14 
The first brassinosteroid isolated from the rape plant led to enhanced stem 
elongation. More than 40 different natural brassinosteroids could be identified, but 
castasteron (4) and brassinolide are the most abundant ones. They differ in the B-
ring of the steroid skeleton and the 2α- and 3α- hydroxy-groups seem to be 
essential for the hormone effects. 













Figure 3. Abscisic acid (5) and ethylene (6) are plant growth inhibitors. 
 
Abscisic acid (5) occurs in high concentrations in dormant seeds. As a natural 
growth inhibitor it maintains the dormancy of buds by inhibiting cell division. 
Abscisic acid (5) regulates transpiration, stress responses and embryogenesis. 
Most effects seem to be related to water availability, where it acts as a signal of 
water loss by regulation of stomatal behaviour.15 5 is a mono-cyclic 
sesquiterpenoid that is involved in rapid opening processes of ion channels and its 
biosynthesis is correlated with coordination of stress.16 
Ethylene (6) is a gaseous effector, participating in many physiological processes; 
it influences plant growth, acts as a stress hormone and exhibits various 
morphogenic effects. 6 triggers senescence, accelerates fruit ripening, fading of 
flowers and abscission of leaves and petals.17 The ethylene-signalling pathway 
coordinates together with other phytohormones diverse responses to all kinds of 
stresses. It slows down plant growth until the stress situation is solved. On the 
genetic level, 6 induces the expression and transcription of several genes involved 
in defensive responses.18 
The number of physiological processes controlled by such phytohormones is 
enormous and it is difficult to differentiate functions of each hormone from the 
others. Besides such classical plant hormones, another class of hormone-like 
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substances was identified as being ubiquitous in higher plants, the oxylipins. 
Jasmonic acid (JA) (7), its methyl ester (MeJA) (8) and its biosynthetic precursor 
12-oxophytodienoic acid (OPDA) (9) are the predominant oxylipins researches are 
focussing their interest on. 
As a consequence of oxidative stress, caused by mechanical wounding, 
pathogen or herbivore attack, the plant’s surface is damaged and an oxidation of 
free or esterified lipids is initiated either by enzymes (lipoxygenases) or by reactive 
oxygen species (ROS). These peroxidation processes lead to a highly diverse 
class of oxylipins (Figure 4). Derived from linolenic (10), linoleic acid or other poly-
unsaturated fatty acids (PUFAs) located in the plant’s membrane, oxylipins of 
different chain length or different degrees of functionalisation are formed. The 
pathway leading to OPDA (9) and jasmonates is also called the octadecanoid 
pathway (Figure 5). α-Linolenic acid (10) is released from the membrane lipids by 
phospholipases and is oxidised to the (13S)-hydroperoxyperoxide (11) by a 
lipoxygenase. 11 is then converted to an unstable allene oxide intermediate (12) 
by the allene oxide synthase and undergoes cyclisation catalysed by the allene 
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Figure 4. Enzymatically formed oxylipins derived from the α-linolenic acid (13S)-hydroperoxide 
(11). 
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Activation and cyclisation of linolenic acid (10) (Figure 5) take place in the 
chloroplast, whereas the steps downstream of OPDA (9) take place in 
peroxisomes and in the cytoplasm, where OPDA (9) or its CoA ester is transported 
to. In the cytoplasm, the cyclopentenone ring double bond of 9 is reduced by a 12-
oxophytodienoate reductase. In the peroxysomes, stepwise β-oxidation finally 
leads to the plant hormone cis-JA (7).19 The highly 
active cis-7 rapidly undergoes epimerisation to the 
thermodynamically more stable but less active 
trans-isomer.20 7 is biologically active and has 
hormone properties. It plays a key role in regulating 
plant growth and development by influencing seed 
germination,21 flower formation22 and fertility23 and 
seems to participate in leaf senescence and in 







Figure 5. The octadecanoid pathway in plants. 
 
Similar to other plant hormones, jasmonates have both activating and inhibiting 
effects. The early precursor of the JA-biosynthesis OPDA (9), is also biologically 
active as a signal transducer independent from the JA (7) signalling pathway.27 
Besides 7 and 9, other fatty acid derived oxylipins recently came into focus of 
researchers. All are derived from 13- or 9-fatty acid hydroperoxides, that are 
further converted by different enzymes to aldehydes (13), ketones (14), alcohols 
(15), epoxides (16) or ethers (17) (Figure 4). But plant oxylipins are not only 
formed enzymatically, they can also be produced without the action of enzymes. 
Phytoprostanes are a recently characterised class of such non-enzymatically 
formed oxylipins.28 The effects of oxylipins are widespread and in many cases not 
fully understood. However, there is increasing evidence, that not only jasmonates, 
but also other oxylipins play an important role and/or are even the major signalling 
compounds in plant defensive strategies.29 
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1.3 Phytoprostanes and dinor isoprostanes  
 
The octadecanoid pathway in higher plants leading to jasmonates is relatively 
well-studied.27 Many enzymes are involved in the oxidation and transformation of 
linolenic acid (10) leading to a defined stereochemistry of the resulting oxylipin 
metabolites. But more and more information is arising, that there are other fatty 
acid derived oxylipins independently from JA (7) that also have biological 
importance.29 Especially on the fungal and pathogen level, a direct protection of 
the plant can be mediated by OPDA (9). 9  and other molecules containing an α,β-
unsaturated carbonyl group have been postulated as potent gene regulators in 
diseased plant tissues,30 as a result of their activity as Michael-acceptors. A new 
substance class belonging to this JA-independent group is the so-called dinor 
Isoprostanes (DIP) or phytoprostanes (PP), which are formed non-enzymatically 
from α-linolenic acid (10). 
 
 
1.3.1 Occurrence, biosynthesis and diversity of 
phytoprostanes 
 
In the early 1990s, a series of prostaglandin like compounds was identified to be 
produced in mammals independently of the cyclooxygenase pathway from 
arachidonic acid.31 These compounds were termed isoprostanes, because their 
cyclopentenoid structure is closely related to that of the prostaglandins; however 
they are completely racemic.  
Since higher plants generally do not possess arachidonic acid (C20:4), neither 
prostaglandins nor isoprostanes can be produced. The major poly-unsaturated 
fatty acid in higher plants is α-linolenic acid (18:3ω3) (10). Similar to the origin of 
mammalian isoprostanes, a new substance class was identified to be produced in 
higher plants, termed phytoprostanes (PPs). PPs are generated from α-linolenic 
acid (10) in a non-enzymatical pathway initiated by enhanced formation of free-
radicals.32 They are denominated analogous to the prostaglandin nomenclature.33 
γ-Linolenic acid (18:3ω6) (18) is only a minor fatty acid in higher plants; it occurs 
in high levels (10-24 % of dry weight) in borage seeds (Borago officinalis), black 
currant (Ribes nigrum) or evening primerose (Oenotherae biennis) and is a trace 
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compound in animal lipids. Analogous to the oxidation of α-linolenic acid (10) that 
forms phytoprostanes (PPs), γ-linolenic acid (18) can be transformed to dinor 
isoprostanes (DIPs), that only differ from the PPs by the length of their side chains 
attached to the cyclopentenone ring system.34 
As shown in Figure 6, the cyclopentenone skeleton is a result of the free-radical 
oxidation of α-linolenic acid (10) via its 12- or 13-hydroperoxy radical (19) initiated 
by reactive oxygen species (ROS). Oxidation of γ-linolenic acid (18) occurs via the 
9- or 10-hydroperoxy radical (20). Two different regioisomeric products are formed 
in each case. The resulting bicyclic endoperoxides (PPG1) (21) are instable 
intermediates that are prone to undergo reduction, rearrangements or elimination 
of water leading to the high diversity of different PP structures. Figure 6 focuses 
on the biosynthesis of the B1-PP skeleton (22) that is synthesised within this work; 
































dinor isoprostane G1 type III and IV












Figure 6. Biosynthesis of phytoprostanes (PP) B1 type I and II and of dinor isoprostanes (DIP) B1 
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 PPB1 type I (22a) PPB1 type II (22b) 
DIPB1 type III 
(22c) 
DIPB1 type IV 
(22d) 
R1 (CH2)7COOH CH2CH3 (CH2)4COOH (CH2)4CH3 
R2 CH2CH3 (CH2)7COOH (CH2)4CH3 (CH2)4COOH 
 
O O HO HO O
HO O HO
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Figure 7. Structural diversity of PPs denominated according to the prostaglandin nomenclature. 
(R1, R2 see Figure 6) 
 
PPs are formed ubiquitously in higher plants at a low background level, but their 
concentration dramatically increases in response to oxidative stress caused by 
leaf damage or pathogen infection.35 
 
 
1.3.2 Biological importance of B1-phytoprostanes 
 
Phytoprostanes (PP) are generated by free radical processes during aerobic 
metabolism. PPs are therefore considered as reliable markers of oxidative stress 
in higher plants.35 Oxidative stress on the leaf surfaces can be caused by different 
factors, such as mechanical wounding, herbivore or pathogen attack. High levels 
of PPs were observed after in vivo treatment with fungal pathogens (Botrytis 
cinerea) or peroxides and after addition of heavy metal ions.34 PP accumulation is 
a transient process, suggesting that these biomarkers are rapidly generated and 
metabolised in vivo.32 Despite other PP classes, the B1-types (22a,b) seem to be 
particularly active in certain plant species. A cDNA microarray of Arabidopsis 
thaliana callus cultures showed after treatment with both enantiomeric PPB1 types 
(22a,b) a strong detoxification and defence response.36 The expression levels of 
several glutathione-S-transferases, glycosyl transferases and a putative ATP-
binding cassette were increased. This enhances the plant’s ability to detoxify and 
sequestrate reactive and therefore dangerous products of lipid peroxidation. PPs 
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might thus be regarded as sensitive biomarkers that occur in response to oxidative 
stress. 
The induction of secondary metabolism is another important factor in plant 
defence reactions. Both PPB1 (22a,b) stimulated the accumulation of secondary 
metabolites (Figure 8) in different plant species.36 In Eschscholzia californica cell 
cultures, the PPB1 type II isomer (22b) induced the accumulation of 
benzophenanthridine alkaloids similar to methyl jasmonate (MeJA) (8). Crotalaria 
cobalticola cell cultures accumulated the chalcone isobavachalcone (29) in 
response to PPB1 type II (22b) and MeJA (8) treatment, whereas type I PPB1 (22a) 
was less active. Also in tobacco cell cultures, 22b showed a comparable activity to 
8 by inducing the accumulation of scopoletin (30). Interestingly, there was no 
difference in the activity of the corresponding R- and S-enantiomer of both PPB1 
species (22a,b), suggesting that the postulated biosynthetic pathway, based on 
racemic products, is correct. The biosynthesis of the phytoalexin camalexin (31) in 


















28 29 30 31
 
 
Figure 8. Secondary metabolites that are produced after treatment with PPB1s (22a,b) or MeJA 
(8): a) benzophenanthridine alkaloids; b) chalcones; c) scopoletin; d) camalexin play a 
role in the plant’s defence against bacteria or fungi. 
 
Currently, interest is rising in the activity of PPs in humans. Four classes of PPs 
(F1, E1, A1, B1) were found in quite high concentrations up to 99 mg/l in several 
fresh cooking oils and after oral consumption of the oils in the human gastro-
intestinal tract.37 Thus, humans might be exposed to high levels of PPs and their 
effects should be studied in detail. Results of this study indicate that PPs are 
novel, biologically active lipids in plant nutrition. It is further suggested that PPs do 
not only modulate plant defence but also have an impact on human immune cells 
similar to their arachidonic acid derived congeners of the prostaglandin family. PPs 
might be involved in reducing the risk of several cardiovascular diseases, such as 
atherosclerosis or infarction. It has been shown, that pollen-derived PPE1 (26) can 
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modulate dendritic cell function similar to prostaglandins E2.38 Especially in fresh 
birch pollen, high concentrations of PPF1 (24) were found, suggesting that certain 
PPs are involved in allergic reactions similar to the mammalian isoprostanes. 




1.3.3 Relationship between prostaglandins, isoprostanes and 
phytoprostanes  
 
Formerly, the understanding of animal and plant signalling mechanisms 
developed independently. In recent years, more work has been done to show that 
different stimuli are similar across these two kingdoms. The responses to certain 
stress factors, such as wounding or pathogen attack, overlap in the prostaglandin 
and octadecanoid signalling processes.39 The structural relation between 
prostaglandins, isoprostanes and phytoprostanes is obvious because of the 
mechanistically related biosynthesis from polyunsaturated fatty acids. Although 
prostaglandins are formed by enzymes, there is no evidence, that iso- or 
phytoprostanes do require enzymes for their formation. In contrast to a defined 
stereochemistry in prostaglandins, iso- and phytoprostanes are biosynthesised as 
racemic mixtures. All three natural product classes contain a cyclopentanoid ring 
structure, and differ only in the substitution and length of the side chains derived 
















Figure 9. Comparison between prostaglandin A2 (32), isoprostane A2 (33) and phytoprostane A1 
(23a). 
 
The unsubstituted cyclopentenone-system is a highly active unit being able to act 
as a Michael-acceptor and thus might bind to electrophilic substrates (Figure 10). 
A covalent bond between this α,β-unsaturated oxo moiety of the cyclopentenones 
and a thiol-group of proteins and glutathione (34) is possible. Prostaglandin 
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derivatives and PPs are able to induce enzymes, such as glutathione-S-
transferases, that catalyse the conjugation of toxic products of lipid peroxidation. 
This indicates that these cyclopentenone metabolites might also act as 




































Figure 10. Nucleophilic attack of glutathione (34) to the “soft” electrophile, the α,β-unsaturated 
carbonyl group of PPs. 
 
The side chains of prostaglandins are mostly oriented trans, whereas the ones 
from iso- and phytoprostanes mainly exist in cis-configuration. A carboxyl-moiety is 
located at the end of one side chain and the C3-side chain contains an allylic 
hydroxyfunction, which is important for the biological activity of the cyclopentanoid 
metabolites.  
 
Prostaglandins have been found in nearly all mammalian organs in 
concentrations ranging from 0.01 to 1 μg/g bodyweight.10 Higher concentrations 
were isolated from the mammalian seminal fluid.40 Derived from phospholipids, 
containing arachidonic acid, the prostaglandins, prostacyclins, or thromboxanes 
can be generated. There are many different physiological effects caused by 
prostaglandins. They act as local hormones on a variety of cells such as vascular 
smooth muscle cells causing constriction or dilation. Therefore prostaglandins are 
involved in reproductive processes. PGE2 causes uterine contractions and has 
been used to induce childbirth or abortion. Prostaglandins activate the 
inflammatory response, cause pain and fever. After tissue damage, the level of 
prostaglandins is increased. Certain prostaglandins are found in several other 
organs of the gastrointestinal tract (inhibit acid synthesis and increase secretion of 
protective mucus) and increase blood flow in kidneys. Recently, it has been 
shown, that prostaglandins could also be detected in plants and microorganisms. 
Several prostaglandins were found in plant species, such as onion,41 red alga,42 
poplar and larch43, in prokaryotic organisms, such as cyanobacteria or 
Pseudomonas,44 or in yeasts.45 Similar to their physiological importance in 
animals, there should be analogous or different effects in higher and lower plants. 
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In mammals, prostaglandins regulate reproduction, and in certain plant species, 
e.g. the short day plant Pharbitis nil,46 they are possibly involved in flower 
induction. They regulate cell membrane permeability in mammals and in plants.47 
It was found, that certain prostaglandins promoted the effect of a phosphatase 
enzyme in barley similar to the plant hormone gibberellic acid (3).48 
Isoprostanes have been found in many animal tissues and in most biological 
fluids, such as plasma and urine.49 Their occurrence depends on the extent of 
oxidative stress. Isoprostanes are linked to an excessive production of lipid 
peroxidation products, eventually leading to the development of cancer, 
cardiovascular or neurological diseases. They have been associated with an 
excessive generation of free radicals and with various disease states of the lung or 
oxidative damage of the liver. An increased concentration of isoprostanes has also 
been found in patients with Alzheimer’s or Parkinson’s diseases. Indeed, the 
extent of their biological importance in vivo is still unclear and controversial. But 
they are regarded as indicators of oxidative stress in mammals. Perhaps they act 
in a similar way to their enzymatically formed analogues, the prostaglandins, by 
regulating the vascular smooth muscle cells. It has been shown, that many, but not 
all, isoprostanes are able to bind to and activate prostaglandin receptors. 
Phytoprostanes (PPs) are somehow different from their mammalian 
counterparts, consisting only of an 18-carbon skeleton. The functional groups 
around the active centre are similar, suggesting that there is also similar 
physiological importance. Although the occurrence is limited to the plant kingdom, 
it is suggested that PPs are also active in animals.37-39 In plants PPs are mediators 
of oxidative stress, being connected to the enhanced formation of free radicals 
causing an oxidation of α-linolenic acid (10).32 As discussed in chapter 1.3.2, PPs 
act in stimulating defensive and detoxification genes and increase the amount of 
secondary metabolites, involved in plant defence and detoxification processes. It 
might also be possible, that PPs are able to bind to certain prostaglandin receptors 
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2 Objectives for this work 
 
Prostaglandins were discovered in the human seminal plasma by von Euler et al. 
in the 30s of the 20th century.40 More interest on this specific substance group 
arose about 20 years later, as they were identified as hormone-like substances in 
animals derived from arachidonic acid. Until today more than 77.000 publications 
exist dealing with these compounds. The biological relevance of prostaglandins 
was first studied by extracting the active compounds from the seminal fluids and 
performing different activity tests with. Later, also chemical syntheses were 
designed to obtain these metabolites in higher concentrations than by extraction of 
biological tissues.  
Isoprostanes were first identified and characterised in the early 90s as 
prostaglandins-like compounds.31 Similar to their enzymatically-formed analogues, 
they were extracted from mammalian tissue material and then used for specific 
tests for investigating their biological importance. But the lack of satisfactory 
natural sources has prompted scientists to focus on chemical synthesis. According 
to databases, more than 2.000 publications deal with the topic of isoprostanes 
including many synthetic approaches. 
The field of phytoprostanes was opened in 2000, when Müller et al. detected 
these metabolites by non-enzymatic oxidation of α-linolenic acid (10).32 
Phytoprostanes were then regarded as sensitive markers of oxidative stress in 
higher plants similar to the isoprostanes formed in mammals. Currently, there exist 
only about 20 publications dealing with this topic, showing that there can be done 
a lot to contribute to this interesting and new field of science. Until 2003, 
phytoprostane activity was only studied by using the compounds derived from 
autoxidation processes. The first synthetic approach was published in 2003 for 
PPF1 (24).51 Later, syntheses for PPE1 (26), PPB1 (22) and deoxy- PPJ1 (27) were 
developed, but most of them are quite long and ineffective.52-54 
The aim of this work was to develop a short and effective synthetic access to the 
phytoprostane (PP) B1 series (22) (Figure 11). Despite the types I (22a) and II 
(22b) derived from α-linolenic acid (10), the dinor isoprostanes (DIP) B1 type III 
(22c) derived from γ-linolenate (18) should be generated using this synthetic 
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approach. Different structural analogues should give more insight into structure-

















Figure 11. Structures of PPB1-I methyl ester (22a), PPB1-II methyl ester (22b) and DIPB1-III methyl 
ester (22c). 
 
In order to better understand the biological importance of phytoprostanes, more 
bio-assays dealing with different topics must be performed. It is known, that 
phytoprostanes accumulate with enhanced free radical formation and are 
considered as markers of oxidative burst. However, their ultimate function in 
higher plants is still unknown. It has to be determined, in which defensive 
mechanisms due to oxidative stresses, phytoprostanes are involved. Is it defence 
against herbivores (induction of volatile emission), against pathogens (growth 
inhibition) or just an answer to mechanical wounding? Are phytoprostanes just 
artefacts, that are formed incidentally by linolenate oxidation? Are they just by-
products or really important metabolites for plant defence? Do they have an impact 
on the induction of the accumulation of defensive genes similar to jasmonic acid 
(7) treatment, wounding or pathogen attack? These are some of the questions, 




 Synthesis of the methyl esters of phytoprostane B1 types I (22a) and II 
(22b) and dinor isoprostane B1 type III (22c) 
 Synthesis of structural analogues to the natural occurring phytoprostanes 
 Studies with DNA microarrays of extracted total RNA from phytoprostane-
treated Arabidopsis thaliana plants 
 Antimicrobial tests on different bacterial strains (agar-diffusion test) 
 Volatile emission tests 
 Intracellular Ca2+-measurements 
 
Results and discussion  17 
    
3 Results and discussion 
 
3.1 Synthetic strategies 
 
3.1.1 Known phytoprostane syntheses 
 
Phytoprostanes (PPs) can be generated by autoxidation of α-linolenic acid (10)55 
or by following established prostaglandin- or isoprostane syntheses. Autoxidation 
processes are always time consuming and mostly lead to a complicated product 
mixture from which the desired compounds have to be isolated using complex 
cleaning steps.  
The first total synthesis of prostaglandins, the enzymatically formed mammalian 






























Scheme 1. Corey’s first total synthesis of prostaglandin F2α(43) starting from cyclopentadiene (35). 
 
In this synthetic approach cyclopentadiene (35) was alkylated to 36 and a Diels-
Alder addition with 2-chloroacrylnitrile to 37 was performed, yielding after alkaline 
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saponification two enantiomeric ketones, that were oxidised to give two 
enantiomeric seven-ring lactones 38. Further acetylation and oxidation steps 
generated the so-called Corey-lactone (39), a versatile synthetic building block. In 
a Wittig-reaction, the C3-side chain was introduced into 39 to form 40 and after 
reduction and protection of the hydroxy-groups with THP to 41, a mild reduction 
with isobutyl aluminium hydride gave a hemiacetal in which the C2-side chain 
could then be introduced via Wittig-reaction to form 42. After deprotection, the 
pure prostaglandin F2α (43) was obtained. This first total synthesis of 
prostaglandins included many steps, yielding only 2 % of the pure prostaglandin 
F2α(43).  
Later, more efficient syntheses for prostaglandins were introduced using three-
component-coupling processes (Scheme 2) by attaching the α- and ω-side chain 
to a five-membered ring.57 For these reactions, organic copper compounds served 
as donor synthons (Rω-), whereas aldehydes were used as acceptors (Rα+). Thus, 
the nucleophilic attack on the β-C-atom and the electrophilic attack on the α-C-













Scheme 2. General mechanism of the three-component coupling reaction to introduce various α- 
and ω-side chains into five membered rings of prostaglandins or analogues. 
 
In the last few years, also phytoprostane (PP) syntheses along this concept have 
been developed. 
Rodriguez et al.58 reported a two-component coupling process for isoprostanes 
combined with a diastereoselective protonation with chelating proton donors under 
reaction control, that was later adapted for a synthesis of PPE1 (26) (Scheme 3).52 
Furan (44) was acylated with azelaic acid monomethyl ester (45) to give the 
ketoester 46, which was then reduced and rearranged to the racemic 
hydroxycyclopentenone 47 in H2O using a catalytic amount of chloral in the 
presence of triethylamine. The racemic precursor 47 could be converted into its 
chiral intermediate by lipase-catalysis. The product was further coupled with the 
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optically pure iodovinyl side chain followed by a diastereoselective protonation. 
After deprotection, the PPE1 (26) could be generated within 10 steps. Overall 


















Scheme 3. Essential steps for the synthesis of PPE1 (26) starting from furan (44). 
 
A French group excelled at working on efficient synthetic strategies on 
phytoprostanes (PPs). They first synthesised PPF1 type I and its 16-epimer (24)51 
by introducing the C2-chain via Wittig reaction into the ester 48 to form 49 followed 
by certain reduction, protection and oxidation steps and a Horner-Wittig-Emmons-
condensation with the C3-side chain. Final reduction with R- or S- BINAL-H gave 
the desired compound 24 in about 11 % yield over 8 steps (Scheme 4). This route 
required enhanced synthetic effort, since all precursors had to be generated first. 
In 2004, this group published a similar synthetic approach, but now covering all 
diastereomers of PPF1 types I and II (24) 59 Again, the synthetic effort was high 

















Scheme 4. Essential steps for the synthesis of all diastereomers of PPF1 type I (24). 
 
In 2005, the same group found a way to synthesise PPB1 type I and II (22) 
(Scheme 5).53 Therefore, they modified their original method and used furfural 
(50) as starting material. First, 50 had to be transformed to a 3-hydroxy-4-
cyclopentenone precursor 51 in 6 steps, including a Wittig reaction, hydrogenation 
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of the additional double bond, followed by a formylation step, protection, oxidation 
and an acidic hydrolysis of the resulting bis-acetal. After further steps of 
hydrogenation, dehydration and acidic hydrolysis, the resulting aldehyde 52 
underwent reaction with chiral phosphonium ylides to introduce the corresponding 
C3-chains. This synthetic route required 10 synthetically demanding steps with an 
overall yield of only 5 % and much presynthetic work had to be done for 












phytoprostane B1 type I
50 51 52 22
 
 
Scheme 5. Essential steps for the synthesis of R/S-PPB1 type I (22). 
 
In 2005, an approach was published54 using a disclosed conjugate addition-
olefination process resulting in racemic deoxy-J1-PP type I and II (dPPJ1) (27). 
This synthesis is also lengthy and consequently not useful for larger scale 
production. Since the dPPJ1 (27) are the major metabolites of the PP pathway, 
shorter chemical syntheses are required to generate these metabolites in larger 
amounts. Interestingly, these PPJ1s are structurally closely related to 12-oxo-
phytodienoic acid (9), an important enzymatically formed plant defence mediator.  
Considering the enormous synthetic effort and the low yields of published 
synthetic approaches to PPs, the attempt for this work was to develop a shorter 
and more efficient synthesis that should also be suitable for synthesising structural 
analogues of PPs. 
 
 
3.1.2 Synthetic concepts 
 
Due to the increasing interest in the biological activity of phytoprostanes (PPs), 
many total syntheses have been developed.51-54,59,60 Most of them include many 
reaction steps, are time-consuming and ineffective. Therefore, the aim of this 
thesis was to design a short, effective and high yielding synthetic route to obtain 
the PPs of the B1-family (22). Based on the previously published protocol for the 
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synthesis of tetrahydrodicranenone B,61 a flexible approach to the B1-PPs (22) and 
several structural analogues was developed (Scheme 6).  
PPs of the B1-series (22), that represent 2-alkyl-3-alkenyl-substituted 
cyclopentenones, can be generated as follows. By transition metal catalysis 
following Heck- or Sonogashira protocols, the C3-substituent could be introduced 
into the cyclopentenone molecule by substitution of the alkenyl iodide 53. 53 could 
be generated from the mono-alkylated hydroxycyclopentenone 54 via standard 
iodination reactions. For PPB1 type II (22b), the mono-alkylated 
hydroxycyclopentenone 54b was commercially available, whereas for type I (22a) 
and III (22c), the C2-chain had to be attached to 1,3-cyclopentanedione (55) first. 
 
phytoprostane B1 type I, II 
methyl ester, dinor isoprostane B1 
type III methyl ester

















22 53 54 55
 
 
Scheme 6. Retrosynthetic approach to PPs of the B1-series (22). 
 
 PPB1 type I (22a) PPB1 type II (22b) DIPB1 type III (22c) 
R1 (CH2)7COOMe CH2CH3 (CH2)4COOMe 
R2 CH2CH3 (CH2)7COOMe (CH2)4CH3 
 
The central alkenyl-iodide 53 turned out to be an excellent and versatile synthon 
for coupling of various side chains to the cyclopentenone molecule. It cannot only 
be coupled with allylic alcohols to yield PPs, but also with non-functionalised side 
chains or with diverse side chains containing an oxo- or alkynyl-moiety etc. Side 
chains with different degrees of functionalisation and lengths can be attached to 
53. Thus, it is possible to generate many analogous of PPs as well as substances 
of the isoprostane or prostaglandin family along the same protocol. 
In the following subchapters, the synthetic approach is described, allowing a 
simple and highly efficient synthesis of PPs of the B1-series (22). This synthetic 
method turned out to be a useful approach for generating a variety of structural 
analogues to the natural occurring PPs. 
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3.1.2.1 Attachment of the C2-substituent to the five-membered ring 
 
Phytoprostanes (PPs) belong to a large group of natural products that comprise 
a substituted cyclopentanoid ring system. The C2- and C3-substituents can be 
attached to the molecule by different coupling reactions. For PPB1 (22) syntheses, 
1,3-cyclopentanedione (55) appeared to be a useful precursor. Analysing the 
structure of 55, it can easily be seen, that this precursor is prone to undergo keto-
enol-tautomerism; it predominantly occurs in its enol-from. As known from 
literature,62 the percentage of the enol-form is high with two 1,3-carbonyl groups. 
The enol-form contains a system of conjugated double bonds and can build out a 
hydrogen bond for stabilisation. Both effects lower the energy of the enol-form. 
The resulting enolate anion as an ambident nucleophile can either be C- or O-
alkylated. The favoured reaction product here was always the O-alkylated 
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Scheme 7. The problem of keto-enol-tautomerism of 55 in the synthesis of C-alkyated cyclo-
pentenones. 
 
Therefore, an alternative route had to be developed. Chemists working on 
steroid synthesis found a method to overcome the problem of O-alkylation.64 For 
the synthesis of 2-ethylcyclopentane-1,3-dione or better 2-ethyl-3-hydroxy-
cyclopent-2-enone (54b), succinic acid (56) could be cross-coupled in a Friedel-
Crafts-analogous acylation with butyryl chloride (57) in the presence of 2 equiv 
aluminium trichloride (Scheme 8). The mechanism for this alkylation is not clearly 
understood. Probably, the acid chloride attacks the positively charged C-atom of 
the keto-function as a nucleophile. After elimination of water, the resulting double 
bond could attack the second positively charged carbonylcarbon. The ring is 
closed and after decarboxylation and elimination of the chloride and the aluminium 
chloride, the desired product 54b can be generated.  
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Scheme 8. Proposed mechanism for the generation of 2-ethyl-3-hydroxycyclopent-2-enone (54b). 
 
Yields for this procedure were generally good, but with respect to the handling of 
butyryl chloride and the not well elaborated cleaning steps, commercially available 
2-ethyl-3-hydroxycyclopent-2-enone (54b) was used for synthesis of PPB1 type II 
(22b). Furthermore, this method is limited to short alkyl chains. For introduction of 
the C2-substituent of PPB1 type I (22a) and DIPB1 type III (22c), having longer C-
chains and a carboxyl function, the method has limitations, because of competing 
side reactions and formation of by-products. Therefore, an alternative alkylation 
method was used. 
Following a Russian three step procedure, the alkylation in C2-position of the 

















59 54  
 
Reagents and conditions: a) 1.1 equiv of ClOCR1, 1 equiv of pyridine, C2H4Cl2, 20 h; b) 0.4 equiv 
of acetone cyanohydrine, 1.4 equiv of Et3N, CH3CN, 24 h; c) 3 equiv 
Et3SiH, CF3COOH with 1 % LiClO4, 24 h.  
 
Scheme 9. Synthesis of C-alkyl-hydroxycyclopentenones 54a,c. 
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The first step was an O-acylation of the enolate of cyclopentane-1,3-dione (55) 
with bifunctional acylhalides, e.g. methyl 7-(chlorocarbonyl)heptanoate, in the 
presence of pyridine in dry dichloroethane. This yielded 58a,b nearly 
quantitatively.65 Subsequent treatment of the resulting enol esters 58a,b with 
acetone cyanohydrine or, less efficiently, with Lewis acids such as AlCl3, ZnCl2 or 
with 4,4-dimethylaminopyridine,66 promoted the rearrangement of the side chain 
from the O- to the C-position to form 59a,b. Despite the toxicity of cyano 
compounds, acetone cyanohydrine was the reagent of choice, since it generated 
the rearranged products 59a,b in high yields. AlCl3 caused problems due to 
required anhydrous conditions. Final reduction of the oxo-moiety in the side chain 
of 59a,b gave the mono-alkylated precursors 54a,b in good yields. 
The mechanism of such an O-C-rearrangement of 58 under Lewis-acid catalysis is 







































Scheme 10. Proposed mechanism for the rearrangement of O-acylated cyclopentenones 58 to C-
acylated isomers 59 according to Fries-rearrangement. 
 
 R1 
Compound (yield in %) 
PPB1 type I (CH2)6COOMe 58a (98), 59a (92), 54a (89) 
DIPB1 type III (CH2)3COOMe 58b (98), 59b (85), 54c (83) 
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The reaction is catalysed by Lewis acids that complex the O-acylated educt 58 
and generate an acylium ion. The acylium ion then reacts with the double bond 
and after hydrolysis the product 59 is released. 
Using acetone cyanohydrine, another mechanism is most likely (Scheme 11). The 
cyanide ion might be released into the medium and can attack the O-alkylated ring 
C3-atom of 58. A carbanion is generated with localisation of the negative charge at 
the C2-atom. Now, an intra molecular nucleophilic attack on the carbonyl-C-atom 
of the neighboured ester group can happen. After elimination of the cyanide ion, 






















Scheme 11. Proposed mechanism for the O-C-rearrangement of 58 to 59 under cyanide catalysis. 
 
Reduction of the oxofunction in the side chain of 59a,b forming 54a,c was best 
achieved using triethylsilane as hydride donor in trifluoroacetic acid containing 1 % 
of lithium perchlorate.67 The selectivity of this reduction was surprising, because 
normally the ring oxo moiety and the side chain ketone are chemically identical. 
Perhaps the differentiated behaviour might be explained by the resonance stability 
(Scheme 12), whereby the preferred position of the enolate is in the ring. The acid 
media seems to play a role in stabilising the hydride donor and the lithium additive 
coordinates the oxygen. But so far nothing is known from literature, why this side 

















Scheme 12. Resonance stability of the enon-system in 59. 
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Reduction with sodium cyano boron hydride in acidic media turned out to be 
inconvenient because of difficulties in the isolation of products from the reaction 
mixtures.67 
The 2-alkyl-3-hydroxycyclopentenones 54a-c were easily converted to their 
corresponding alkenyl iodides 53a-c by heating with an in situ generated mixture 
of PPh3 and I2 in dry acetonitrile in the presence of triethylamine (Scheme 13).61 
Other standard iodination reactions, for example using imidazole as a base and a 











Reagents and conditions: a) 1.125 equiv of PPh3, 1.125 equiv of I2, 1.1 equiv of Et3N, CH3CN,  
24 h. 
Scheme 13. Iodination of 2-alkyl-3-hydroxycyclopentenones 53a-c. 
 
 
With the sequence of O-acylation, rearrangement and reduction, the C2-side 
chain could be introduced into the cyclopentanedione molecule in three steps with 
overall yields between 69 and 80 %. The following iodination reaction worked well 
for all three types of PPB1. With the alkenyl iodides 53a-c as synthons, useful 
precursors for the introduction of the second C3-side chains by organometallic 
coupling reactions were generated.  
 
 
3.1.2.2 Attachment of the C3-substituent to the five-membered ring 
 
The aim was to generate phytoprostanes and a variety of structural analogues 
based on one simple and uniform synthetic route. Initial retrosynthetic approaches 
 R1 Compound (yield in %) 
PPB1 type I (CH2)6COOMe 53a (68) 
PPB1 type II CH3 53b (77) 
DIPB1 type III (CH2)3COOMe 53c (82) 
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were to couple the alkenyl iodides 53a-c in a Stille-type reaction with the 
corresponding allylic alcohol containing C2-substituents (Scheme 14). The first 
step for this alkylation could be a hydrostannylation of the corresponding 
acetylenic alcohols 60a-c using tributylstannane in the presence of 
azobis(isobutyronitrile (AIBN),69 followed by palladium catalysed coupling of the 
cyclopentenone electrophiles 53a-c.70 An advantage for this coupling is the alcohol 
function, which does not need to be protected; however, the toxicity of tin reagents 



















Scheme 14. Stille coupling reaction to B1-phytoprostanes (22). 
 
 PPB1 type I (22a) PPB1 type II (22b) DIPB1 type III (22c) 
R1 (CH2)6COOH CH3 (CH2)3COOH 
R2 CH2CH3 (CH2)7COOH (CH2)4CH3 
 
The alternative use of Grignard reagents for the C-C-coupling is not applicable 
for these types of molecules, because the carbonyl moiety at the terminus of the 
side chains can interfere.  
Instead, the Heck-type alkylation of the alkenyl iodides 53a-c with protected 
terminal 1-alken-3-ols was chosen, using a 2:1 mixture of PPh3 and Pd(OAc)2 as 
catalyst and triethylamine for trapping hydrogen iodide. The catalytic cycle of the 
Heck-reaction according to Brückner71 is shown in Scheme 15. The Pd0 
compound required in this cycle is prepared in situ from a Pd2+ precursor. In the 
first step, the oxidative addition, Pd0 inserts into the alkenyl-iodide bond of 53, 
whereby the oxidation level of Pd increases to +2. Afterwards, Pd forms a 
Π−complex with the protected allylalkenol and the alkenol inserts into the Pd-
carbon bond. After rotation around the central bond, a β-hydride elimination step 
occurs with the formation of a new Pd-alkene Π−complex. This complex is 
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destroyed and the product 61 is released. The Pd0 species is regenerated by 
reductive elimination of Pd2+ by Et3N.  
 





























































R1 = (CH2)6COOMe (PPB1-I); 
        CH3 (PPB1-II);    
        (CH2)3COOMe (DIPB1-III)
R2 = CH2CH3 (PPB1-I); 
       (CH2)7COOMe (PPB1-II); 








Scheme 15. Mechanism of the Heck-coupling reaction to generate PPB1s. 
 
First attempts for this reaction with tert-butyldimethylsilyl-protected alcohols 
according to the synthesis of prostaglandin B172 were promising (yields of around 
30 %), but problems occurred upon removal of the protective group. According to 
literature, tetrabutylammonium fluoride should easily cleave off the silyl-group, but 
it failed completely in case of the phytoprostane molecules. Even an aqueous 
solution of HF did not cleave off the protecting group; the tert-butyldimethylsilyl-
group turned out to be resistant to deprotection. Therefore, trimethylsilyl-protected 
alcohols were used instead, because of their enhanced sensitivity to cleaving 
reagents. Heck-coupling worked quite well according to GC-MS, and deprotection 
in the presence of HCl also succeeded, but the yields over these two steps were 
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not satisfying (13-29 %). The reason why silylated alcohols gave such low yields 
for the phytoprostane compounds is unclear, because in prostaglandin syntheses 
this protection group has often been used. Best results were obtained in the case 
of PPB1 (22) syntheses using the tetrahydropyranylethers (THP) of the 1-alken-3-
ols.73 The alkenols were either commercially available or synthesised by allylic 
oxidation with selenium dioxide.74 After Heck-coupling according to Naora et al.,72 
the THP-group in 61a-c could be easily removed by a mixture of CH3COOH / THF 















Reagents and conditions: a) 1.67 equiv of CH2CHCH(OTHP)R2, 2 equiv Et3N, Pd(OAc)2*2PPh3, 
24 h, 100 °C; b) CH3COOH / THF / H2O, 45 °C, 20 h 
 
Scheme 16. Heck reaction of alkenyl iodides 53a-c with THP-protected allylic alcohols. 
 
 R1 R2 
Compound 
(yield in %) 
PPB1 type I (CH2)6COOMe CH2CH3 22a (65) 
PPB1 type II CH3 (CH2)7COOMe 22b (69) 
DIPB1 type III (CH2)3COOMe (CH2)4CH3 22c (52) 
 
Even though there should be no difference in the biological activities of the R- or 
S-enantiomer of the PPs, the synthetic route is also applicable for the synthesis of 
chiral products. To demonstrate the general applicability, commercially available 
(R)-(-)-oct-1-en-3-ol was protected and subjected to a Heck coupling and yielded 
the chiral DIPB1 type III (R)-(-)-22c in overall 57 % along the same protocol. 
 
 
3.1.2.3 Syntheses of structural analogues of phytoprostanes 
 
Cyclopentanoid natural products, such as prostaglandins or jasmonic acid (7), 
are diverse and represent biologically significant classes of compounds. 
Cyclopentanones are useful precursors for the synthesis of various cyclopentyl 
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compounds due to the versatility of their functionality. The introduction of the 
cyclopentenone moiety into different target molecules may enhance their 
anticancer potential.75 It has been shown, that the ability of binding of the α,β-
unsaturated carbonyl function of cyclopentenones to specific nucleophiles, such as 
free sulfhydryl groups of reduced glutathione or cysteine residues in proteins 
located in damaged cells might lead to an inactivation of these proteins. This fact 
might be useful for developing anticancer drugs containing a cyclopentenyl group 
as an essential phamacophore. 
Coronalon (62) is a synthetic 6-ethyl indanoyl isoleucine conjugate that shows 
high activity in mimicking octadecanoid phytohormones, such as OPDA (9) or JA 
(7). It is derived from the natural product coronatine (63), first isolated from P. 
syringae or X. campestris. Lauchli et al.76 developed a synthetic strategy for the 
analogue 62, being of comparable activity like coronatine (63) itself or like JA (7) in 













a) coronatine b) coronalon
c) OPDA






Figure 12. Structures of a) coronatine (63), b) coronalon (62), c) OPDA (9) and d) PPB1 type II 
(22b) are comparable to each other, perhaps leading to a similar biological activity in 
higher plants. 
 
62 and 63 appeared to be the most effective elicitors of plant responses, such as 
volatile emission in lima bean, induction of secondary metabolites, such as certain 
benzophenanthridine alkaloids or flavanoids.77 A comparison of the biological 
activity of coronalon (62) with that of PPs suggests similarities, for example the 
induction of the accumulation of secondary metabolites, e.g. benzophenanthridine 
alkaloids.  
Eventually, the analogues structural elements of coronalon (62), OPDA (9) and 
PPs, may account for the comparable biological importance in higher plants 
(Figure 12). 
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Due to such interesting structural relationships between different classes of 
natural products, it seems promising to develop structural analogues of the natural 
occurring PPs. This might help to better understand their mode of action and to 
study structure-function-relationships. Modifications of the parent structure of the 
PPB1s (Figure 13) can be performed at the allylic alcohol, first by removing the 
oxygen atom or secondly by oxidising the OH-group further to its oxo-analogue. 
Moreover, the double bond can be substituted by a triple bond or by the electron 







Figure 13. Positions for structural modifications of the PPB1 type I (22a) parent structure. 
 
Synthesis of non-functionalised analogues of PPB1 types 
Having developed a short synthetic access to the PPB1-series (22a-c), a variety of 
analogues can be generated using this method. Based on the Heck protocol (see 
chapter 3.1.2.2), alkenylation with non-functionalised alkenes giving 64a-c 
proceeded in high yields and without formation of side products (Scheme 17).  
For the PPB1 type I analogue 64a, pent-1-ene had to be coupled with the alkenyl 
iodide 53a. Due to its low boiling point the reaction had to be carried out at only 
40°C under reflux, and at each of the 4 days of reaction time, fresh pentene was 
added to the reaction mixture to give the PP analogue 64a in nearly quantitative 









53 64  
 
Reagents and conditions: a) 1.67 equiv of CH2CHCH2R2, 2 equiv of Et3N, Pd(OAc)2*2PPh3, 24 h, 
4d, 100 °C (40 °C) 
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Synthesis of oxo-analogues of the PPB1 types 
During oxidative stress the allylic hydroxy group of the C3-side chain of the PPs 
could be further oxidised to the corresponding diketones 65. Such diketones 65 
might have interesting biological activity owing to the presence of two Michael-
acceptor systems that might be able to react with different biomolecules, e.g. 
proteins. Since the direct coupling with terminally unsaturated alken-3-ones failed 
due to reductive elimination of the side chain double bond, the PPs 22a-c were 
oxidised to the diketones 65a-c. Oxidation with mild reagents, such as MnO2,78 
required long reaction times and resulted in low yields (15-23 %). Chromium 
reagents are typically quite successful, but work-up and disposal problems limit 
their utility. Bobbitt’s reagent (4-acetylamino-2,2,6,6-tetramethylpiperidine-1-
oxoammonium per-chlorate) in the presence of silica gel was used instead for 
oxidation of the hydroxy group (Scheme 18).79,80 During oxidation, the bright 
yellow Bobbitt’s reagent was reduced to a white hydroxylamine salt allowing visual 















OH ClO4  
 
Reagents and conditions: a) 1.05 equiv of Bobbitt’s reagent (4-acetylamino-2,2,6,6-tetramethyl-
piperidine-1-oxoammonium perchlorate), silica gel, CH2Cl2, 5 h. 




 R1 R2 
Compound 
(yield in %) 
PPB1 type I (CH2)6COOMe CH2CH3 64a (88) 
PPB1 type II CH3 (CH2)7COOMe 64b (91) 
DIPB1 type III (CH2)3COOMe (CH2)4CH3 64c (86) 
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Synthesis of acetylenic analogues of the PPB1 types 
The introduction of an acetylenic moiety instead of the (E)-allyl alcohol into the 
PPs changes the electronic and steric properties of the molecules (Figure 14) and 
may result in altered biological activities. The triple bond makes the molecule more 
rigid and inflexible, which may lead to a binding to different target structures. Also, 
the affinity of binding to a JA (7) receptor might be altered. 
 
Figure 14. 3D structures of the PPB1 type I (22a) and its acetylenic analogue 66a. 
 
Precursors to introduce triple bond containing side chains were either 
commercially available or, in case of PPB1 type II (22b), synthesised from methyl 
undec-10-ynoate using a procedure similar to the allylic oxidation with SeO2.74 The 
alkenyl iodides 53a-c proved to be excellent substrates for a Sonogashira-type 
alkylation with terminal acetylenes (Scheme 19).81 The iodides 53a-c were 
coupled with the acetylenic side chains by reaction with PdCl2(PPh3)2 and CuI as 
catalyst in dry DMF. After stirring the mixture for 24 h at room temperature, higher 
yields (91-96 %) than those for the Heck-type alkylation were obtained. The same 
reaction could also be carried out with commercially available (R)-(+)-oct-1-yn-3-ol, 
yielding the chiral PP analogue (R)-(+)-66c in 70 %. 
 
 R1 R2 
Compound 
(yield in %) 
PPB1 type I (CH2)6COOMe CH2CH3 65a (81) 
PPB1 type II CH3 (CH2)7COOMe 65b (86) 
DIPB1 type III (CH2)3COOMe (CH2)4CH3 65c (78) 
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Reagents and conditions: a) 1.5 equiv of CHCC(OH)R2, 0.07 equiv of PdCl2(PPh3)2, 0.15 equiv of 
CuI, 1.2 equiv of Et3N, DMF, 24 h. 
 
Scheme 19. Synthesis of acetylenic PPB1 analogues 66a-c. 
 
 
Attempts to reduce the triple bond with activated zinc82 were not successful 
(Scheme 20) since the resulting (Z)-alkenes were unstable and readily underwent 




















Scheme 20. The reduced (Z)-alkenes readily underwent isomerisation to the more stable (E)-
alkenes 22. 
 
 Synthesis of ether analogues of the PPB1 types 
To examine structure-function-relationships, compounds 67a-c were synthesised. 
The analogues contain an ether oxygen instead of an allylic hydroxy group in the 
C3-side chain. The electron lone pairs of the oxygen could mimic the function of 
the double bond of the natural PPs. Such O-alkylated substances 67a-c could 
easily be generated by reaction between the 2-alkyl-3-hydroxy-cyclopent-2-enones 
54a-c and the corresponding haloesters. Sodium hydride served as the base for 
deprotonation of the alcohol function of 54a-c in DMSO (Scheme 21). 
 R1 R2 
Compound 
(yield in %) 
PPB1 type I (CH2)6COOMe CH2CH3 66a (88) 
PPB1 type II CH3 (CH2)7COOMe 66b (91) 
DIPB1 type III (CH2)3COOMe (CH2)4CH3 66c (86) 
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Reagents and conditions: a) 1 equiv of X(CH2)2R2, 1.5 equiv of NaH, DMSO, 24 h. 
 
Scheme 21. O-alkylation of the alkylhydroxycyclopentenones 54a-c. 
 
 
Yields for this O-alkylation were generally not very high, perhaps due to the 
presence of the dimsyl-anion that might react with the ester moiety to form α-keto 
sulfoxides (Scheme 22). 
S
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Scheme 22. Side reaction of the O-alkylation leading to α-keto-sulfoxides. 
 
The developed synthetic strategy of first C-alkylating cyclopentanedione (55), 
followed by iodination and organo metallic coupling reactions served as an elegant 
and short method for generating PPs of the B1-series (22a-c) and for a variety of 
different structural analogues (64, 65, 66, 67) (Figure 15). The route includes 





 R1 R2 
Compound 
(yield in %) 
PPB1 type I (CH2)6COOMe CH2CH3 67a (42) 
PPB1 type II CH3 (CH2)7COOMe 67b (74) 
DIPB1 type III (CH2)3COOMe (CH2)4CH3 67c (48) 
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PPB1 type I 
steps (overall yield) 
PPB1 type II 
steps (overall yield) 
DIPB1 type III 








































































4 (33 %) 
 
Figure 15. Overview of synthesised PPs and analogues. Required synthetic steps and overall 
yields are shown. 
 
With all the substrates synthesised so far, several biological activity tests could 
be performed. First results of altered gene expression levels after phytoprostane 
treatment using the Arabidopsis thaliana whole genome microarray are presented 
and discussed in the following chapters. The effect of PPB1s and analogues on the 
growth of several plant pathogens, the influence of certain PPB1s on lima bean 
volatile emission and the effect on intracellular calcium levels after PPB1 treatment 
in tobacco suspension cells are shown. 
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3.2 Bioactivity tests 
 
3.2.1 DNA microarrays 
 
3.2.1.1 Introduction to the microarray technology83 
 
A microarray, or DNA chip, is a collection of microscopic DNA spots attached to 
a solid surface, such as glass, plastic or silicon. It enables researchers to monitor 
the entire genome, or parts of it, on a single chip. With it, researchers can have a 
better picture of the interactions among thousands of genes simultaneously 




Figure 16. Representative scanner-picture (of a phytoprostane hybridisation) of the Agilent ATH3 
Arabidopsis array (44.000 spots). 
 
The microarray technology evolved from southern blotting, whereby fragmented 
DNA is attached to a substrate and then probed with a known gene or fragment. 
Measuring gene expression by using microarrays is relevant in many research 
fields of biology and medicine. Differences in transcription patterns of different 
tissues and differences on the genomic level can be monitored. For example, 
microarrays can be used to identify disease genes by comparing gene expression 
in diseased and normal cells. 
There exists a difference between protein- and nucleic acid microarrays. Proteins 
(mostly antibodies) must be cleaned first or directly synthesised before they can 
be coupled to a biochip. Aminosilane-biochips belong to the class of planar 
biochips, useful for nucleic acids or proteins. The aminosilane surface has a 
positive charge and allows an unspecific, non-covalent coupling with a negatively 
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charged amino acid end of a peptide or protein. This electrostatic interaction is 
called unspecific adsorption and the spatial distribution of the bound 
macromolecules is unpredictable. A covalent alternative is achieved by using 
planar aldehyde surfaces. The reactive aldehyde group is coupled onto the chip 
surface and primary amines of peptides or proteins can bind to form covalent C=N 
double bonds (Schiff’s bases) with elimination of water. The spatial distribution is 
again random. Besides such planar biochips, two and three dimensional structures 
exist, where the glass is coated with thin layers of polymer membranes. Protein 
biochips have several disadvantages compared to nucleic acid chips. They require 
complex cleaning and amplification steps and are not very stable in isolated forms. 
On so-called nucleic acid microarrays, normally DNA or sometimes RNA is 
bound to the surface. The DNA is the target for hybridisation partners. Nucleic acid 
mircoarrays are subdivided into two large groups; the oligonucleotide and the 
“classical” DNA- or PCR-microarrays. On oligonucleotide arrays, short, single 
stranded DNA fragments are bound, whereas on the classical ones, longer nucleic 
acid chains are fixed.  
Today, different methods exist to produce DNA-microarrays. Arrays are being 
distinguished between the so-called on-chip or in situ synthesis of oligonucleotides 
directly on the glass surface and the deposition arrays, where cDNA or 
oligonucleotides are presynthesised and then deposited onto the surface of the 
array. There exist commercially available designs from companies, such as GE 
Healthcare, Affymetrix, Ocimum Biosolution or Agilent, covering complete 
genomes.  
Such DNA microarrays can be used to detect RNAs that may or may not be 
translated into active proteins. Scientists refer to this kind of analysis as 
expression analysis or expression profiling. Since there can be tens of thousands 
of distinct probes on an array, each microarray experiment can accomplish the 
equivalent number of genetic tests in parallel. 
The principle of microarray detection is mostly based on the measurement of 
fluorescence intensities, but also radioactive markers are applied. Fluorophores, 
such as cyanine dyes, are bound to the free nucleotides, and after interaction of 
both partners a specific fluorescence signal can be detected. The detection with a 
microarray scanner allows the visualisation of up-regulated and down-regulated 
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genes. The method has the drawback that the absolute levels of gene expression 
cannot be observed, but only one chip is needed per experiment.  
 
In this work, an Agilent microarray design was applied, which uses an in situ 
synthesised 60-mer oligonucleotide technology representing the full Arabidopsis 
thaliana genome (all predicted and verified coding regions and small mRNAs). The 
extracted total RNA was amplified and fluorescently labelled. Therefore, one 
sample from phytoprostane treated plants was labelled with cyanine 5 (excited by 
a 633 nm laser) and a second sample, the water negative control, labelled with 
cyanine 3 (excited by a 532 nm laser). A primer containing a polymerase promoter 
was annealed to the RNA and a reverse transcriptase synthesised the first and 
second strands of cDNA. Then, cRNA was synthesised from the double-stranded 
cDNA using a RNA polymerase. When labelling was complete, samples were 
hybridised to the microarray, which means the cRNA was attached to the 
complementary strands of the fixed oligonucleotides on the array by hydrogen 
bonds. Genes whose expression differs between the two samples were detected 
and identified by laser scanning. Afterwards, the data were analysed using the 




Figure 17. Principle of the amplification, labelling and hybridisation of extracted RNA. 
 
 
3.2.1.2 First results of the Agilent Arabidopsis whole genome array 
 
The application of microarrays for studying biological activities of certain 
chemicals on the genomic level becomes more interesting for researchers. Within 
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this work, first details of the effect of selected phytoprostanes (PPs) on gene 
expression in Arabidopsis thaliana plants are given and partly analysed. 
Leaves of this model plant were either treated with 1 mM, 100 μM or 10 μM 
aqueous solutions of synthesised PPB1s or their analogues. After 9 h, leaves were 
harvested, immediately frozen in liquid nitrogen and the total RNA was extracted. 
Due to the time-consuming and highly expensive microarray technology, only 
three compounds out of the variety of synthesised PPs and analogues, with 
promising biological activity, were selected. The extracted total RNA was 
amplified, labelled, hybridised on the microarray and scanned. Samples of treated 
leaves after application of 100 μM PPB1 type I (22a) and II (22b) and the type I 
ketone (65a) in comparison to a water control were used on the array in two 
replicates. A 1 mM concentration of the ketone (65a) was used to study the effect 
of higher concentrations on gene expression. The whole Arabidopsis genome 
contains about 29.000 annotated genes. This fact makes a complete data analysis 
of the array rather complex and therefore just the 100 most up- or down-regulated 
genes were selected for analysis. Lists of those genes are attached in the 
supplementary material. 
 
Looking at the performed microarray data analysis in total, a general stress 
induced answer can be seen. The Arabidopsis plants reacted strongly under the 
influence of the PPs. The 1 mM treatment resulted in an up-regulation of about 
1800 genes, whereas about 2000 genes were down-regulated. In response to the 
applied 100 μM concentrations, still about 800 genes were up- and about 1500 
were down-regulated. Genes with relative expression levels higher than 1.8 fold 
for up-regulation and more than 0.6 fold for down-regulation compared to the 
untreated controls were considered. It turned out to be difficult to distinguish 
between the PP-induced answers, because several answers overlapped and at a 
certain point also toxic effects of too high concentrations might have occurred, a 
fact that is also common for other phytohormones. Reactive oxygen species 
(ROS) are known as highly toxic molecules depending on their nature and 
concentration, but are also involved as important signalling molecules that control 
various processes in higher plants, including pathogen defence, programmed cell 
death and stomatal behaviour.84 Similar to this phenomenon, PPs might also be 
toxic for plants in higher concentrations. Additionally, it is not possible to judge 
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how much of the externally applied PPs were actually transported into the tissue. 
Although elicitor-specific concentrations of 1 mM or 100 μM were applied in this 
bio-assay, it might be possible that only 10 percent were actually taken up by the 
plant. To statistically support expression differences of individual genes, at least 
four replicates have to be employed. With only two replicates used in this assay, 
there might be a large variation in response to the PPs. 
 
Application of 1 mM PPB1 type I ketone 65a 
It remains unclear, whether the strong answer after application of 1 mM 65a is 
due to the activity of the PP itself or is just a general stress-induced answer of the 
plant because of the toxicity of this high concentration. A number of up-regulated 
genes (see Figure 18) indicate a more general stress answer. Heat shock proteins 
and glutathione S-transferases were highly up-regulated after application of a 1 
mM concentration of 65a. These genes are often connected with and also up-
regulated in response to increased environmental stress.  
If plants are exposed to elevated temperatures, the expression of so-called heat 
shock proteins (HSP) is increased.85  Production of high levels of heat shock 
proteins can also be triggered by exposure to different kinds of environmental 
stress conditions, such as infection, inflammation, starvation, water deprivation or 
exposure of the cell to certain toxins. Consequently, heat shock proteins are 
implicated with or even referred to as stress proteins and their upregulation is 
sometimes described more generally as part of the plant’s response to 
environmental stress. Many of these heat shock proteins function as molecular 
chaperones. They play an important role in protein-protein interactions such as 
folding and assisting in the establishment of proper protein conformation. By 
helping to stabilise partially unfolded proteins, HSPs aid in transporting proteins 
across membranes within the cell.  
Glutathione S-transferases (GSTs) are enzymes that catalyse the nucleophilic 
attack of the tripeptide glutathione on lipophilic cytotoxins with electrophilic 
centres. Thus, their fundamental function in plants is the detoxification of 
endogenous and xenobiotic compounds.86 GSTs have been intensively studied for 
their role in herbicide metabolism and selectivity.87 Besides the formation of 
glutathione-conjugates, GSTs may also act as peroxidases by catalysing the 
reduction of hydroperoxy fatty acids into less toxic hydroxy fatty acids, thus 
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protecting cells from oxygen toxicity. GSTs may be implicated in many plant 
physiological processes. They are differentially regulated in response to certain 
biotic or abiotic stresses and can be induced upon pathogen attack or fungal 
elicitors,88 in response to treatment with hydroperoxides,89 mechanical wounding 
and insect feeding,90 heavy metals,86 heat schock and plant hormones, such as 
ethylene,91 auxin,92 methyl jasmonate and salicylic acid,93 and abscisic acid.94 
Consequently, GSTs play an important role in plant growth and development and 
are linked to many phytohormone activities.  
Applying 65a at 1 mM, the expression levels of certain pathogenesis- or defence-
related genes and several enzymes belonging to the class of cytochrome P-450 
(Figure 18) were also affected. But again, there is no evidence that PPs are 
involved in specific plant defence reactions, although some genes linked to 
defence were up-regulated. 
Pathogenesis related (PR) proteins have been defined as proteins induced by 
various types of pathogens, such as viruses, bacteria, fungi or by the application of 
certain chemicals mimicking the effect of pathogen infection.95 The induction of PR 
gene expression during pathogen infection is mediated by various signalling 
molecules. Salicylic acid and reactive oxygen species (ROS) mediate the 
expression of acidic PR genes,96 whereas ethylene and methyl jasmonate mediate 
basic PR genes.97 PR proteins are known to have antifungal activity and some of 
them are glucanases or chitinases degrading fungal cell wall components. Other 
PR proteins are referred to as thaumatin- or osmotin- like proteins, leading to lysis 
of spores, inhibition of hyphal growth or reduction of spore germination.98,99 
Resistance to a pathogen is often correlated with a hypersensitive response (HR), 
a localised induced cell death at the site of infection. Pathogenesis related proteins 
are involved in systemically acquired resistance and stress response in plants, 
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Figure 18. Several up- or down-regulated Arabidopsis genes in response to 65a treatment in 1 mM 
concentration and their proposed metabolic function. The 100 most up- or down-
regulated genes are listed in the supplementary material. 
 
Cytochrome P-450 (Cyt P-450) enzymes are a superfamily of haem-containing 
mono-oxygenases that are found in all kingdoms of life, and which show 
extraordinary diversity in their reaction chemistry.100 They are regarded as soluble 
or membrane-bound oxygenases that are able to perform hydroxylation reactions. 
These enzymes play an important role in many essential biotransformations in 
mammals, such as the biosynthesis of steroids, the arachidonic acid metabolism 
or the transformation of xenobiotics. In plants, these proteins are important for the 
biosynthesis of several compounds such as hormones, defensive compounds and 
fatty acids. Cyt P-450 enzymes are involved in the plant’s secondary metabolism 
and have been implicated in several biosynthetic pathways leading to the 
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synthesis of lignin phenolics, membrane sterols, phytoalexins and terpenoids.101 It 
has been shown that plants have evolved highly specific Cyt P-450-linked 
secondary pathways to produce defence-related phytoalexins. Many Cyt P-450 
enzymes are expressed in response to pathogenesis and are involved in 
detoxification of herbicides. 
 
Many auxin-responsive proteins (Aux/IAA) were down-regulated after treatment 
with 1 mM PP-analogue 65a. Aux/IAA genes were identified as members of a 
family of genes that were rapidly induced in response to auxin.102 They can 
regulate many of the developmental processes governed by auxin. Recent 
findings indicate that repression of auxin signalling contributes to antibacterial 
disease resistance.11 Thus, down-regulation of auxin-responsive proteins by PPs 
might contribute to the plant’s defence against pathogens. 
 
The performed microarray showed that certain disease-resistant proteins were 
up-regulated, whereas many auxin-responsive proteins were down-regulated, 
suggesting more or less regulatory functions for PPs during disease resistance of 
higher plants. It is likely to propose a role of PP compounds in the stress-induced 
answering cascade of higher plants; their exact function, however, remains 
uncertain. It is also unknown whether these compounds are mainly positively or 
negatively involved in plant stress responses. Interestingly, there was a substantial 
amount of overlap of PPB1-induced gene expression compared with the 
microarray performed by Müller et al.36 Several GSTs, HSPs and Cyt P-450s were 
identified to be up-regulated in response to PPB1 treatment, similar to the present 
results. However, a direct comparison is not possible, since Müller used 
Arabidopsis callus cultures and a custom-designed mini microarray, encoding for 
only 626 defence- and pathogenesis-related proteins. It is expected, that the 
applied PP concentrations to the callus cultures might have also been too high and 
thus were toxic for the plant. Performing such microarray analyses should always 
include preliminary tests to determine the correct concentration barriers for 
application and it is necessary to known how much of the applied substances will 
really reach the plant’s inside. 
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Application of 100 μM PPB1 type I (22a), type I ketone (65a) and type II (22b) 
The response to 100 μM PP concentrations was not a clear general stress 
answer as for the 1 mM concentration. Several prominent genes were up- or 
down-regulated and even opposed regulation as compared to the 1 mM treatment 
occurred. No large differences were obvious between the PPB1 type I (22a), the 
corresponding ketone 65a and the type II (22b). Looking solely at the quantity, 
type II (22b) was perhaps a bit more active than type I (22a) and its ketone 65a. 
Qualitatively no substantial differences were visible. Therefore the expression 
rates of all three treatments were combined and analysed together.  
The dominant gene families, up-regulated in response to 1 mM PP 
concentration, such as heat shock proteins, glutathione S-transferases, 
pathogenesis-related and cytochrome P-450 proteins, only played a minor role in 
response to lower elicitor concentrations. This suggests that the gene expression 
levels after PP treatment are extremely dependent on the applied concentration. It 
could not be tested whether the 100 μM PP-concentrations might have been too 
low for a specific answer, or if PPs represented only by-products of lipid 
metabolism without important defence-related function. 
Some prominent genes regulated by lower PP concentrations should be 
mentioned here. The ribonuclease 1 (RNS1) was strongly up-regulated in 
response to 100 μM PP concentrations, whereas in response to 1 mM application 
there was only a minor induction visible. RNases have been postulated to 
accumulate in response to wounding or pathogen attack in tomato and 
tobacco,103,104 thus contributing to the control of fungal invasion. In Arabidopsis, 
the RNS1 transcript accumulates in both wounded and systemic but unwounded 
leaves.105 The regulation of these activities by wounding was independent of JA 
(7) and oligosaccharides, indicating a novel, not yet identified wound signalling 
pathway. PPs might probably be involved in such a JA-independent pathway. 
PPF1 (24) compounds have been shown to occur after wounding in peppermint 
leaves,28 and all PP classes have been connected with oxidative stress. It has to 
be further studied, if those PPs are minor or even major components involved in 
oxidative stress reactions caused by wounding. 
Other highly up-regulated genes after PP application to Arabidopsis leaves were 
β-amylases. These are the key enzymes for starch degradation106 and are 
regulated as a consequence of stress, caused by phytohormone activity107 or 
46  Results and discussion 
 
   
abiotic factors.108 In contrast to PPs, gibberellic acid (3) did not enhance β-
amylase activity, and abscisic acid (5) even inhibits its activity. Interestingly, after 1 
mM PP application, the amylase activity was also down-regulated. 
Another prominently up-regulated gene in this array was the Arabidopsis Touch 
4 gene. Its gene expression is regulated by auxin (1) and brassinosteroids, by 
environmental stimuli, and during development.109 It encodes a xyloglucan 
endotransglucosylase/hydrolase that affects cell wall-modifications in response to 
environmental stress and growth. After 1 mM PP application, this enzyme was 
down-regulated. 
Lipid transfer protein 4 (LTP4) was up-regulated by lower, and down-regulated 
by higher applied PP concentrations. LTPs are small, basic and abundant proteins 
in higher plants.110 They are capable of binding fatty acids and of transferring 
phospholipids between membranes in vitro. Their biological function is presently 
unknown, but they have been suggested to participate in the defence of plants 
against pathogens. 
Arabinogalactan-proteins (AGP) were also up-regulated in response to 100 μM 
PP concentration, but down-regulated after 1 mM concentration. AGPs are widely 
distributed in plants and are involved in growth and developmental processes, in 
cell signalling and programmed cell death.111 It was found, that these enzymes 
allow Agrobacterium to rapidly reduce the systemic acquired resistance response 
during infection.112 
In response to the applied low PP concentrations, vegetative storage protein 
(VSP) 1 and 2 were also strongly up-regulated, whereas in response to 1 mM 65a 
both were down-regulated, indicating that there is high concentration dependence 
for expression of these types of genes. VSPs are synthesised and accumulated in 
cell vacuoles, which are well supplied with carbon and nitrogen to be used for 
growth and development of organs.113 Their mRNAs are inducible in developed 
leaves by various environmental stresses, such as water deficiency.114 
Additionally, VSP genes in Arabidopsis thaliana can be regulated by wounding, 
treatment with MeJA (8) or coronatine (63).115 
 
Based on the collected data, it becomes obvious that PP treatment leads to 
down-regulation of certain proteins involved in flowering. MAF5, MAF4 and FLC 
genes were significantly down-regulated. The Arabidopsis FLOWERING LOCUS 
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C (FLC) gene is a key floral repressor in the maintenance of a vernalisation 
(induction of flowering in response to a long cold period) response.116 But MAF5 is 
upregulated by vernalisation and could therefore play an opposite role to FLC. 
Overexpression of MAF3 or MAF4 produces alterations in flowering time that 
suggest that these genes also act as floral repressors and might contribute to the 
maintenance of a vernalisation requirement. 
Several proteins involved in chlorophyll binding were also down-regulated. These 
proteins bind non-covalently to chlorophyll and harvest light energy for 
photosynthesis.117 Similar to the PP activity in Arabidopsis, abscisic acid (5) 
repressed chlorophyll binding protein expression in soybean.118 
 
Whether PPs are involved in plant defence reactions, are metabolites of JA-
independent pathways or play a role in detoxification responses, cannot be 
concluded from the microarray data. It could just be demonstrated, that PPs might 
be involved in several wounding processes and might somehow be related to 
phytohormones and phytohormone activities. Using the GeneSifter software, 
functional classifications of the expressed genes can be made by means of 
statistical analysis. Figure 19 shows a diagram of regulated genes involved in 
response to a stimulus (47 %), physiological processes (20 %), cellular processes 




Figure 19. Functional classification of phytoprostane-regulated genes. 
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Figure 20. Classification of regulated genes in response to a stimulus. 
 
The response to a stimulus can be further separated into endogenous stimulus 
(38 %), chemical stimulus (34 %) and other abiotic or biotic stimuli and stress 
responses (Figure 20).  
Such endogenous or chemical responses can be further split into defined stimuli, 
belonging to responses of hormones (71 %), salicylic or jasmonic acid (7) (10 % 
and 9 %) and other chemical substances (Figure 21). These results suggest that 
the genes induced as a plant response to PPs and JA (7) are not closely related. 
The correlation of PPs to the response of other phytohormones is much higher, as 
it can be seen in Figure 22. Especially auxin-responsive genes seem to be 
affected by PPs. 
 




Figure 22. Classification of regulated genes in response to phytohormone stimulus. 
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Generally, PPs might be able to mimic the expression of certain genes being 
connected with phytohormone activities or to those being regulated by wounding 
of the plant or pathogenesis. However, due to the limited number of biological 
replicates in this bioassay, final conclusions on the absolute effect of PPs on plant 
cells could not be drawn. 
 
 
3.2.2 Phytoprostanes and antimicrobial tests 
 
Antibiotic activity is known from several oxylipins, such as 13-ketotrienoic acid or 
12-oxo-phytodienoic acid (9).119 Many of these oxylipins were active against 
several pathogens, including bacteria, fungi or oomycetes by inhibiting in vitro 
growth. Since phytoprostanes occurred in high levels after infection with the 
fungus Botrytis cinerea34, it needs to be tested, if they are able to act directly 
against such microorganisms. Recent results showed,120 that levels of PPF1s (24) 
and several other non-enzymatically formed oxylipins increased after infection with 
Pseudomonas syringae, indicating that there exists a non-enzymatic lipid oxidation 
component in the plant response to pathogens. 
In this chapter, first results of an agar diffusion test121 are presented, by applying 
the synthesised test substances to different bacterial plant pathogens. The 
influence on fungi or oomycete growth was not tested.  
To test growth inhibition of synthetic PPs, the following plant pathogens were 
selected: Pseudomonas syringae, Ervinia amylovora, Erwinia carotovora and 
Xanthomonas campestris. The pathogen-induced plant diseases are shown in 
Figure 23. 
 
bacterial strain disease 
Pseudomonas syringae soybean blight, producer of coronatine 
Erwinia amylovora fire blight of Rosaceae 
Erwinia carotovora soft rot of many vegetables 
Xanthomonas campestris black rot of crucifers 
 
Figure 23. Diseases of higher plants caused by certain pathogens. 
 
50  Results and discussion 
 
   
For the agar diffusion test, PPB1s and analogues were applied at concentrations 
of 20 mM. These concentrations are very high but give first hints for the inhibitory 
activity. Synthetic substrates were used as ethanolic solutions. They were put into 
punched 8 mm wells of agar minimal medium plates, where the bacteria were 
growing on. After 48 h incubation time, the diameters around the wells were 
measured (Figure 24). Based on these results, further dilutions of the PPs were 





Figure 24. Agar diffusion test of applied PPs, using different bacterial strains. Inhibition zones 
around the wells were compared. 
 
Two unsaturated ketotrienoic acids, 9-,13-KOTE, served as positive, pure 
ethanol as a negative control. First measurements with high concentrations (20 
mM) of synthesised PPs and their analogues showed no influence on growth of P. 
syringae, E. carotovora and X. campestris. At this concentration, the substrates 
only inhibited the growth of E. amylovora. Therefore, this plant pathogen, the so-
called fire-blight bacteria, was used in further experiments. Fire blight is a bacterial 
disease of apples and pears, killing blossoms, shoots, limbs and sometimes, even 
whole trees. Especially in warm und humid regions, the bacterium spreads 
immediately by building out drops of bacterial ooze (Figure 25). First step to 
overcome and manage the incidence of fire blight is the removal of the source of 
infection. Chemical control is achieved by applying copper salts on the outer 
surfaces of infected trees or by antibiotic treatment at blooms. But since this 
disease is relatively widespread and some strains of the pathogen are already 
resistant against certain antibiotics, more effective biological weapons have to be 
developed. 
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Figure 25. Symptoms of rosaceae 
plants after infection with the fire-blight 







For investigating the influence of synthesised PPs and analogues on the growth 
of E. amylovora, higher dilutions of the test substances were applied. Based on 
these results, a prediction of structure-function relationships seems to be possible. 
Figure 26 shows the applied substances at different concentrations and the 
resulting inhibition zone diameters. 
The inhibition zones after applying both ketotrienoic acids were generally about 
one third higher than those of the synthesised compounds (data not shown). 
Except for the synthesised analogues with non-functionalised side chains 64a-c, 
all tested substrates were active in a concentration of about 10 mM. The non-
functionalised analogues 64a-c just showed small inhibition zones at 
concentrations higher than 10 mM (data not shown). After applying lower 
concentrations of 2 and 1 mM, a trend was visible, showing that only the ketones 
65a-c, the acetylenic analogues 66a-c and the O-alkyl ethers 67a-c of all three 
types were still active. Interestingly, all compounds of type I and III were less 
active than those of type II, a fact that corresponds with the bio-activity of PPB1 
type II (22b) on secondary metabolite induction.36 The oxygen atom in the ω-side 
chain seems to be important for the antimicrobial activity of certain PPs. 
Analogues containing no oxygen 64a-c were not active at all. The highest activity 
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Figure 26. Resulting diameters of inhibitions zones [mm] after treatment of Erwinia amylovora 
strains with different concentrations of PPs and analogues. 
 
PPs were produced after treatment of plants with heavy metal solutions.28 
Treatment of tobacco cell suspensions with high concentrations of copper salts 
lead to a high amount of dead cells.36 Preincubation of the cells with B1-PPs (22) 
extremely reduced the mortality. This indicates that PPs increase the plant’s 
capability to detoxify lipid peroxidation products. Interestingly, the fire-blight 
disease is chemically treated with copper salts, suggesting that there might be a 
connection between the copper treatment and induced PP accumulation leading to 
defined defence or repair mechanisms of the infested plants. How and to which 
extend PPs are able to act against such microorganisms, is still not known. 
Perhaps they induce the production of signal molecules subsequently inducing 
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defence gene expression or regulating localised cell death, known as 
hypersensitive response. This is a powerful tool for plant defence mechanisms 
against pathogens.122 It causes necrosis and cell death to restrict the growth of the 
infesting pathogen. Cells undergoing the hypersensitive response produce 
reactive oxygen species, such as peroxides or radicals.123 As known from 
literature, PPs are formed as a result of free radical formation or as consequence 
of enhanced oxidative stress caused by peroxides and induce the synthesis of 
antimicrobial secondary metabolites.35 Copper as a heavy metal itself also 
stimulates ROS124 and PP formation.28 But the reason why synthesised B1-PPs 
(22) were only active against E. amylovora, is still not clear. Moreover, why the 
corresponding diketones 65a-c were more active than the natural occurring PPs 
22a-c, is also not known. Perhaps during oxidative stress, the hydroxy function 
could be further oxidised to an oxo group, creating a perfect Michael-acceptor 
system that might then be responsible for the enhanced activity. To test the 
acetylenic analogues 66a-c on their inhibitory effect on the growth of E. amylovora 
appeared to be interesting, since these metabolites were the most active ones. It 
is not surprising, that these acetylenic metabolites 66a-c play a role in acting 
against microorganisms. Previously, it has been reported, that several 
hexadecadiynoic or nonadecadiynoic acids display potent antifungal activities.125 
Acetylenic compounds are found in plants, fungi, microorganisms and marine 
invertebrates. Natural occurring aquatic acetylenes are of particular interest, since 
some display important biological activities and have antitumor, anticancer, 
antibacterial and antimicrobial properties.126 Most include an α-acetylenic hydroxy 
or keto group, similar to the synthesised compounds 66a-c. Whether the 
antimicrobial activity is based on the electrophilic nature of those compounds or on 
the interaction with specific cellular targets, is not known. Previously it was been 
shown, that different oxylipins, including an electrophilic unit, like OPDA (9) and 
KOTE, have antimicrobial activity, whereas JA (8) did not affect bacterial 
growth.119 It is also not clear, why the synthesised O-alkyl ethers 67a-c do inhibit 
bacterial growth better than their corresponding natural occurring PPs 22a-c.  
Such agar diffusion tests are good methods for giving first hints of the inhibitory 
effects of synthetic substrates on microbial growth, but are not reliable for 
investigating exact functions of those chemicals. Other methods have to be taken 
into account. 
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3.2.3 Phytoprostanes and volatile emission (indirect defence) 
 
Higher plants have developed efficient strategies for indirect defence. The 
emission of volatiles is one of the most interesting strategies to cope with a variety 
of environmental stresses the plant is confronted with each day. The plant reacts 
with the emission of a specified volatile pattern, which might serve a a signals for 
long distance interactions with neighboured uninfected plants or to guide different 
predatory wasps or flies to their prey.5 
There exist different methods for measuring plant emitted volatiles.127  
 
The zNose (Figure 27) is a portable miniaturised GC, 
including a short column for separation. It is equipped 
with a small Helium bottle and can be used easily for 
field experiments. With the zNose, collection of kinetic 








Figure 27. zNose instrument during volatile collection. 
 
The method of closed-loop stripping (Figure 28) is limited to laboratory work. It 
serves as the routine method for measuring volatile patterns due to treatments of 
different plants with different elicitors. Plant leaves are placed into water solutions 
of the elicitor. With small pumps, volatiles are 
circulated and absorbed onto charcoal traps. After a 
certain time period, the filters are eluted with 
dichloromethane and the volatiles measured with 
GC/MS. Compounds are identified via their retention 






Figure 28. Closed-loop stripping method on lima bean plants. 
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Solid phase micro extraction (SPME) (Figure 29) 
uses a silica fibre with a non-volatile polymer, such as 
polydimethylsiloxane. The SPME fibre is directly 
inserted to the headspace of a sample and afterwards 
into the injector of the GC/MS, where the volatiles can 









Figure 29. Volatile collection using SPME. 
 
To test the influence of the synthesised PPs and analogues as elicitors for 
volatile emission from lima bean leaves (Phaseolus lunatus), the closed-loop 
stripping method was applied. But the results proved to be less satisfactory. In 
some cases there was an induction of volatile emission upon treatment and in 
some none. This fact made it hard to correctly evaluate the results. The free acids 
of substrates 22a,b, 64a,b, 65a,b, 67a,b (after hydrolysis using porcine pancreas 
lipase) were tested for their ability to induce specific volatile biosynthesis in lima 
bean plants. 1 mM aqueous solutions of the synthesised PPs and analogues were 
applied to the plants over a time period of 48 h. But due to the low amount of 
replicates, there were no conclusive results. Figure 30 shows a volatile pattern 
that was most often emitted after treatment with the test substances. No specific 
differences in the emitted volatile patterns, which could be listed to different 
structural properties of the applied PPs, could be detected. The peaks at around 
6:56 and 12:62 minutes represent the two homoterpenoids 4,8-dimethylnona-
1,3,7-triene (DMNT) (68) and 4,8,12-trimethyltrideca-1,3,7,11-tetraene (TMTT) 
(69) and the peak at 7:64 is the methyl ester of salicylic acid (MeSa) (70). DMNT 
(68) and TMTT (69) originate from degradation products of the tertiary terpenoid 
alcohols nerolidol and geranyllinalool. 
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Figure 30. General volatile emission pattern after treatment of lima bean leaves with different 
synthesised PPs. 
 
Both PPB1 types showed a rather weak activity when compared to the released 
volatile patterns after treatment with JA (8), OPDA (9) or coronalon (62).76,128 The 
volatile pattern largely corresponded to the volatiles observed upon treatment of 
lima bean leaves with several microbial elicitors. The channel-forming peptaibol 
alamethicin is an antibiotic, which forms voltage-dependent three-dimensional 
structures in membranes that act as ion channels. Alamethicin is also able to 
induce the emission of ethylene (6) and other volatiles.129 The same volatiles, like 
after PP treatment, namely DMNT (68), TMTT (69) and MeSa (70), were emitted. 
JA (8) treatment induced a more complex mixture including other terpenoids, such 
as ocimene, linalool and caryophyllene.128 OPDA (9) in low concentrations induced 
DMNT (68) and TMTT (69), whereas in higher concentrations a more complex 
spectrum similar to JA (8) was induced. Mechanical wounding, caused by 
treatment of the lima bean plant with MecWorm also induced a complex mixture of 
fatty acid derived volatiles and different terpenoids. This mode of treatment was 
sufficient to induce the emission of a volatile blend qualitatively similar to that as 
known from real herbivore feeding.130 Taken together these results indicate, that 
PPs might not be relevant for plant-herbivore interactions, but appear to play some 
kind of role in plant-pathogen reactions. The corresponding volatile pattern 
suggests the ability of PPs to act similar to microbial elicitors. The plant is able to 
answer microbial infections with a variety of different defence mechanisms to limit 
the pathogen attack or to inhibit their growth. B1-PPs were able to inhibit the 
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growth of the plant pathogen E. amylovora and induced, at least in some cases, 
the emission of volatiles resembling the effect of channel-forming microbial 
elicitors. This could be a first hint of those chemicals being involved in 
antimicrobial defence reactions. 
 
 
3.2.4 Phytoprostanes and Ca2+-dependent signalling 
 
The importance of calcium as a “second messenger” in animal cells is known for 
long time, but its regulative function in plant cells has gained more attention during 
the last years.131,132 The general mode of action of Ca2+ is through a change in its 
intracellular concentration. After a certain stimulus, the messenger system 
interacts with the membrane and opens channels that allow a transient Ca2+ influx 
from external space. Usually, the intracellular concentration of Ca2+ is maintained 
at low levels. There is an increasing number of Ca2+-mediated processes in plant 
life. It is for instance involved in polarised cell growth, mitosis and cytokinesis.133 
Ca2+ also acts as a “second messenger” in plants by triggering light-stimulated 
responses, such as germination,134 peroxide secretion135 or membrane 
depolarisation.136 Calcium also interacts with certain phytohormones; e.g. 
gibberellic acid (3) and abscisic acid (5) regulate cytoplasmatic calcium in 
barley.137 
As a result of increasing interest on calcium signatures in plants, a practical 
approach to follow such signatures based on the non-invasive aequorin 
technology has been published.138 Aequorin is a Ca2+-binding photoprotein, first 
isolated from the luminescent jellyfish. It is composed of two distinct units, the 
apoprotein apoaequorin, with an approximate molecular weight of 22 kDa, and the 
prosthetic group coelenterazine (71) (molecular weight 472). It belongs to the so-
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Figure 31. Aequorin as a light-emitting molecule, consisting of apoaequorin and coelenterazine 
(71). 
 
In the presence of molecular oxygen the two components of aequorin reconstitute 
spontaneously. The protein contains three Ca2+-binding sites. When Ca2+ occupies 
these sites, the protein undergoes a conformational change and converts through 
oxidation its prosthetic group, coelenterazine (71), into excited coelenteramide 
(72) and CO2. As the excited 72 relaxes to the ground state, blue light with a 
wavelength of 469 nm is emitted (Figure 32). The emitted light can be detected 





















Figure 32. Light emission by relaxation of coelenteramide (72) to the ground state. 
 
Within this work, the cytosolic and nucleoplasmatic calcium concentrations in two 
different plant systems, transgenic tobacco and soybean cells, were examined. 
Therefore, tobacco cells were exposed to a biotic stimulus, the type II PPB1 (22b), 
and the calcium concentration based on the described aequorin system was 
measured. Additionally, soybean cells were treated with both types of PPB1 
(22a,b), but only the cytosolic calcium concentrations were investigated. Ethanol 
served as negative control and 1 or 2 mM ethanolic solutions were applied. The 
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aequorin light emission was detected with a luminometer using a calibration curve 
for quantification of the Ca2+ concentration.  
The addition of PP 22b to tobacco cells in both concentrations resulted in a rapid 
increase of luminescence indicating an increase in the intracellular calcium 
concentration in the cytosol as well as in the nucleus (Figure 33, 34). The maximal 
concentration of intracellular calcium after the addition of 1 and 2 mM PPB1 type II 
(22b) in the cytosol was found to be approximately 0.5 μM after about 30 sec. In 
the nucleus, the free calcium concentration was detected to be much higher, for 2 
mM PPB1 type II (22b) 2.4 μM after about 25 min and for 1 mM 22b 1.94 μM after 
about 49 min.  
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Figure 33. Intracellular cytosolic Ca2+-concentration (average of 3 measure-ments) after PPB1 type 
II (22b) treatment of tobacco cells. For 2 mM 22b the highest Ca2+-level is 0.54 μM, for 
1 mM 22b 0.49 μM, both after about 30 sec. 
 
The Ca2+-concentrations in the nucleus reached their maximum later than in the 
cytosol and were much higher. The time difference of the maxima in the cytosol 
was negligible at both concentrations, whereas in the nucleus it was more than 20 
minutes. The PP treatment in the cytosol led to a sharp increase in the 
concentration of free calcium and also to a sharp decrease, while in the nucleus 
the in- and decrease were more steady over a longer period. 
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nuclear Ca2+ concentration after treatment with PPB1 type II
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Figure 34. Intracellular nuclear Ca2+-concentration (average of 3 measurements) after PPB1 type II 
(22b) treatment of tobacco cells. For 2 mM 22b the highest Ca2+-level is 2.4 μM, for 1 
mM 22b 1.94 μM. 
 
This resulting transient increase in the cytosolic calcium levels in tobacco could 
be confirmed in the tested soybean cell cultures. The curves looked similar for 
both types of PPB1 (22a,b), although type II (22b) led to a slightly higher calcium 
concentration than type I (22a). In soybean, the basic level of calcium seemed to 
be somewhat higher than in tobacco, so the concentration maxima after addition of 
PPB1s showed a slight increase in comparison to tobacco (data not shown). 
Hence, treatment of transgenic tobacco or soybean cells with PPB1 showed an 
increase of intracellular free calcium levels. In the cytosol, the calcium answer was 
faster than in the nucleus. In plants, an increase in cytosolic calcium 
concentrations has been reported in response to certain external stimuli, such as 
light,139 oxidative stress,140 hormones and different elicitors.141 Thus, calcium 
seems to mediate many processes in plant growth and development and of 
course, in plant defence. The key role of Ca2+ in the signalling pathways received 
particular attention in the field of plant defence against pathogens.142 Large and 
sustained calcium influx triggers numerous reactions in plant-pathogen 
interactions, such as the activation of membrane depolarisation, production of 
reactive oxygen species, MAPK activation, protein phosphorylation, nitric oxide 
production, and defence gene activation and cell death.133 The way this second 
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messenger acts in special cases has been the focus of intense research for many 
years. 
 
The increase of intracellular Ca2+-levels by PPs is consistent with the results 
obtained from the antimicrobial and the volatile emission test. It was shown that 
PPB1s could be active against the plant pathogen Erwinia amylovora. Additionally, 
synthetic PPs did not induce the emission of herbivore-specific volatiles in lima 
bean. It might be possible that PPs play a role in plant-pathogen interactions. In 
which special way PPs act, if they are perhaps mediators of pathogen-related 
answers or if they have a direct impact on pathogen recognition, signal 
transduction and defensive gene activation leading to cell death, is not known from 
those tests. A first microarray analysis showed that high concentrations of PPB1s 
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4 Summary and perspectives 
 
During their whole lifetime, plants are exposed to a variety of stresses. Plants 
have either adapted to such stress or have developed effective strategies to 
overcome and fight against it. Phytohormones are known as key intermediates of 
such signalling pathways, but unfortunately, our knowledge on detailed recognition 
mechanisms and their mode of action is quite limited. Particularly, the influence of 
oxidised fatty acid-derived phytoprostanes is not fully understood. 
This work was envisaged to contribute to a better understanding in the field of 
phytoprostane activity in higher plants. By developing efficient synthetic strategies 
of selected phytoprostanes and analogues thereof and by performing selected 
bioassays with these synthesised compounds, the presented work provides helpful 
suggestions for further studies in this interesting field of natural product chemistry. 
 
Development of a short and effective synthesis to B1-phytoprostanes 
In recent years, several syntheses of phytoprostanes (PPs) have been 
developed,51-54,59 requiring many steps and providing only low overall yields. 
Within this work, a short and effective synthetic method was developed to 
generate phytoprostanes of the B1-series with less synthetic effort and in high 
overall yields. Based on the previously published protocol to 
tetrahydrodicranenone B by Lauchli et al.,61 a flexible approach was designed to 
allow the preparation of a whole spectrum of compounds. By using only two key 
operations to introduce different side chains with different lengths and degrees of 
functionalisation, a number of B1-PPs types (22a-c) and various analogues thereof 
(64-67 a-c) became rapidly accessible. 
Cyclopentanedione (55) served as a multi-functional precursor for a number of 
syntheses. 55 was first mono-alkylated at C2 with substituents of different chain 
lengths (54a-c). Followed by an iodination, several oxocyclopentenyl iodides (53a-
c) were generated, that could be then coupled with various side chains under 
Heck- or Sonogashira-like reactions (Figure 35). Furthermore, it was shown, that 
this protocol is also applicable for synthesis of chiral products. 
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Figure 35. General protocol for the synthesis of B1-PPs and several analogues with different C3-
side chains. 
 
 PPB1 type I  PPB1 type II  DIPB1 type III 
R1 (CH2)6COOMe CH3 (CH2)3COOMe 
R2 CH2CH3 (CH2)7COOMe (CH2)4CH3 
 
This general and flexible synthetic protocol might be useful for synthesising 
additional analogous compounds of PPs. Such analogues could have different 
degrees of functionalisation also in the C2-side chains. Also heterocyclic 
analogues, similar to prostaglandin heteroanalogues,67 could be generated to 
examine structure-function relationships. An additional ring-oxygen might also 
increase the biological activity of those compounds. 
 
Phytoprostanes induce gene expression in Arabidopsis thaliana 
Together with Dr. H. Vogel from the Department of Entomology, the influence of 
selected PPs on inducing gene expression in Arabidopsis thaliana plants was 
investigated. The total RNA of treated leaves was extracted, amplified, labelled, 
and hybridised on the Agilent microarray, representing the whole Arabidopsis 
genome. After applying a 1 mM aqueous solution of PPB1 type I ketone 65a to the 
plant, more than 1800 genes were up- and about 2000 down-regulated. In 
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response to lower (100 μM) concentrations of PPB1 type I (22a), II (22b) and type I 
ketone (65a), still about 800 genes were up- and 1500 down-regulated. 
The gene expression levels in response to the 1 mM application showed a 
general stress induced answer, which might be in part a result of the toxicity of 
compound 65a in this non-physiological concentration. Several heat shock 
proteins (HSPs), glutathione-S-transferases (GSTs) and cytochrome P-450 
enzymes (Cyt P-450s) were significantly up-regulated indicating a response typical 
for increasing environmental stress. The up-regulation of certain pathogenesis-
related (PR) proteins after 65a treatment might suggest a more specific response 
to pathogens. Many auxin-responsive genes were noticeably down-regulated, 
supposing that PPs and auxin-related answers are differentially regulated within 
the plant. 
Treatment of the plant with PP-compounds 22a,b and 65a in 100 μM 
concentrations led to a more selective gene expression. In comparison to the 1 
mM assay several prominent genes were even regulated to the opposite. The up-
regulation of many prominent genes, such as ribonuclease 1 (RNS1), lipid transfer 
protein 4 (LTP4), arabinogalactan-proteins (AGPs) or vegetative storage proteins 
(VSP1,2) by PPs suggests a role of PPs in defence responses to pathogens or 
wounding and supports the correlation with other phytohormones. 
By statistical analyses, only a functional classification of the expressed genes 
was possible. Thus, PPs can be associated with a response to a certain stimulus, 
mainly a hormone stimulus. PPs induced the expression of genes that were also 
regulated by other phytohormones, especially by auxins.  
 
For further studies it might be helpful to determine the actual concentration within 
the plant cells prior to assays. This could be done by measuring the non-absorbed 
PP material by washing it from the leave surface prior to RNA extraction. 
This microarray was performed with only two replicates, which was not sufficient 
to allow statistical support. For this, at least four replicates are essential that will 
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Phytoprostanes inhibit the growth of Erwinia amylovora 
In cooperation with Dr. B. Völksch from the Department of Microbiology of the FSU 
Jena, the direct antimicrobial effect of synthesised PPB1s on several pathogens 
was studied. An agar diffusion test with different concentrations of the PPs was 
performed. The synthesised PPs were only active in inhibiting the growth of the 
plant pathogen Erwinia amylovora, whereas the growth of Pseudomonas syringae, 
Erwinia carotovora and Xanthomonas campestris was not prevented by PPs in the 
agar medium. The ketones 65a-c, the acetylenes 66a-c and the O-alkylethers 
67a-c, all derivatives of natural occurring B1-phytoprostanes, showed the highest 
activity even in lower (1 mM) concentration ranges. 
This direct antimicrobial effect, even though only found against one of the 
chosen bacterial strains, supports the conclusion from the microarray analysis, 
that PPs could be involved in certain plant responses to stress, especially against 
pathogens. Perhaps PPs are only mediators formed during the course of infection, 
but they could also have a primary function in pathogen defence reactions, such 
as inducing localised cell death to restrict the spread of the infecting pathogen. 
 
Phytoprostanes do not induce herbivore-typical volatiles in lima bean 
To test the effect of synthesised PPs on the induction of volatile emission in lima 
bean, plants were treated with 1 mM aqueous solutions of the free acids of 22a,b, 
64a,b, 65a,b, 67a,b. Using the closed-loop-stripping method, the PP-induced 
volatiles could be collected and analysed by GC/MS. 
The results after different repeats varied; ranging from no induction to the 
release of volatile patterns similar to those after treatment with microbial elicitors, 
such as alamethicin. PPs do not induce herbivore-specific volatile patterns, 
indicating no significance for plant-herbivore interactions. 
 
Phytoprostane treatment leads to an increase of intracellular calcium 
levels in tobacco and soybean 
 
In cooperation with A. Walter from the Botanical Institute of the LMU München, the 
impact of PPB1 type II (22b) on changing cytosolic and nucleoplasmatic Ca2+-
concentrations was studied. Therefore, transgenic tobacco or soybean cell 
cultures were stimulated with this elicitor and the concentration changes were 
measured using luminescence.138 Treatment of tobacco cells with 1 mM or 2 mM 
66  Summary and perspectives 
 
   
22b showed a transient increase of Ca2+- levels in the cytosol as well as in the 
nucleus. The cytosolic Ca2+-increase could also be monitored in soybean cultures. 
The increase of cytosolic Ca2+- reached its maximum of about 0.5 μM within about 
30 sec, whereas in the nucleus, the concentration maximum was visible after 
several minutes, but turned out to be much higher (~ 2.0-2.4 μM). 
A similar intense and long-lasting Ca2+-influx is involved in several plant-
pathogen interactions.123 The transient elevation of cytosolic calcium is necessary 
for stimulation of reactive oxygen species (ROS) that might act as direct toxicants 
to pathogens, leading to defensive gene activation and phytoalexin accumulation, 
which might finally induce programmed cell death. 
PPs have been identified as markers of oxidative stress in plants, being 
connected with enhanced formation of ROS. This fact and their ability to induce 
strong intracellular Ca2+-influx might suggest that those metabolites might be 
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5 Zusammenfassung 
 
Im Verlauf ihres Lebens sind Pflanzen verschiedenen Stressfaktoren ausgesetzt, 
an die sie sich entweder anpassen oder gegen die sie sich durch Entwicklung 
effektiver Verteidigungsstrategien zur Wehr setzen müssen. Eine zentrale Aufgabe 
kommt dabei den Phytohormonen oder phytohormon-ähnlichen Substanzen als 
wichtigen Signalsubstanzen zu. Jedoch ist das Wissen auf dem Gebiet spezieller 
Erkennungsmechanismen derartiger Verbindungen noch unvollständig. Besonders 
die Rolle der Phytoprostane als neue fettsäure-abgeleitete Substanzen ist nicht im 
Detail geklärt.  
Die vorliegende Arbeit soll zu einem besseren Verständnis der biologischen 
Relevanz von Phytoprostanen dienen. Durch die Entwicklung effizienter 
Synthesestrategien zu ausgewählten Phytoprostanen und deren Analoga, sowie 
durch die Durchführung gezielter biologischer Experimente mit synthetischen 
Substanzen, ist diese Arbeit als hilfreiche Grundlage für weitere wissenschaftliche 
Studien mit Phytoprostanen zu sehen. 
 
Entwicklung einer kurzen und effektiven Synthesestrategie zu  
B1-Phytoprostanen 
 
In den letzten Jahren wurden einige Totalsynthesen zu verschiedenen 
Phytoprostanklassen beschrieben, welche aber meist viele Syntheseschritte 
beinhalteten und zu geringen Gesamtausbeuten führten.51-54,59 
Im Rahmen dieser Doktorarbeit wurde eine kurze und effektive 
Synthesestrategie entwickelt, um Phytoprostane (PP) der B1-Klasse in wenigen 
Schritten und guten Gesamtausbeuten zu generieren. Auf dem von Lauchli et al.61 
veröffentlichten Protokoll zum Tetrahydrodicranenone B basierend, wurde eine 
flexible Route erarbeitet, über die eine Vielzahl von Verbindungen hergestellt 
werden konnte. Dabei sind lediglich zwei Schlüsselschritte nötig, um Seitenketten 
verschiedener Länge und Funktionalität in das Cyclopentandion-Grundgerüst 
einzuführen. Es wurden Verbindungen vom Typ I, II und III des PPB1 (22a-c) und 
zahlreiche strukturelle Analoga (64-67 a-c) hergestellt. 
Cyclopentandion (55) erwies sich dabei als multifunktionelle synthetische 
Vorstufe. Zunächst wurde 55 an C2 mit unterschiedlichen Kettenlängen mono-
alkyliert (54a-c), anschließend ins Hydroxycyclopentenyl-Iodid (53a-c) überführt, 
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um danach mit verschiedenartigen Seitenketten mittels Heck- oder Sonogashira-
Reaktionen gekoppelt zu werden (Abbildung 1). Diese Syntheseroute konnte 




































Abbildung 1. Allgemeine Syntheseübersicht für PPB1 Verbindungen und entsprechende 
Strukturanaloga. 
 
 PPB1 Typ I  PPB1 Typ II  DIPB1 Typ III 
R1 (CH2)6COOMe CH3 (CH2)3COOMe 
R2 CH2CH3 (CH2)7COOMe (CH2)4CH3 
 
 
Phytoprostane induzieren Genexpression in Arabidopsis thaliana 
In Zusammenarbeit mit Dr. H. Vogel aus der Abteilung Entomologie des MPICOE 
wurde die Wirkung verschiedener PP auf die Genexpression in Arabidopsis 
thaliana Pflanzen untersucht. Dazu wurde die RNA von behandelten Blättern 
extrahiert, amplifiziert, markiert und auf einem Agilent Microarray hybridisiert. Eine 
Behandlung der Pflanze mit einer 1 mM wässrigen Lösung vom PPB1-I Keton 
(65a) führte zu einer Hochregulierung von ca. 1800 Genen und zu einer 
Herunterregulierung von ca. 2000 Genen. Selbst geringere applizierte 
Konzentrationen (100 μM) von 22a,b und 65a zeigten noch, dass ca. 800 Gene 
hoch- und 1500 herunterreguliert wurden. 
Zusammenfassung  69 
    
Als Reaktion auf die 1 mM Zugabe wurde eine generelle stress-induzierte 
Antwort der Pflanze provoziert, die eventuell auch auf eine zunehmende Toxizität 
der applizierten Substanz 65a in derartig hohen Konzentrationen schließen lässt. 
Dabei wurden zahlreiche Heat-Shock Proteine (HSPs), Glutathion-S-Transferasen 
(GSTs) und verschiedene Cytochrom P-450 Enzyme (Cyt P-450) signifikant 
hochreguliert. Die Hochregulierung einiger Pathogenese-verwandten Gene (PRs) 
deutet auf eine spezifischere Antwort der Pflanze in Verbindung mit 
Pathogenbefall hin. Hingegen wurden einige Auxin-zugeordnete Gene durch 65a 
merklich herunterreguliert. 
Die Zugabe geringerer Konzentrationen von 22a,b und 65a führte zu 
selektiveren Expressionmustern; einige prominente Gene wurden sogar 
entgegengesetzt zur Behandlung mit 1 mM reguliert. Die Hochregulierung 
bestimmter Gene, welche die Ribonuclease 1, das Lipid-transfer Protein 4, 
verschiedene Arabinogalactan-Proteine oder vegetative Storage-Proteine 
codieren, deutet weiterhin auf Rolle von PP innerhalb der pflanzlichen 
Verteidigung gegen Verwundung oder Pathogenbefall hin and bestätigt deren 
Wirkungsverwandtschaft zu anderen Phytohormonen. 
Da mittels der Microarray-Technologie allein keine detaillierten Informationen zur 
biologischen Funktion von PP erhalten werden können, wurde eine Klassifizierung 
vorgenommen, die auf eine Wirkungsverwandtschaft der getesteten PP zu 
anderen Pflanzenhormonen hindeutet. Dabei ließ sich besonders eine Verbindung 
zum Auxin herstellen und es kann vermutet werden, dass PP bei der pflanzlichen 
Verteidigung, eventuell auch gegen Pathogene, aktiv sind und eine Stressantwort 
der Pflanze hervorrufen. 
 
Phytoprostane verhindern das Wachstum von Erwinia amylovora 
In Zusammenarbeit mit Dr. B. Völksch vom Institut für Mikrobiologie der FSU Jena 
wurden Hemmhofmessungen nach Applikation von synthetischen PP zu 
verschiedenen Indikatorstämmen durchgeführt. Die untersuchten PP waren 
lediglich gegen den Feuerbranderreger Erwinia amylovora unmittelbar aktiv. 
Verschiedene Konzentrationen der Verbindungen zeigten deutlich, dass 
besonders die zu den natürlich vorkommenden PPB1 analogen Ketone 65a-c, die 
Acetylene 66a-c und die O-Alkylether 67a-c wachstumsinhibierende Wirkung 
aufweisen.  
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Dieser Test kann als Hinweis angesehen werden, dass PP eine Rolle bei der 
pflanzlichen Verteidigung gegen Mikroorgansimen, hier Pflanzen-pathogene, 
spielen. 
 
Phytoprostane induzieren kein herbivoren-spezifisches Duftmuster in 
Limabohnen 
 
Um die Wirkung von PP auf die Emission spezifischer Duftstoffe zu testen, wurden 
Limabohnen mit 1 mM Konzentrationen verschiedener PP (22a,b, 64a,b, 65a,b, 
67 a,b) behandelt. Unter Anwendung der etablierten Closed-loop-stripping 
Methode wurden die von der Pflanze emittierten Duftstoffe gesammelt und mittels 
GC/MS analysiert. 
Nach Applikation verschiedener PP und Analoga konnte jedoch keine genaue 
Aussage über die Wirkung dieser Verbindungsklasse getroffen werden. Teilweise 
wurde ein Duftmuster ähnlich dem nach Applikation des mikrobiellen Elizitors 
Alamethicin erhalten, in einigen Fällen konnte jedoch keinerlei Duft detektiert 
werden. Vermutlich spielen PP daher keine Rolle bei der pflanzlichen Verteidigung 
gegen Herbivoren. 
 
Phytoprostane bewirken einen intrazellulären Calciumionenanstieg in 
Tabak und Soja 
 
In Zusammenarbeit mit A. Walter vom Botanischen Institut der LMU München 
wurde die Wirkung von PPB1-II (22b) auf Konzentrationsänderungen von 
zyosolischem und nukleoplasmatischem Calcium untersucht. Mit Hilfe von 
Lumineszenzmessungen138 konnte die Wirkung in transgenen Tabak- und Soja-
Zellkulturen getestet werden. In beiden Pflanzen konnte ein starker Anstieg der 
Calciumkonzentration verzeichnet werden. Das zytosolische Calcium erreichte 
seinen Maximalwert von ca. 0.5 μM nach wenigen Sekunden, wohingegen im Kern 
erst nach mehreren Minuten ein stärkerer, dauerhafter Anstieg (~ 2.0-2.4 μM) 
sichtbar wurde. 
Von einem ähnlich starken, lang anhaltenden Calciumioneneinstrom wurde bei 
bestimmten Pflanzen-Pathogen-Interaktionen berichtet.123 Ein erhöhter 
Calciumionenfluss ist notwendig, um reaktive Sauerstoffspezies (ROS) zu 
generieren, die dann ihrerseits direkt gegen Pathogene wirken können. Es werden 
bestimmte verteidigungsspezifische Gene reguliert, die zur Aktivierung 
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verschiedener Phytoalexine beitragen, was schlussendlich zum programmierten 
Zelltod  und damit zur Verteidigung der Pflanze führt. 
PP wurden mit erhöhten ROS-Pegeln assoziiert und als Marker von oxidativem 
Stress identifiziert. Dies und das Verursachen starker intrazellulärer 
Calciumeinströme durch PP-Applikation könnten weitere Hinweise darauf sein, 
dass PP im engen Zusammenhang mit der pflanzenspezifischen Verteidigung 
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6 Experimental part 
 
6.1 General methods and instruments 
 
6.1.1 Synthetic methods 
 
Melting points 
Melting points of solids were recorded on a BÜCHI Melting apparatus Point B-540. 
 
Fourier Transform Infrared Spectroscopy (FT-IR) 
IR-Spectra were recorded with a Bruker Equinox 55 FT-IR. Solids were measured 
as KBr plates, liquids as a film between two ZnS plates. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
NMR-spectra were recorded with a Bruker Avance DRX 500 or Bruker AV 400. 
Chemical shifts are given in ppm and coupling constants J in Hz. The solvent 
signal of DCCl3 was used for calibration: 1H NMR δ = 7.26 ppm, 13C NMR δ = 
77.16 ppm. 
 
Electronic Ionisation Mass Spectrometry (EI-MS) 
High resolution mass spectrometry was performed by direct injection of the sample 
on a double focussing magnetic sector mass spectrometer. For GC-MS (70 eV) a 
DB5 column was used (15 m × 0.25 mm, 0.25 μm), He served as carrier gas. 
 
Specific rotation 
Specific rotations were measured on a Jasco P-1030 Polarimeter based on the 
equation [α] = (100 × α) / (l × c), where the concentration c is in g/100 ml of 
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Chromatography 
Silica gel (Si 60, 0.2-0.063 mm, VWR International GmbH) was used for flash 
chromatography. TLC plates (Si 60, F254, Merck) were used for analytical 
chromatography. 
 
Solvents and chemicals 
Solvents for syntheses were purchased from Sigma-Aldrich as p.a. grade or as 
dried over molecular sieves. Solvents for chromatography were purchased from 
VWR International GmbH or KMF Laborchemie Handels GmbH. Selected 
chemicals were obtained from specified providers. 
 
 
6.1.2 Biomolecular methods 
 
Treatment of the Arabidopsis thaliana plants 
Arabidopsis thaliana ecotype Columbia (Col-0) seeds were purchased from 
Nottingham Arabidopsis Stock Centre and cultivated in Vötsch-chambers under 
11.5 h light conditions (20 °C, 50 % humidity, 80 % light) and 12.5 h under dark 
conditions (16 °C, 50 % humidity). After 5 weeks, one leaf each plant was treated 
with a 1 mmol, 100 μmol or 10μmol aqueous solution of the phytoprostanes or 
their analogues in two repeats. After 9 h under continuous light conditions, the 
leaves were immediately harvested and shock-frozen in liquid N2. Water-treated 
leaves served as negative control. 
 
RNA extraction of the Arabidopsis thaliana leaves 
General procedure for RNA-extraction: 
• Grind frozen plant material in liquid N2, put 2 spatula-points in an Eppendorf 
tube  
• Add 1 ml TRIzol Reagent (Invitrogen, Carlsbad, CA), collect on ice, vortex, 
leave 10-20 min at rt 
• Add 120 μl 1-bromo-3-chloropropane, vortex for 20 s, leave 15-20 min on 
ice 
• Centrifuge 15 min at full speed, pipette off the upper phase 
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• Add 500 μl propan-2-ol, vortex, leave over night at -20 °C  
• Centrifuge 30 min at 4°C at full speed, discard the supernatant 
• Add 0.8 ml 80 % ethanol, centrifuge 10 min at full speed, discard 
supernatant, centrifuge, pipette off the rest of the solvent, dry ~ 10 min 
• Add 90 μl RNA storage solution, heat 30 min at 55 °C, centrifuge 
• Add 10 μl TURBO DNAse buffer and 1 μl DNAse (TURBO DNAse, 
Ambion), incubate 30 min at 37 °C 
• Use the RNeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany) for 
further cleaning (procedure is written in the handbook) 
• Determine RNA quantity spectrophotometrically 
• Verify RNA integrity on an Agilent 2100 Bioanalyser using RNA Nano chips 
(Agilent) 
 
Agilent Arabidopsis 3 arrays 
The content on the Arabidopsis 3 microarray is derived from the ATH1 v.5 
database of The Institute for Genomic Research (TIGR) and from the Arabidopsis 
MPSS database at the University of Delaware. Nearly 40,000 features (60-mer 
oligonucleotides) represent full genome coverage of Arabidopsis thaliana (28,500 
annotated genes from TIGR) and more than 10,000 unannotated transcripts from 
University of Delaware (Arabidopsis MPSS website). 
 
Amplification, Labelling and Hybridisation 
Total RNA was amplified using the Agilent low input linear amplification kit 
according to the process outlined by the manufacturer (Agilent Technologies). 1-5 
µg of amplified target cRNA was labelled with either cy5 or cy3 using the 
Micromax kit (Perkin Elmer). The labelled material was passed through zymo RNA 
Clean-up Kit-5 columns (Zymo Research Corporation, CA) to remove any surplus 
label and eluted in 15-20 µl of RNAse-free water (Ambion, Austin, TX). 
Concentration of labelled cRNA and label incorporation was determined by 
Nanodrop-1000 spectrophotometer analysis. All of the labelling and post labelling 
procedures were conducted in ozone-free enclosure to ensure the integrity of the 
label. Labelled material was setup for fragmentation reaction according to the 
Agilent protocol described in their processing manual and hybridised overnight in 
the rotating oven at 60° C in an ozone-free chamber. Wash conditions were as 
Experimental part  75 
    
outlined in the Agilent processing manual and arrays were scanned using the 
Agilent G2565BA fluorescent microarray scanner. Agilents feature extraction 
software (Version 7.5) was used for extracting array data. Further analysis was 
done using Rosetta Luminator and GeneSifter software. 
 
 
6.1.3 Microbiological methods 
 
The inhibitory activities of the toxins (compounds, substances) were evaluated by 
an agar plate diffusion test using following strains; Ervinia amylovora, 
Xanthomonas campestris, Pseudomonas syringae, Escherichia coli, Bacillus 
subtilis, Erwinia carotovora. The test plates (130 mm in diameter) contained 50 ml 
agar-minimal medium to which 2 ml of the bacterial suspension (A578nm = 1) were 
added. 50 or 100 µl of the toxin solution (different dilutions) were added into wells 
(8 mm in diameter) in the agar plates. After 48 h incubation at 28 °C, the test 
plates were checked for inhibition zones around the wells. 
 
 
6.1.4 Volatile emission tests 
 
Lima bean plants 
Induction experiments were performed with plantlets of the Lima bean Phaseolus 
lunatus (Ferry Morse cv. Jackson Wonder Bush). Individual plants were grown 
from seeds in a plastic pot (Ø = 5.5 cm) at 23  C and 80 % humidity using daylight 
fluorescent tubes at about 270 μE m2 s−1 with a light phase of 14 h. Experiments 
were conducted with 14 day-old seedlings showing two fully developed leaves 
 
Induction experiments 
Test solutions of the synthetic compounds were made in tap water at 1 mM 
concentration. Plantlets of P. lunatus were cut with razor blades and immediately 
transferred into 5 ml vials containing the test solution. These were enclosed in 
small desiccators (750 ml) and maintained at room temperature for 24 h. On top of 
the desiccators, small pumps containing a charcoal trap were put. Air was 
continuously circulated through the closed system and the released volatiles were 
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absorbed on the trap (closed-loop stripping). Experiments were started in the 
afternoon and the light dark cycle completed as above. Control experiments were 
conducted under identical conditions by placing freshly cut plantlets into pure tap 
water. All experiments were carried out on 3 plants. 
 
Collection and analysis of headspace volatiles 
The volatiles emitted from the plants were collected continuously on small 
charcoal traps (1 mg charcoal, CLSA-Filter, Le Ruisseau de Montbrun, F-09350 
Daumazan sur Arize, France) over a period of 24 h using air circulation as 
described. After desorption of the volatiles from the carbon trap with 2 × 20 μl of a 
solution of 1-bromodecane (internal standard, 200 μg/ml) in dichloromethane. The 
extracts were directly analysed by GC/MS instrument. The instrument was 
equipped with an Alltech EC-5 capillary (15 m × 0.25 mm × 0.25 μm). Helium at a 
constant flow (1.5 ml min-1) served as carrier gas. Samples were automatically 
injected with a split ratio of 1:10; the injector temperature was adjusted to 220 °C. 
Separation of the compounds was achieved under programmed conditions (40 °C 
for 2 min, 10 °C min−1 to 200 °C, 30 °C min−1 to 280 °C, hold for 2 min). The 
transfer line was set to 270 °C. Filament emission current was 250 μA with an ion 
source temperature of 200 °C. Individual compounds were analysed by their 
retention time and by matching against reference spectra. Their peak area was 






The transformed tobacco (Nicotiana tabacum L. cv BY-2) suspension cells were 
grown under agitation (130 rpm) at 25 °C in darkness in Linsmaier & Skoog (LS) 
medium supplemented with 30 g l-1 of sucrose and 1 mg ml-1 of 2,4-
dichlorophenylacetic acid, pH 5.8. Subculturing was done every 2 weeks with a 2 
% inoculum of a 14 days old culture. The cell suspension cultures of soybean 
(Glycine max L., line 6.6.12) expressing apoaequorin were grown at 22 °C under 
constant light conditions (3,000 lux) on a rotary shaker (125 rpm) in Murashige & 
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Skoog medium supplemented with 5 g l-1 sucrose, 1 mg l-1 α-naphthylacetic acid, 
and 0.2 mg l-1 kinetin, pH 5.8. 
 
Construction of nucleus-targeted apoaequorin  
This preparation was done according to Mithöfer et al.129 
 
Luminescence measurements  
Aequorin light emission was measured using a digital luminometer (Bio Orbit 1250, 
Turku, Finland). BY-2 cells were collected by filtration during the exponential 
growth phase, washed with fresh medium and resuspended at a 20% packed cell 
volume in fresh medium. In vivo reconstitution of the aequorin was performed by 
incubating an appropriate volume of washed cells with 2.5 µM of coelenterazine 
(Calbiochem, Bad Soden, Germany) under agitation for at least 3 hrs. A variable 
amount (50 µl to 100 µl) of reconstituted cells were transferred to a luminometer 
cuvette and luminescence was recorded every second during the experiment. 
Typically, the luminescence was monitored until the base-line luminescence was 
reached. At the end of the experiment, the remaining reconstituted aequorin was 
estimated by discharging by addition of an equal volume of 100 mM CaCl2 
containing 10 % ethanol (v/v) and 2 % Nonidet P-40(v/v). The emitted light 
expressed as RLUs (Relative Luminescence Units) was calibrated as Ca2+ 
concentrations by a method based on the calibration curve of Allen et al:  
[Ca2+] = {(L0/Lmax)1/3 + [KTR(L0/Lmax)1/3] – 1}/{KR – [KR(L0/Lmax)1/3]},  
where L0 is the luminescence intensity per second and Lmax is the total amount of 
luminescence present in the entire sample over the course of the experiment. 
[Ca2+] is the calculated Ca2+ concentration, KR is the dissociation constant for the 
first Ca2+ ion to bind, and KTR is the binding constant of the second Ca2+ ion to 
bind to aequorin. The luminescence data were determined using the KR and KTR 
values of 2 x 106 M-1 and 55 M-1, respectively, calculated by van der Luit et al. 
using native coelenterazine and the specific aequorin isoform that were used in 
these experiments. For soybean, transgenic 6.6.12 cell lines were used to 
reconstitute aequorin in vivo with 10 mM synthetic coelenterazine on a shaker 
(125 rpm) in the dark for up to 24 hrs. The Ca2+-specific luminescence 
measurements were performed at room temperature in a final volume of 100 µl 
containing 5-10 mg (fresh mass) of reconstituted cell suspension culture. Again, 
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the residual aequorin was completely discharged and the resulting luminescence 
was used to estimate the total amount of aequorin present in various experiments 
in order to determine the rate of aequorin consumption. This enabled us to 
calculate the cytosolic Ca2+ concentrations. According to Moyen et al. the equation 
was used:  
pCa = 0.332588(-log k) + 5.5593  
where k is a rate constant equal to luminescence at any time point divided by total 
remaining luminescence counts. In each experiment, the concentration of 
reconstituted aequorin was not limiting under any of the experimental conditions, 





6.2.1 O-alkylation of cyclopentane-1,3-dione 55 (general 
procedure):  
 







To a solution of cyclopentane-1,3-dione (55) (3.14 g, 32 mmol, 1 equiv) and 
pyridine (2.6 ml, 32 mmol, 1 equiv) in 150 ml of absolute dichloroethane was 
added methyl 7-(chlorocarbonyl)heptanoate (5 ml, 35.2 mmol, 1.1 equiv) in 75 ml 
of absolute dichloroethane. The mixture was kept at rt for 20 h. It was then washed 
with water, diluted HCl, saturated NaHCO3 and water again. After drying over 
Na2SO4, the solvent was removed on a rotary evaporator and the 
chromatographically pure enol ester 58a was obtained as a light yellow solid (8.4 
g, 98 %). Mp: 44-47 °C. IR ν (cm-1): 1776 (C=O), 1731 (C=O). 1H NMR (500 MHz, 
CDCl3) δ: 1.31-1.42 (m, 4H), 1.6-1.73 (m, 4H), 2.31 (t, J=7.5 Hz, 2H), 2.42-2.45 
(m, 2H), 2.52 (t, J=7.4 Hz, 2H), 2.73-2.75 (m, 2H), 3.66 (s, 3H), 6.21 (s, 1H). 13C 
NMR (125 MHz, CDCl3) δ: 24.3, 24.8, 28.7, 28.8, 28.9, 33.4, 34.0, 34.5, 51.6, 
116.6, 169.3, 174.2, 179.7, 206.9. EI-MS: [M+H]+• 268 (1), 171 (100), 139 (63), 
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125 (3), 111 (70), 99 (52), 83 (82), 74 (11), 69 (69), 59 (25), 55 (91). HR-MS calcd 
for C14H20O5 (M+•) 268.131074, found: 268.130173. 
 






Synthesised from 2 g (20.4 mmol) cyclopentane-1,3-dione (55), 1.64 ml (20.4 
mmol) pyridine, 100 ml absolute dichloroethane, 3,7 g (22.4 mmol) methyl 4-
(chlorocarbonyl)butanoate in 50 ml absolute dichloroethane. Yield: 4.53 g (98 %), 
yellow oil. IR ν (cm-1): 1782 (C=O), 1737 (C=O). 1H NMR (500 MHz, CDCl3) 
δ:1.98-2.04 (m, 2H), 2.41-2.45 (m, 4H), 2.62 (t, J=7.22 Hz, 2H), 2.73-2.75 (m, 2H), 
3.68 (s, 3H), 6.21 (m, 1H). 13C NMR (125 MHz, CDCl3) δ:19.7, 28.9, 32.7, 33.4, 
33.6, 51.9, 116.7, 168.7, 173.2, 179.7, 206.9. EI-MS: [M-31]+• 195 (13), 167 (13), 
129 (100), 101 (57), 69 (11), 59 (42), 55 (21). HR-MS calcd for C10H11O4 ([M-31]+•) 
195.065734 (-CH3O), found: 195.065903. 
 
 
6.2.2 O-C-isomerisation of the enol esters 58a,b (general 
procedure):  
 








To a solution of methyl 3-oxocyclopent-1-enyl octanedioate (58a) (6 g, 22.4 mmol, 
1 equiv) in 60 ml of absolute CH3CN was added triethylamine (4.4 ml, 31.3 mmol, 
1.4 equiv) and acetone cyanohydrine (0.8 ml, 9 mmol, 0.4 equiv). The mixture was 
stirred at rt for 24 h and then treated with 100 ml of diluted HCl. After extraction 
with 3 x CHCl3, the combined organic extracts were washed with water, dried over 
Na2SO4 and evaporated (yellow solid, 5.53 g, 92 %). Mp: 51-53 °C. IR ν (cm-1): 
1737 (C=O), 1703 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.28-1.4 (m, 4H), 1.57-
1.66 (m, 4H), 2.29 (t, J=7.4 Hz. 2H), 2.48-2.51 (m, 2H), 2.72-2.75 (m, 2H), 2.89 (t, 
J=7.5 Hz, 2H), 3.65 (s, 3H). 13C NMR (125 MHz, CDCl3) δ:23.9, 24.8, 28.6, 28.9 
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(2C), 33.8, 34.1, 38.4, 51.6, 114.2, 174.3, 199.9, 201.8, 204.4. EI-MS: M+• 268 
(29), 250 (5), 237 (23), 218 (28), 195 (23), 167 (8), 153 (92), 140 (95), 125 (100), 
97 (20), 87 (17), 74 (12), 69 (32), 59 (11), 55 (32). HR-MS calcd for C14H20O5 
(M+•) 268.131074, found: 268.130988. 
 







Synthesised from 4 g (17.7 mmol) methyl 3-oxocyclopent-1-enyl glutarate (58b) in 
40 ml of absolute CH3CN, 3.5 ml (24.8 mmol) triethylamine, 0.65 ml (7.1 mmol) 
acetone cyanohydrine. Yield: 3.4 g (85 %), yellow solid. Mp: 35-37 °C. IR ν (cm-1): 
1735 (C=O), 1699 (C=O). 1H NMR (500 MHz, CDCl3) δ:1.94-2.0 (m, 2H), 2.39 (t, 
J=7.45 Hz, 2H), 2.49-2.51 (m, 2H), 2.74-2.76 (m, 2H), 2.97 (t, J=7.22 Hz, 2H), 
3.66 (s, 3H). 13C NMR (125 MHz, CDCl3) δ: 19.0, 28.3, 33.3, 33.7, 38.0, 51.7, 
114.5, 173.5, 199.9, 201.2, 203.7. EI-MS: M+• 226 (72), 208 (10), 195 (57), 166 
(74), 153 (98), 140 (25), 125 (100), 97 (22), 74 (39), 69 (58), 59 (28), 55 (60). HR-
MS calcd for C11H14O5 (M+•) 226.084124, found: 226.084606. 
 
 
6.2.3 Reduction of 59a,b (general procedure):  
 







To a solution of methyl 8-(2-hydroxy-5-oxocyclopent-1-enyl)-8-oxooctanoate (59a) 
(5 g, 18.7 mmol, 1 equiv) in 90 ml trifluoroacetic acid containing 1 % of lithium 
perchlorate was added in portions triethylsilane (8.9 ml, 56 mmol, 3 equiv). The 
mixture was left overnight at rt. The acid was distilled off and the residue was 
cooled and washed 3× with cold hexane. Then the residue was treated with 
CHCl3, filtered and evaporated (white solid, 4.21 g, 89 %). Mp: 91-93 °C. IR ν (cm-
1): 1739 (C=O). 1H NMR (500 MHz, CDCl3) δ:1.29-1.4 (m, 4H), 1.58-1.67 (m, 6H), 
2.29 (t, J=7.4 Hz, 2H), 2.49-2.52 (m, 2H), 2.72-2.75 (m, 2H), 2.89 (t, J=7.3 Hz, 
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2H), 3.65 (s, 3H). 13C NMR (125 MHz, CDCl3) δ:6.5, 6.9, 21.1, 25.0, 28.0, 29.1, 
29.2, 29.5, 30.6, 34.2, 51.7, 118.6, 174.8, 198.6. EI-MS: M+• 254 (27), 223 (27), 
181 (24), 153 (17), 139 (36), 125 (61), 112 (100), 99 (12), 83 (19), 74 (7), 69 (14), 
59 (10), 55 (41). HR-MS calcd for C14H22O4 (M+•) 254.151809, found: 254.152723. 
 







Synthesised from 2.5 g (11.1 mmol) methyl 5-(2-hydroxy-5-oxocyclopent-1-enyl)-
5-oxopentanoate (59c) in 55 ml trifluoroacetic acid containing 1 % of lithium 
perchlorate, 5.3 ml (33.2 mmol) triethylsilane. Yield: 1.94 g (83 %), white solid. Mp: 
126-128 °C. IR ν (cm-1): 1737 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.43-1.48 (m, 
2H), 1.58-1.64 (m, 2H), 2.18 (t, J=7.45 Hz, 2H), 2.34 (t, J=7.45 Hz, 2H), 2.55 (s, 
4H), 3.66 (s, 3H). 13C NMR (125 MHz, CDCl3) δ: 22.5, 24.4, 27.6, 31.0, 33.8, 35.7, 
51.7, 174.0, 177.4, 197.6, 198.7. EI-MS: M+• 212 (46), 181 (57), 152 (36), 139 
(100), 125 (53), 111 (67), 83 (22), 74 (17), 59 (29), 55 (40). HR-MS calcd for 
C11H16O4 (M+•) 212.104859, found: 212.104912. 
 
 
6.2.4 Iodination of C-alkylated cyclopentane-1,3-diones 54a-c 
(general procedure): 
 







To a solution of triphenylphosphine (3.5 g, 13.3 mmol, 1.125 equiv) in 120 ml of 
dry CH3CN was added iodine (3.4 g, 13.3 mmol, 1.125 equiv) in one portion. This 
slurry was stirred for 2 h at rt and methyl 8-(2-hydroxy-5-oxocyclopent-1-
enyl)octanoate (54a) (3 g , 11.8 mmol, 1 equiv) was added in one portion followed 
by immediate addition of triethylamine (1.8 ml, 13 mmol, 1.1 equiv). The resulting 
mixture was heated to 80 °C for 1h, stirred over night at rt and then heated again 
to 90 °C for 1h. Ether was added and the mixture was filtered and evaporated. The 
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residue was loaded onto a silica column using petrol ether / diethyl ether (1:2) as 
eluent (light yellow oil, 2.94 g, 68 %). IR ν (cm-1): 1737 (C=O), 1704 (C=O). 1H 
NMR (500 MHz, CDCl3) δ: 1.28-1.44 (m, 8H), 1.59-1.64 (m, 2H), 2.21-2.31 (m, 
4H), 2.49-2.51 (m, 2H), 2.98-3.0 (m, 2H), 3.65 (s, 3H). 13C NMR (125 MHz, CDCl3) 
δ:25.0, 27.3, 27.5, 29.1 (2C), 29.4, 34.2, 36.9, 39.3, 51.6, 133.9, 151.5, 174.4, 
202.5. EI-MS: M+• 364 (23), 333 (35), 291 (8), 249 (19), 237 (100), 222 (34), 205 
(84), 177 (11), 145 (18), 69 (13), 59 (27), 55 (43). HR-MS calcd for C14H21IO3 (M+•) 
364.053547, found: 364.054787. 
 




Synthesised from 4.5 g (17.9 mmol) triphenylphosphine in 150 ml dry CH3CN, 4.7 
g (17.9 mmol) iodine, 2 g (15.9 mmol) 2-ethylcyclopentane-1,3-dione (54b), 2.4 ml 
(17.5 mmol)  triethylamine, column: petrol ether / diethyl ether (1:1). Yield: 2.9 g 
(77 %), yellow oil. IR ν (cm-1): 1709 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.0 (t, J= 
7.55Hz, 3H), 2.25-2.3 (m, 2H), 2.5-2.52 (m, 2H), 2.97-3.0 (m, 2H). 13C NMR (125 
MHz, CDCl3) δ: 11.9, 21.1, 36.9, 39.3, 133.2, 152.6, 202.4. EI-MS: M+• 236 (100), 
127 (2), 109 (24), 81 (32). HR-MS calcd for C7H9IO3 (M+•) 235.969817, found: 
235.969070. 
 







Synthesised from 2.1 g (8 mmol) triphenylphosphine in 60 ml dry CH3CN, 2 g (8 
mmol) iodine, 1.5 g (7.1 mmol) methyl 5-(2-hydroxy-5-oxocyclopent-1-
enyl)pentanoate (54c), 1.1 ml (7.8 mmol) triethylamine. Yield: 1.82 g (82 %), 
yellow solid. Mp: 46-48 °C. IR ν (cm-1): 1739 (C=O), 1688 (C=O). 1H NMR (500 
MHz, CDCl3) δ: 1.43-1.49 (m, 2H), 1.61-1.67 (m, 2H), 2.25-2.28 (m, 2H), 2.33 (t, 
J=7.55 Hz, 2H), 2.5-2.52 (m, 2H), 2.98-3.0 (m, 2H), 3.66 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ: 24.8, 26.8, 27.2, 33.9, 36.9, 39.4, 51.7, 134.2, 151.0, 174.1, 202.4. 
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EI-MS: M+• 322 (14), 290 (49), 249 (72), 222 (15), 195 (15), 163 (84), 129 (54), 
115 (59), 100 (69), 87 (58), 59 (100), 55 (78). HR-MS calcd for C11H15IO3 (M+•) 
322.006597, found: 322.006295. 
 
 
6.2.5 Alkylation of the alkenyl iodides 53a-c (general 
procedure): 
 







A mixture of methyl 8-(2-iodo-5-oxocyclopent-1-enyl)octanoate (53a) (1.7 g, 4.7 
mmol, 1 equiv), tetrahydro-2-(pent-1-en-3-yloxy)-2H-pyran (1.3 g, 7.8 mmol, 1.67 
equiv)73 (prepared according to literature and used without chromatographic 
purification) and triethylamine (1.3 ml, 9.3 mmol, 2 equiv) with 120 mg of the 
palladium catalyst (mixture of palladium diacetate and triphenylphosphine, 1:2 
mole ratio) was heated to 100 °C in a small flask for 24 h. Diethyl ether was added 
and the insoluble compounds were filtered off. After evaporation, the residue was 
loaded onto a silica gel column using diethyl ether as eluent. For the protected 
alcohols the THP-group was first cleaved off by dissolving the residue in 42 ml of a 
4:2:1 mixture of acetic acid / THF / water and heating to 45 °C over night (white 
solid, 0.94 g, 65 % over two steps). Mp: 43-46 °C. IR ν (cm-1): 3338 (OH), 1734 
(C=O), 1673 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.98 (t, J=7.46 Hz, 3H), 1.25-
1.28 (m, 6H), 1.35-1.4 (m, 2H), 1.56-1.68 (m, 4H), 2.02 (1H, OH), 2.24-2.29 (m, 
4H), 2.4-2.42 (m, 2H), 2.63-2.65 (m, 2H), 3.65 (s, 3H), 4.24-4.28 (m, 1H), 6.25 (dd, 
J= 5.93, 15.68 Hz, 1H), 6.78 (d, J=15.87 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 
9.8, 23.1, 24.9, 25.7, 28.8, 29.0, 29.1, 29.4, 30.3, 34.0, 34.2, 51.6, 73.7, 124.2, 
140.1, 141.5, 163.3, 174.6, 209.8. EI-MS: M+• 322 (28), 304 (12), 291 (9), 273 
(16), 265 (51), 263 (50), 233 (100), 205 (28), 133 (26), 121 (29), 105 (21), 91 (32), 
79 (28), 59 (21), 55 (42). HR-MS calcd for C19H30O4 (M+•) 322.214410, found: 
322.212974. 
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OH O  
Synthesised from 1 g (4.2 mmol) 2-ethyl-3-iodocyclopent-2-enone (53b), 2.1 g (7.1 
mmol) methyl 9-(tetrahydro-2H-pyran-2-yloxy)undec-10-enoate,73,74 (synthesised 
from methyl 9-hydroxyundec-10-enoate according to literature in 93 % yield; used 
without chromatographic purification) 1.2 ml (8.5 mmol) triethylamine, 70 mg of the 
palladium catalyst (mixture of palladium diacetate and triphenylphosphine, 1:2 
mole ratio), dissolved in 28 ml of a 4:2:1 mixture of acetic acid/THF/water. Yield: 
0.94 g (69 %), yellow oil. IR ν (cm-1): 3430 (OH), 1737 (C=O), 1692 (C=O). 1H 
NMR (500 MHz, CDCl3) δ: 1.0 (t, J=7.55 Hz, 3H), 1.31-1.45 (m, 8H), 1.56-1.64 (m, 
4H), 1.84 (1H, OH), 2.27-2.31 (m, 4H), 2.4-2.42 (m, 2H), 2.62-2.64 (m, 2H), 3.65 
(s, 3H), 4.3-4.34 (m, 1H), 6.25 (dd, J=5.93, 15.68 Hz, 1H), 6.81 (d, J=15.68 Hz; 
1H) 13C NMR (125 MHz, CDCl3) δ: 13.6, 16.4, 25.0, 25.4, 25.7, 29.1, 29.3, 29.4, 
34.0, 34.2, 37.4, 51.6, 72.5, 123.9, 140.2, 142.9, 162.8, 174.4, 209.6. EI-MS: M+• 
322 (0.25), 304 (100), 273 (13), 189 (55), 175 (23), 161 (25), 133 (18), 119 (10), 
105 (18), 91 (20), 59 (4), 55 (10). HR-MS calcd for C19H30O4 (M+•) 322.214410, 
found: 322.214393. 
 







Synthesised from 0.5 g (1.6 mmol) methyl 5-(2-iodo-5-oxocyclopent-1-enyl) 
pentanoate (53c), 0.6 g (2.6 mmol) tetrahydro-2-(oct-1-en-3-yloxy)-2H-pyran,73 0.4 
ml (3.1 mmol) triethylamine, 35 mg of the palladium catalyst (mixture of palladium 
diacetate and triphenylphosphine, 1:2 mole ratio), dissolved in 14 ml of a 4:2:1 
mixture of acetic acid/THF/water. Yield: 0.26 g (52 %), yellow oil. IR ν (cm-1): 3435 
(OH), 1736 (C=O), 1689 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.9 (t, J=7.1 Hz, 
3H), 1.29-1.38 (m, 4H), 1.4-1.47 (m, 4H), 1.57-1.64 (m, 4H), 1.91 (s, 1H, OH), 
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2.28-2.33 (m, 4H), 2.4-2.43 (m, 2H), 2.64-2.65 (m, 2H), 3.65 (s, 3H), 4.33-4.35 (m, 
1H), 6.28 (dd, J=15.68 Hz, 1H), 6.81 (d, J=15.68 Hz, 1H). 13C NMR (125 MHz, 
CDCl3) δ: 14.2, 22.6, 22.7, 24.8, 25.2, 25.8, 28.3, 31.9, 33.9 (2C), 37.3, 51.7, 72.5, 
123.8, 140.7, 140.9, 163.7, 174.3, 209.6. EI-MS: M+• 322 (0.4), 304 (100), 273 
(40), 244 (70), 215 (44), 187 (64), 173 (46), 159 (33), 147 (48), 133 (70), 105 (49), 









Synthesised from (R)-(-)-oct-1-en-3-ol-THP. Yield: 57 %. [α]25D= -24.5° (c 0.51, 
MeOH). 
 





Synthesised from 0.15 g (0.41 mmol) methyl 8-(2-iodo-5-oxocyclopent-1-
enyl)octanoate (53a), 4 × 90 μl (4 × 0.82 mmol) pent-1-ene, 115 µl (0.82 mmol) 
triethylamine, 12 mg of the palladium catalyst (mixture of palladium diacetate and 
triphenylphosphine, 1:2 mole ratio), 40 °C, 4 d. Yield: 122 mg (97 %), yellow oil. IR 
ν (cm-1): 1738 (C=O), 1693 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.95 (t, J=7.35 
Hz, 3H), 1.26-1.38 (m, 8H), 1.48-1.54 (m, 2H), 1.57-1.63 (m, 2H), 2.21-2.29 (m, 
6H), 2.37-2.39 (m, 2H), 2.61-2.63 (m, 2H), 3.65 (s, 3H), 6.23-6.29 (m, 1H), 6.59 (d, 
J=15.7 Hz), 1H). 13C NMR (125 MHz, CDCl3) δ: 13.8, 22.3, 23.1, 25.1, 25.7, 29.0, 
29.2 (2C), 29.6, 33.9, 34.2, 35.6, 51.5, 125.3, 139.4, 139.8, 164.3, 174.4, 209.7. 
EI-MS: M+• 306 (32), 275 (24), 263 (65), 231 (100), 203 (20), 191 (15), 177 (9), 
163 (7), 133 (20), 121 (55), 105 (16), 91 (18), 79 (15), 59 (3), 55 (10). HR-MS 
calcd for C19H30O3 (M+•) 306.219495, found: 306.220961. 
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Synthesised from 0.2 g (0.85 mmol) 2-ethyl-3-iodocyclopent-2-enone (53b), 0.27 g 
(1.27 mmol) methyl undec-10-enoate, 0.24 ml (1.69 mmol) triethylamine, 15 mg of 
the palladium catalyst (mixture of palladium diacetate and triphenylphosphine, 1:2 
mole ratio). Yield: 159 mg (59 %), yellow oil. IR ν (cm-1): 1738 (C=O), 1704 (C=O). 
1H NMR (500 MHz, CDCl3) δ: 1.0 (t, J=7.56 Hz, 3H), 1.31 (m, 8H), 1.43-1.49 (m, 
2H), 1.59-1.63 (m, 2H), 2.23-2.31 (m, 6H), 2.39-2.4 (m, 2H), 2.61-2.63 (m, 2H), 
3.66 (s, 3H), 6.24-6.3 (m, 1H), 6.61 (d, J=15.58 Hz, 1H). 13C NMR (125 MHz, 
CDCl3) δ: 13.6, 16.4, 25.1, 25.7, 29.0, 29.2, 29.3 (2C), 29.4, 33.6, 34.0, 34.2, 51.6, 
125.0, 139.6, 141.1, 164.0, 174.4, 209.6. EI-MS: M+• 306 (18), 275 (8), 163 (26), 
135 (100), 124 (10), 107 (8), 91 (10), 69 (1), 59 (2), 55 (6). HR-MS calcd for 
C19H30O3 (M+•) 306.219495, found: 306.218033. 
 






Synthesised from 0.2 g (0.62 mmol) methyl 5-(2-iodo-5-oxocyclopent-1-
enyl)pentanoate (53c), 0.12 g (1.04 mmol) oct-1-ene, 0.17 ml (1.24 mmol) 
triethylamine, 15 mg of the palladium catalyst (mixture of palladium diacetate and 
triphenylphosphine, 1:2 mole ratio). Yield: 132 mg (70 %), yellow oil. IR ν (cm-1): 
1739 (C=O), 1693 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.89 (t, J=6.99 Hz, 3H), 
1.26-1.35 (m, 6H), 1.39-1.49 (m, 4H), 1.58-1.64 (m, 2H), 2.22-2.32 (m, 6H), 2.38-
2.4 (m, 2H), 2.62-2.64 (m, 2H), 3.65 (s, 3H), 6.25-6.31 (m, 1H), 6.58 (d, J=15.8 Hz, 
1H). 13C NMR (125 MHz, CDCl3) δ: 14.2, 22.7, 22.8, 25.0, 25.8, 28.4, 29.0, 29.1, 
31.8, 33.7, 33.9, 34.0, 51.6, 125.0, 139.1, 140.1, 164.7, 174.2, 209.6. EI-MS: M+• 
306 (38), 275 (23), 221 (97), 189 (100), 147 (29), 121 (25), 105 (17), 91 (23), 59 
(4), 55 (11). HR-MS calcd for C19H30O3 (M+•) 306.219495, found: 306.220204. 
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6.2.6 Oxidation of phytoprostanes 22a-c (general procedure):  
 






To a stirred solution of Phytoprostane B1 type I methyl ester (22a) (50 mg, 155 
μmol, 1 equiv) in 3 ml of methylene chloride was added Bobbitt’s reagent (4-
acetylamino-2,2,6,6-tetramethylpiperidine-1-oxoammonium perchlorate) (51 mg, 
163 μmol, 1.05 equiv) and 50 mg of silica gel to catalyse the oxidation. The yellow 
slurry was stirred until the colour changed to white (~ 5 h) and GC showed 
complete oxidation of the alcohol. The slurry was filtered and the filter washed with 
methylene chloride. After evaporation of the solvent, the residue was loaded onto 
a silica gel column using diethyl ether for elution (yellow oil, 40 mg, 81 %). IR ν 
(cm-1): 1737 (C=O), 1698 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.16 (t, J=7.22 Hz, 
3H), 1.27-1.29 (m, 6H), 1.39-1.42 (m, 2H), 1.58-1.6 (m, 2H), 2.29 (t, J=7.45 Hz, 
2H), 2.32-2.36 (m, 2H), 2.46-2.48 (m, 2H), 2.66-2.71 (m, 4H), 3.65 (s, 3H), 6.57 (d, 
J=15.8 Hz, 1H), 7.64 (d, J=15.8 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 8.1, 23.6, 
25.0, 25.5, 29.1 (3C), 29.5, 34.0, 34.2, 34.9, 51.6, 130.4, 134.1, 148.0, 160.2, 
174.4, 200.6, 209.0. EI-MS: M+• 320 (17), 289 (18), 263 (96), 231 (100), 203 (27), 
189 (9), 171 (8), 161 (10), 147 (11), 133 (19), 121 (21), 105 (14), 91 (18), 59 (7), 








Synthesised from 100 mg (0.31 mmol) Phytoprostane B1 type II methyl ester (22b) 
in 5 ml methylene chloride, 102 mg (0.33 mmol) Bobbitt’s reagent (4-acetylamino-
2,2,6,6-tetramethylpiperidine-1-oxoammonium perchlorate), 100 mg silica gel. 
Yield: 85 mg (86 %), yellow oil. IR ν (cm-1): 1737 (C=O), 1697 (C=O). 1H NMR 
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(500 MHz, CDCl3) δ: 1.04 (t, J=7.56 Hz, 3H), 1.32-1.35 (m, 6H), 1.58-1.68 (m, 4H), 
2.29 (t, J=7.56 Hz, 2H), 2.38 (q, J=7.56 Hz, 2H), 2.46-2.48 (m, 2H), 2.62-2.68 (m, 
4H), 3.65 (s, 3H), 6.56 (d, J=16.04 Hz, 1H), 7.65 (d, J=16.04 Hz, 1H). 13C NMR 
(125 MHz, CDCl3) δ: 13.8, 16.9, 24.1, 25.0, 25.5, 29.1 (2C), 29.2, 34.0, 34.2, 41.6, 
51.6, 130.6, 134.1, 149.4, 159.7, 174.3, 200.2, 208.9. EI-MS: M+• 320 (26), 289 
(11), 178 (11), 163 (43), 135 (100), 121 (11), 107 (9), 91 (11), 59 (3), 55 (13). HR-
MS calcd for C19H28O4 (M+•) 320.198760, found: 320.199601. 
 






Synthesised from 50 mg (155 μmol) Phytoprostane B1 type III methyl ester (22c) in 
3 ml methylene chloride, 51 mg (163 μmol) Bobbitt’s reagent (4-acetylamino-
2,2,6,6-tetramethylpiperidine-1-oxoammonium perchlorate), 50 mg silica gel. Yield: 
39 mg (78 %), yellow oil. IR ν (cm-1): 1737 (C=O), 1697 (C=O). 1H NMR (500 MHz, 
CDCl3) δ: 0.9 (t, J=7 Hz, 3H), 1.31-1.37 (m, 4H), 1.43-1.49 (m, 2H), 1.6-1.7 (m, 
4H), 2.32 (t, J=7.45 Hz, 2H), 2.38 (t, J=7.68 Hz, 2H), 2.46-2.48 (m, 2H), 2.64-2.69 
(m, 4H), 3.65 (s, 3H), 6.57 (d, J=15.81 Hz, 1H), 7.59 (d, J=16.04 Hz, 1H). 13C 
NMR (125 MHz, CDCl3) δ: 14.1, 22.6, 23.3, 23.9, 24.9, 25.6, 28.5, 31.5, 33.9, 34.0, 
41.7, 51.7, 130.9, 134.0, 147.4, 160.6, 174.0, 200.4, 209.0. EI-MS: M+• 320 (100), 
289 (20), 221 (71), 189 (92), 161 (36), 147 (46), 133 (23), 105 (17), 91 (24), 59 (5), 
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6.2.7 Alkynylation of alkenyl iodides 53a-c (general procedure): 
 






To a stirred solution of PdCl2(PPh3)2 (40 mg, 0.06 mmol, 0.07 equiv) and CuI (24 
mg, 0.12 mmol, 0.15 equiv) in 1 ml of anhydrous DMF was added successively 
pent-1-yn-3-ol (0.1 g, 1.24 mmol, 1.5 equiv), a solution of methyl 8-(2-iodo-5-
oxocyclopent-1-enyl)octanoate (53a) (0.3 g, 0.82 mmol, 1 equiv) in 4 ml of 
anhydrous DMF and triethylamine (0.14 ml, 0.99 mmol, 1.2 equiv). The mixture 
was stirred for 24 h at rt and saturated NH4Cl was added and extracted with 
diethyl ether. After washing with saturated NaCl and water and drying over 
Na2SO4, the ether was evaporated and the crude residue loaded onto a silica gel 
column using diethyl ether as eluent (yellow oil, 0.23 g, 88 %). IR ν (cm-1): 3424 
(OH), 1738 (C=O), 1699 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.06 (t, J=7.45 Hz, 
3H), 1.26-1.31 (m, 6H), 1.42-1.48 (m, 2H), 1.57-1.63 (m, 2H), 1.77-1.85 (m, 2H), 
2.27-2.31 (m, 4H), 2.4-2.42 (m, 2H), 2.61-2.63 (m, 2H), 3.66 (s, 3H), 4.6 (t, J=6.5 
Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 9.6, 24.6, 25.0, 27.7, 29.0, 29.1, 29.3, 
30.3, 30.9, 34.2, 34.3, 51.7, 64.4, 80.7, 106.4, 149.1, 149.8, 174.6, 209.0. EI-MS: 
M+• 320 (5), 302 (20), 271 (28), 261 (100), 231 (30), 203 (31), 191 (37), 187 (33), 
161 (27), 147 (26), 133 (46), 121 (30), 105 (29), 91 (54), 59 (14), 55 (34). HR-MS 
calcd for C19H28O4 (M+•) 320.198760, found: 320.198096. 
 




OH O  
Synthesised from 31 mg (0.04 mmol) PdCl2(PPh3)2, 18 mg (0.09 mmol) CuI in 1 ml 
anhydrous DMF, 0.2 g (0.95 mmol) methyl 9-hydroxy-undec-10-ynoate,74 
(synthesized from methyl undec-10-ynoate according to literature in 22 % yield) 
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0.15 g (0.64 mmol) 2-ethyl-3-iodocyclopent-2-enone (53b) in 3 ml anhydrous DMF, 
0.11 ml (0.76 mmol) triethylamine. Yield: 185 mg (91 %), brown oil. IR ν (cm-1): 
3423 (OH), 1738 (C=O), 1699 (C=O). 1H NMR (500 MHz, CDCl3) δ: 1.05 (t, J=7.59 
Hz, 3H), 1.31-1.38 (m, 6H), 1.46-1.52 (m, 2H), 1.59-1.65 (m, 2H), 1.74-1.83 (m, 
2H), 2.08 (s, 1H, OH), 2.28-2.33 (m, 4H). 2.4-2.42 (m, 2H), 2.6-2.62 (m, 2H), 3.66 
(s, 3H), 4.64 (t, J=6.6 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 12.5, 18.0, 25.0, 
25.2, 29.1 (2C), 29.3, 30.2, 34.2, 34.3, 37.7, 51.6, 63.1, 80.6, 106.5, 149.2, 150.4, 
174.4, 208.9. EI-MS: M+• 320 (3), 302 (49), 289 (10), 187 (24), 163 (54), 135 (100), 
91 (56), 74 (36), 59 (17), 55 (53). HR-MS calcd for C19H28O4 (M+•) 320.198760, 
found: 320.199075. 
 






Synthesised from 31 mg (0.04 mmol) PdCl2(PPh3)2, 18 mg (0.09 mmol) CuI in 1 ml 
anhydrous DMF, 0.12 g (0.93 mmol) oct-1-yn-3-ol, 0.2 g (0.62 mmol) methyl 5-(2-
iodo-5-oxocyclopent-1-enyl)pentanoate (53c) in 3 ml anhydrous DMF, 0.1 ml (0.75 
mmol)  triethylamine. Yield: 171 mg (86 %), brown oil. IR ν (cm-1): 3423 (OH), 
1739 (C=O), 1699 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.9 (t, J=7.1 Hz, 3H), 
1.32-1.36 (m, 4H), 1.46-1.55 (m, 4H), 1.6-1.66 (m, 2H), 1.73-1.85 (m, 2H), 2.3-
2.36 (m, 4H), 2.4-2.42 (m, 2H), 2.61-2.63 (m, 2H), 3.66 (s, 3H), 4.63 (q, J=6.11 Hz, 
1H). 13C NMR (125 MHz, CDCl3) δ: 14.1, 22.7, 23.9, 24.7, 25.0, 27.2, 30.2, 31.6, 
33.8, 34.2, 37.6, 51.8, 63.0, 80.5, 107.5, 148.5, 150.4, 174.6, 208.8. EI-MS: M+• 
320 (1), 302 (100), 271 (22), 245 (16), 215 (56), 189 (34), 171 (37), 147 (31), 133 
(27), 105 (19), 91 (39), 59 (8), 55 (22). HR-MS calcd for C19H28O4 (M+•) 
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Synthesised from (R)-(+)-oct-1-yn-3-ol. Yield: 70 %. [α]25D= 6.2° (c 0.50, MeOH). 
 
 
6.2.8 Preparation of the O-alkyl ethers from 54a-c (general 
procedure): 
 






To a stirring solution of methyl 8-(2-hydroxy-5-oxocyclopent-1-enyl)octanoate 
(54a) (0.5 g, 2 mmol, 1 equiv) in 10 ml DMSO was added 1-iodobutane (0.36 g, 2 
mmol, 1 equiv). Sodium hydride (0.12 g, 3 mmol, 1.5 equiv) was added in portions 
and the mixture was stirred for 24 h at rt. Water was added and the product 
extracted with diethyl ether. After washing with saturated NaHCO3 and water, the 
organic phase was dried over Na2SO4 and evaporated. The residue was loaded 
onto a silica gel column using petrol ether / ethyl acetate (1:1) for elution (yellow 
oil, 254 mg, 42 %). IR ν (cm-1): 1738 (C=O), 1687 (C=O). 1H NMR (500 MHz, 
CDCl3) δ: 0.96 (t. J=7.5 Hz, 3H), 1.22-1.49 (m, 10H), 1.54-1.63 (m, 2H), 1.69-1.74 
(m, 2H), 2.08-2.11 (m, 2H), 2.27 (t, J=7.5 Hz, 2H), 2.41-2.42 (m, 2H), 2.61-2.63 
(m, 2H), 3.64 (s, 3H), 4.12 (t, J=6.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ: 13.8, 
19.1, 21.3, 25.0, 25.1, 27.9, 29.1, 29.2, 29.4, 31.8, 33.6, 34.2, 51.5, 69.2, 120.9, 
174.4, 184.6, 205.1. EI-MS: M+• 310 (20), 279 (15), 237 (28), 223 (7), 195 (13), 
181 (21), 168 (41), 153 (8), 139 (38), 125 (31), 112 (100), 96 (10), 55 (18). HR-MS 
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Synthesised from 0.5 g (4 mmol) 2-ethylcyclopentane-1.3-dione (54b) in 10 ml 
DMSO, 1.1 g (4 mmol) methyl 10-bromodecanoate, 0.24 g (6 mmol) sodium 
hydride. Yield: 0.91 g (74 %), white solid. Mp: 43-44 °C. IR ν (cm-1): 1739 (C=O), 
1679 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.97 (t, J=7.45 Hz, 3H), 1.3-1.43 (m, 
10H), 1.58-1.62 (m, 2H), 1.7-1.75 (m, 2H), 2.14 (q, J=7.48 Hz, 2H), 2.29 (t, J=7.56 
Hz, 2H), 2.39-2.41 (m, 2H), 2.6-2.62 (m, 2H), 3.65 (s, 3H), 4.12 (t, J=6.53 Hz, 2H). 
13C NMR (125 MHz, CDCl3) δ: 12.7, 14.8, 25.0 (2C), 25.9, 29.2, 29.3 (2C), 29.4, 
29.7, 33.7, 34.2, 51.5, 69.4, 122.2, 174.4, 184.1, 204.9. EI-MS: M+• 310 (29), 279 
(23), 237 (9), 185 (24), 153 (41), 135 (25), 127 (100), 126 (99), 11 (30), 83 (26), 69 
(49), 59 (10), 55 (36). HR-MS calcd for C18H30O4 (M+•) 310.214410, found 
310.214056. 
 






Synthesised from 0.2 g (0.94 mmol) methyl 5-(2-hydroxy-5-oxocyclopent-1-
enyl)pentanoate (54c) in 5 ml DMSO, 0.21 g (0.94 mmol) 1-iodoheptane, 57 mg 
(1.42 mmol) sodium hydride. Yield: 0.14 g (48 %), yellow oil. IR ν (cm-1): 1738 
(C=O), 1688 (C=O). 1H NMR (500 MHz, CDCl3) δ: 0.88 (t, J=7 Hz, 3H), 1.27-1.46 
(m, 10H), 1.55-1.61 (m, 2H), 1.7-1.75 (m, 2H), 2.13 (t, J=7.46 Hz, 2H), 2.29 (t, 
J=7.74 Hz, 2H), 2.4-2.42 (m, 2H), 2.62-2.64 (m, 2H), 3.64 (s, 3H), 4.11 (t, J=6.5 
Hz, 2H). 13C NMR (125 MHz, CDCl3) δ: 14.2, 20.9, 22.7, 24.8, 25.0, 25.8, 27.4, 
29.0, 29.7, 31.8, 33.6, 34.0, 51.5, 69.5, 120.2, 174.4, 184.8, 205.0. EI-MS: M+• 310 
(32), 279 (25), 237 (66), 223 (22), 210 (19), 180 (48), 139 (100), 125 (46), 112 
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6.2.9 Allylic oxidations (general procedure): 
 
Methyl 9-hydroxyundec-10-enoate  
 
O
OH O  
A mixture of selenium dioxide (1.4 g; 12.6 mmol; 0.5 equiv) and tert-butyl 
hydroperoxide (5.6 ml; 50.4 mmol; 2 equiv) in 50 ml of absolute dichloromethane 
was stirred at room temperature for 0.5 h. Then, methyl undec-10-enoate (5 g; 
25.2 mmol; 1 equiv) in 15 ml of absolute dichloromethane was added dropwise 
over a period of 20 min with cooling and the mixture was stirred at room 
temperature for 5 d. Dichloromethane was removed, water added and extracted 
with benzene. The benzene layer was washed with water, saturated NaCl, dried 
over Na2SO4 and evaporated. The oily residue was loaded onto a silica gel column 
using petrol ether / diethyl ether (2:1) as eluent (colourless oil, 3.19 g; 59 %). IR ν 
(cm-1): 3441 (OH), 1739 (C=O). 1H-NMR (500 MHz; CDCl3) δ: 1.25-1.4 (m; 8H); 
1.48-1.62 (m; 4H); 2.29 (t; J= 7.52; 2H); 3.65 (s; 3H); 4.05-4.1 (m; 1H); 5.07-5.22 
(m; 2H); 5.81-5.89 (m; 1H). 13C-NMR (125 MHz; CDCl3) δ: 25.03; 25.35; 29.16; 
29.27; 29.43; 34.2; 37.12; 51.55; 73.31; 114.62; 141.46; 174.42. EI-MS: [M-18]+•0 
196 (1), 158 (37). 125 (11), 115 (29), 101 (12), 87 (100), 74 (54). 59 (17), 55 (53). 






Synthesised from 0.28 g (2.55 mmol) selenium dioxide, 1.2 ml (1.02 mmol) tert-
butyl hydroperoxide in 10 ml anhydrous dichloromethane, 1 g methyl undec-10-
ynoate (5.1 mmol) in 3 ml anhydrous dichloromethane. Yield: 240 mg (22 %), 
colourless oil. IR ν (cm-1): 3292 (OH), 1736 (C=O). 1H-NMR (500 MHz; CDCl3) 
δ: 1.3-1.35 (m; 6H); 1.42-1.48 (m; 2H); 1.58-1.74 (m; 4H); 2.29 (t; J=7.45 Hz; 2H); 
2.45 (d; J=2.06 Hz; 1H); 3.66 (s; 3H); 4.34-4.37 (m; 1H). 13C-NMR (125 MHz; 
CDCl3) δ: 25.02; 25.04; 29.13 (2C); 29.21; 34.2; 37.74; 51.56; 62.4; 72.92; 85.18; 
174.42. EI-MS: [M-54]+• 158 (22), 125 (11), 115 (12), 87 (42), 74 (46), 55 (100). 
HR-MS calcd for C9H18O2 ([M-54]+•) 158.130680 (-C3H2O); Found: 158.131166. 
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To a stirred solution of pent-1-en-3-ol (1 g; 11.6 mmol; 1 equiv) and dihydropyran 
(5.3 ml; 58 mmol; 5 equiv) in 50 ml methylene chloride, was added p-
toluenesulfonic acid monohydrate (22 mg, 0.12 mmol, 0.01 equiv) and the mixture 
was kept at room temperature for 3 h. Then 60 ml of diethyl ether were added and 
the organic phase was washed with a mixture of 20 ml of saturated NaHCO3, 20 
ml of saturated NaCl and 40 ml of water. The water phase was extracted with 
ether and the combined ether phases were dried over Na2SO4 and evaporated 
(1.94 g; 96 %). The resulting oily THP-ether was used in the following Heck 








Synthesised from 2 g methyl 9-hydroxyundec-10-enoate (9.3 mmol), 4.3 ml 
dihydropyran (46.7 mmol) in 100 ml methylene chloride, 18 mg p-toluenesulfonic 
acid monohydrate (0.1 mmol). Yield: 2.58 g (93 %). The resulting oily THP-ether 






Synthesised from 1g oct-1-en-3-ol (7.8 mmol), 3.6 ml dihydropyran (39 mmol) in 
50 ml methylene chloride, 18 mg p-toluenesulfonic acid monohydrate (0.1 mmol). 
Yield: 1.52 g (92 %). The resulting oily THP-ether was used in the following Heck 
reaction without further purification. 
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10.1 1H NMR, 13C NMR, EI-MS, IR spectra of 
synthesised compounds 
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10.2 Tables of differentially expressed genes from the 
microarray 
 
10.2.1 Treatment with 1 mM 65a 
 
10.2.1.1 Up-regulated genes in response to 1 mM treatment 
Gene identifier Description 
At1g53540.1 
17.6 kDa class I small heat shock protein (HSP17.6C-CI) (AA 1-156) identical to 
(17.6 kDa class I heat shock protein (HSP 17.6) (AA 1-156)(SP:P13853) 
(GI:4376161) (Arabidopsis thaliana) (Nucleic Acids Res. 17 (19), 7995 (1989)) 
[At1g53540.1] 
At2g29490.1 
glutathione S-transferase, putative similar to glutathione S-transferase 103-1A 
[Arabidopsis thaliana] SWISS-PROT:P46421 [At2g29490.1] 
At3g28210.1 
zinc finger (AN1-like) family protein contains Pfam profile: PF01428 AN1-like 
zinc finger [At3g28210.1] 
At5g48657.2 
defense protein-related weak similarity to SP|Q8GYN5 RPM1-interacting protein 
4 110 [At5g48657.2] 
At5g51440.1 
23.5 kDa mitochondrial small heat shock protein (HSP23.5-M) similar to heat 
shock 22 kDa protein, mitochondrial precursor SP:Q96331 from [Arabidopsis 
thaliana]; identified in Scharf, K-D., et al,Cell Stress & Chaperones (2001) 6: 
225-237. [At5g51440.1] 
At5g59720.1 
18.1 kDa class I heat shock protein (HSP18.1-CI) identical to 18.2 kDa class I 
heat shock protein (HSP 18.2) (SP:P19037)[Arabidopsis thaliana]; contains 
Pfam profile: PF00011 Hsp20/alpha crystallin family [At5g59720.1] 
At5g52640.1 
heat shock protein 81-1 (HSP81-1) / heat shock protein 83 (HSP83) nearly 
identical to SP|P27323 Heat shock protein 81-1 (HSP81-1) (Heat shock protein 
83) 110; contains Pfam profiles PF02518: ATPase, histidine kinase-, DNA gyrase 
B-,... 
At5g11590.1 
AP2 domain-containing transcription factor, putative similar to transcription factor 
TINY (GI:1246403) [Arabidopsis thaliana] [At5g11590.1] 
At1g02920.1 
glutathione S-transferase, putative similar to glutathione S-transferase 
GI:860955 from [Hyoscyamus muticus]; supported by cDNA GI:443697. 
[At1g02920.1] 
At5g12020.1 
17.6 kDa class II heat shock protein (HSP17.6-CII) identical to 17.6 kDa class II 
heat shock protein SP:P29830 from [Arabidopsis thaliana] [At5g12020.1] 
At1g65390.1 
disease resistance protein (TIR class), putative domain signature TIR exists, 
suggestive of a disease resistance protein. [At1g65390.1] 
At1g51620.1 
protein kinase family protein contains protein kinase domain, Pfam:PF00069 
[At1g51620.1] 
At3g23550.1 
MATE efflux family protein similar to ripening regulated protein DDTFR18 
[Lycopersicon esculentum] GI:12231296; contains Pfam profile: PF01554 
uncharacterized membrane protein family [At3g23550.1] 
At3g26200.1 
cytochrome P450 71B22, putative (CYP71B22) Identical to cytochrome P450 
71B22 (SP:Q9LTM1)[Arabidopsis thaliana];contains Pfam profile: PF00067 
cytochrome P450 [At3g26200.1] 
At1g16030.1 
heat shock protein 70, putative / HSP70, putative similar to heat shock protein 
hsp70 GI:1771478 from [Pisum sativum] [At1g16030.1] 
At1g74310.1 
heat shock protein 101 (HSP101) identical to heat shock protein 101 
GI:6715468 GB:AAF26423 from [Arabidopsis thaliana] [At1g74310.1] 
At1g02930.1 
glutathione S-transferase, putative similar to glutathione S-transferase 
GI:860955 from [Hyoscyamus muticus] [At1g02930.1] 
At4g37990.1 mannitol dehydrogenase, putative (ELI3-2) identical to GI:16269 [At4g37990.1] 
At1g17420.1 
lipoxygenase, putative similar to lipoxygenase gi:1495804 [Solanum tuberosum], 
gi:1654140 [Lycopersicon esculentum] [At1g17420.1] 
At4g23700.1 cation/hydrogen exchanger, putative (CHX17) similar to Na+/H+-exchanging 
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protein slr1595 - Synechocystis sp., EMBL:D90902; monovalent cation:proton 
antiporter family 2 (CPA2) member, PMID:11500563 [At4g23700.1] 
At2g47000.1 
multidrug resistant (MDR) ABC transporter, putative similar to multidrug-resistant 
protein CjMDR1 [Coptis japonica] GI:14715462, MDR-like p-glycoprotein 
[Arabidopsis thaliana] GI:24324262; contains Pfam profiles PF00005: ABC 
transporter, PF00664: ABC... 
At3g16360.1 
phosphotransfer family protein similar to two-component phosphorelay 
mediators ATHP1 (GI:4156241), ATHP3 (GI:4156245) [Arabidopsis thaliana], 
histidine-containing phosphotransfer protein [Catharanthus roseus] GI:13774348 
[At3g16360.1] 
At2g27690.1 
cytochrome P450, putative similar to Cytochrome P450 94A1 (P450-dependent 
fatty acid omega-hydroxylase) (SP:O81117) {Vicia sativa}; contains Pfam profile: 
PF00067 cytochrome P450; supported by cDNA: gi_13877668 [At2g27690.1] 
At2g29460.1 glutathione S-transferase, putative  [At2g29460.1] 
At4g23190.1 
protein kinase family protein contains Pfam PF00069: Protein kinase domain 
[At4g23190.1] 
At1g09080.1 
luminal binding protein 3 (BiP-3) (BP3) Similar to Arabidopsis luminal binding 
protein (gb|D89342); contains Pfam domain PF00012: dnaK protein 
[At1g09080.1] 
At5g42380.1 
calmodulin-related protein, putative similar to regulator of gene silencing 
calmodulin-related protein GI:12963415 from [Nicotiana tabacum] [At5g42380.1] 
At2g26150.1 
heat shock transcription factor family protein contains Pfam profile: PF00447 
HSF-type DNA-binding domain [At2g26150.1] 
At2g38340.1 
AP2 domain-containing transcription factor, putative (DRE2B) Similar to 
DREB2A (GP:3738230) and DREB2B (GP:3738232) [Arabidopsis thaliana]; 
DRE binding proteins may be involved in dehydration or low temp response 
[At2g38340.1] 
At2g21650.1 
myb family transcription factor contains PFAM profile: PF00249 myb-like DNA-
binding domain [At2g21650.1] 
At3g22370.1 
alternative oxidase 1a, mitochondrial (AOX1A) identical to GB:Q39219 
[SP|Q39219] from [Arabidopsis thaliana] [At3g22370.1] 
At3g15356.1 
legume lectin family protein contains Pfam domain, PF00139: Legume lectins 
beta domain [At3g15356.1] 
At3g44870.1 
S-adenosyl-L-methionine:carboxyl methyltransferase family protein similar to 
defense-related protein cjs1 [Brassica carinata][GI:14009292][Mol Plant Pathol 
(2001) 2(3):159-169] [At3g44870.1] 
At3g50260.1 
AP2 domain-containing transcription factor, putative EREBP-3 homolog, 
Stylosanthes hamata, EMBL:U91982 [At3g50260.1] 
At5g64750.1 
AP2 domain-containing transcription factor, putative contains similarity to 
transcription factor [At5g64750.1] 
At5g48540.1 
33 kDa secretory protein-related contains Pfam PF01657: Domain of unknown 
function, duplicated in 33 KDa secretory proteins [At5g48540.1] 
At1g10070.1 
branched-chain amino acid aminotransferase 2 / branched-chain amino acid 
transaminase 2 (BCAT2) identical to SP|Q9M439 Branched-chain amino acid 
aminotransferase 2, chloroplast precursor (EC 2.6.1.42) (Atbcat-2) {Arabidopsis 
thaliana}; contains Pfam... 
At2g40750.1 
WRKY family transcription factor contains Pfam profile: PF03106 WRKY DNA -
binding domain [At2g40750.1] 
At3g46090.1 
zinc finger (C2H2 type) family protein (ZAT7) identical to zinc finger protein 
ZAT7 [Arabidopsis thaliana] gi|1418341|emb|CAA67234; contains Pfam domain, 
PF00096: Zinc finger, C2H2 type [At3g46090.1] 
At3g28740.1 
cytochrome P450 family protein contains Pfam profile: PF00067 cytochrome 
P450 [At3g28740.1] 
At2g38240.1 
oxidoreductase, 2OG-Fe(II) oxygenase family protein similar to flavonol 
synthase [Citrus unshiu][gi:4126403], leucoanthocyanidin dioxygenase [Daucus 
carota][gi:5924383]; contains PF03171 2OG-Fe(II) oxygenase superfamily 
domain [At2g38240.1] 
At1g51790.1 
leucine-rich repeat protein kinase, putative smilar to light repressible receptor 
protein kinase [Arabidopsis thaliana] gi|1321686|emb|CAA66376; contains 
leucine rich repeat (LRR) domains, Pfam:PF00560; contains protein kinase 
domain, Pfam:PF00069... 
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At3g09440.1 
heat shock cognate 70 kDa protein 3 (HSC70-3) (HSP70-3) identical to 
SP|O65719 Heat shock cognate 70 kDa protein 3 (Hsc70.3) {Arabidopsis 
thaliana} [At3g09440.1] 
At3g04010.1 
glycosyl hydrolase family 17 protein similar to beta-1,3-glucanase GB:S12402 
[Nicotiana sp], GB:CAA03908 [Citrus sinensis], GB:S44364 [Lycopersicon 
esculentum] [At3g04010.1] 
At5g43450.1 
2-oxoglutarate-dependent dioxygenase, putative similar to 2A6 (GI:599622) and 
tomato ethylene synthesis regulatory protein E8 (SP|P10967) [At5g43450.1] 
At3g44300.1 
nitrilase 2 (NIT2) identical to SP|P32962 Nitrilase 2 (EC 3.5.5.1) {Arabidopsis 
thaliana} [At3g44300.1] 
At4g37370.1 
cytochrome P450, putative similar to Cytochrome P450 91A1 (SP:Q9FG65 
)[Arabidopsis thaliana]; cytochrome P450, Glycyrrhiza echinata, AB001379 
[At4g37370.1] 
At5g62480.1 glutathione S-transferase, putative  [At5g62480.1] 
At2g18193.1 
AAA-type ATPase family protein contains Pfam profile: ATPase family PF00004 
[At2g18193.1] 
At5g48570.1 
peptidyl-prolyl cis-trans isomerase, putative / FK506-binding protein, putative 
similar to rof1 [Arabidopsis thaliana] GI:1373396 [At5g48570.1] 
At1g02850.1 
glycosyl hydrolase family 1 protein contains Pfam PF00232 : Glycosyl hydrolase 
family 1 domain; TIGRFAM TIGR01233: 6-phospho-beta-galactosidase; similar 
to hydroxyisourate hydrolase (GI:19569603) [Glycine max] [At1g02850.1] 
At1g02400.1 
gibberellin 2-oxidase, putative / GA2-oxidase, putative similar to GA2ox2 
[GI:4678368]; similar to dioxygenase GI:1666096 from [Marah macrocarpus]; 
contains PF03171 2OG-Fe(II) oxygenase superfamily domain [At1g02400.1] 
At3g16530.1 
legume lectin family protein contains Pfam domain, PF00139: Legume lectins 
beta domain [At3g16530.1] 
At2g03760.1 
steroid sulfotransferase, putative strong similarity to steroid sulfotransferases 
from [Brassica napus] GI:3420008, GI:3420004, GI:3420006; contains Pfam 
profile PF00685: Sulfotransferase domain [At2g03760.1] 
At1g65970.1 
peroxiredoxin type 2, putative strong similarity to type 2 peroxiredoxin [Brassica 
rapa subsp. pekinensis] GI:4928472; contains Pfam profile: PF00578 AhpC/TSA 
(alkyl hydroperoxide reductase and thiol-specific antioxidant) family 
[At1g65970.1] 
At3g24954.1 
leucine-rich repeat family protein contains leucine rich-repeat domains 
Pfam:PF00560, INTERPRO:IPR001611 [At3g24954.1] 
At5g48657.1 
defense protein-related weak similarity to SP|Q8GYN5 RPM1-interacting protein 
4 {Arabidopsis thaliana} [At5g48657.1] 
At3g25882.1 
NPR1/NIM1-interacting protein 2 (NIMIN-2) identical to cDNA NIMIN-2 protein 
(nimin-2 gene)GI:12057155 [At3g25882.1] 
At5g41080.1 
glycerophosphoryl diester phosphodiesterase family protein weak similarity to 
SP|P37965 Glycerophosphoryl diester phosphodiesterase (EC 3.1.4.46) 
{Bacillus subtilis}; contains Pfam profile PF03009: Glycerophosphoryl diester 
phosphodiesterase family... 
At5g01600.1 
ferritin 1 (FER1) identical to ferritin [Arabidopsis thaliana] GI:1246401, 
GI:8163920 [At5g01600.1] 
At5g20480.1 
leucine-rich repeat transmembrane protein kinase, putative protein kinase Xa21, 
Oryza sativa, PIR:A57676 [At5g20480.1] 
At4g01700.1 
chitinase, putative similar to peanut type II chitinase GI:1237025 from [Arachis 
hypogaea] [At4g01700.1] 
At4g01870.1 
tolB protein-related contains weak similarity to TolB protein precursor (Swiss-
Prot:P44677) [Haemophilus influenzae] [At4g01870.1] 
At2g40670.1 
two-component responsive regulator / response regulator 16 (ARR16) identical 
to response regulator 16 GI:11870067 from [Arabidopsis thaliana] [At2g40670.1] 
At5g17860.1 
cation exchanger, putative (CAX7) contains similarity to SWISS-PROT:Q9HC58 
NKX3_HUMAN Sodium/potassium/calcium exchanger 3 precursor {Homo 
sapiens}; Ca2+:Cation Antiporter (CaCA) Family member PMID:11500563 
[At5g17860.1] 
At3g26290.1 
cytochrome P450 71B26, putative (CYP71B26) identical to cytochrome P450 
71B26 (SP:Q9LTL0) [Arabidopsis thaliana]; contains Pfam profile: PF00067 
cytochrome P450 [At3g26290.1] 
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At1g67810.1 
Fe-S metabolism associated domain-containing protein contains Pfam PF02657: 
Fe-S metabolism associated domain [At1g67810.1] 
At1g06160.1 
ethylene-responsive factor, putative similar to ethylene response factor 1 
GB:AAD03544 GI:4128208 from [Arabidopsis thaliana] [At1g06160.1] 
At2g40330.1 
Bet v I allergen family protein contains Pfam profile PF00407: Pathogenesis-
related protein Bet v I family [At2g40330.1] 
At4g12290.1 
copper amine oxidase, putative similar to copper amine oxidase [Cicer 
arietinum] gi|3819099|emb|CAA08855 [At4g12290.1] 
At5g47330.1 palmitoyl protein thioesterase family protein   [At5g47330.1] 
At4g22590.1 
trehalose-6-phosphate phosphatase, putative similar to trehalose-6-phosphate 
phosphatase (AtTPPA) GI:2944178; contains Pfam profile PF02358: Trehalose-
phosphatase [At4g22590.1] 
At1g23090.1 
sulfate transporter, putative similar to sulfate transporter [Arabidopsis thaliana] 
GI:2285885; contains Pfam profiles PF00916: Sulfate transporter family, 
PF01740: STAS domain [At1g23090.1] 
At5g18470.1 
curculin-like (mannose-binding) lectin family protein contains Pfam profile: 
PF01453 lectin (probable mannose binding) [At5g18470.1] 
At2g39210.1 
nodulin family protein similar to nodulin-like protein [Arabidopsis thaliana] 
GI:3329368, nodule-specific protein Nlj70 [Lotus japonicus] GI:3329366 
[At2g39210.1] 
At5g59820.1 
zinc finger (C2H2 type) family protein (ZAT12) identical to zinc finger protein 
ZAT12 [Arabidopsis thaliana] gi|1418325|emb|CAA67232 [At5g59820.1] 
At5g62070.1 
calmodulin-binding family protein contains Pfam profile PF00612: IQ calmodulin-
binding motif [At5g62070.1] 
At1g32940.1 
subtilase family protein contains similarity to subtilase; SP1 GI:9957714 from 
[Oryza sativa] [At1g32940.1] 
At1g32870.1 
no apical meristem (NAM) family protein similar to to NAC2 (GI:645671) 
[Arabidopsis thaliana]; contains Pfam PF02365: No apical meristem (NAM) 
protein [At1g32870.1] 
At3g28007.1 
nodulin MtN3 family protein contains Pfam PF03083 MtN3/saliva family; similar 
to LIM7 GI:431154 (induced in meiotic prophase in lily microsporocytes) from 
[Lilium longiflorum] [At3g28007.1] 
At5g44420.1 
plant defensin protein, putative (PDF1.2a) plant defensin protein family member, 
personal communication, Bart Thomma (Bart.Thomma@agr.kuleuven.ac.be); 
similar to antifungal protein 1 preprotein [Raphanus sativus] 
gi|609322|gb|AAA69541 [At5g44420.1] 
At3g61630.1 
AP2 domain-containing transcription factor, putative transcription factor Pti6 - 
Lycopersicon esculentum, PIR:T07728 [At3g61630.1] 
At2g26560.1 
patatin, putative similar to patatin-like latex allergen [Hevea 
brasiliensis][PMID:10589016]; contains patatin domain PF01734 [At2g26560.1] 
At1g07180.1 
pyridine nucleotide-disulphide oxidoreductase family protein contains similarity 
to alternative NADH-dehydrogenase GI:3718005 from [Yarrowia lipolytica], 
SP|P32340 Rotenone-insensitive NADH-ubiquinone oxidoreductase, 
mitochondrial precursor (EC... 
At4g03320.1 
chloroplast protein import component-related similar to P. sativum Tic20 
chloroplast protein import component (GI:3769673) [At4g03320.1] 
At3g50930.1 
AAA-type ATPase family protein contains Pfam profile: ATPase family PF00004 
[At3g50930.1] 
At2g26010.1 
plant defensin-fusion protein, putative (PDF1.3) plant defensin protein family 
member, personal communication, Bart Thomma 
(Bart.Thomma@agr.kuleuven.ac.be); similar to antifungal protein 1 preprotein 
[Raphanus sativus] gi|609322|gb|AAA69541 [At2g26010.1] 
At4g05020.1 
NADH dehydrogenase-related similar to alternative NADH-dehydrogenase 
[Yarrowia lipolytica] GI:3718005, 64 kDa mitochondrial NADH dehydrogenase 
[Neurospora crassa] GI:4753821; contains Pfam profile PF00070: Pyridine 
nucleotide-disulphide oxidoreductase... 
At1g08630.1 
L-allo-threonine aldolase-related similar to L-allo-threonine aldolase (EC 4.1.2.-) 
(L-allo-TA) (L-allo-threonine acetaldehyde-lyase) (SP:O07051) {Aeromonas 
jandaei}; similar to ESTs gb|R30517, gb|T42772, gb|R90493, and gb|R90493 
[At1g08630.1] 
At1g06620.1 2-oxoglutarate-dependent dioxygenase, putative similar to 2A6 (GI:599622) and 
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tomato ethylene synthesis regulatory protein E8 (SP|P10967); contains Pfam 
profile: PF00671 Iron/Ascorbate oxidoreductase family [At1g06620.1] 
At2g14560.1 
expressed protein contains Pfam profile PF04525: Protein of unknown function 
(DUF567) [At2g14560.1] 
At3g09270.1 
glutathione S-transferase, putative similar to glutathione transferase 
GB:CAA71784 [Glycine max] [At3g09270.1] 
At2g40100.1 
chlorophyll A-B binding protein (LHCB4.3) identical to Lhcb4:3 protein 
[Arabidopsis thaliana] GI:4741956; contains Pfam profile: PF00504 chlorophyll 
A-B binding protein [At2g40100.1] 
At4g15490.1 
UDP-glucoronosyl/UDP-glucosyl transferase family protein contains Pfam 
profile: PF00201 UDP-glucoronosyl and UDP-glucosyl transferase ;simalr to 
UDP-glucose:sinapate glucosyltransferase GI:9794913 from [Brassica napus] 
[At4g15490.1] 
At3g22060.1 
receptor protein kinase-related contains Pfam profile: PF01657 Domain of 
unknown function that is usually associated with protein kinase domain 
Pfam:PF00069 [At3g22060.1] 
At1g76680.1 
12-oxophytodienoate reductase (OPR1) identical to 12-oxophytodienoate 
reductase OPR1 GB:AAC78440 [Arabidopsis thaliana] [At1g76680.1] 
At1g66580.1 
60S ribosomal protein L10 (RPL10C) contains Pfam profile: PF00826: 
Ribosomal L10 [At1g66580.1] 
At4g36010.1 
pathogenesis-related thaumatin family protein similar to receptor 
serine/threonine kinase PR5K [Arabidopsis thaliana] GI:1235680; contains Pfam 
profile PF00314: Thaumatin family [At4g36010.1] 
At2g44840.1 ethylene-responsive element-binding protein, putative  [At2g44840.1] 
At4g17090.1 
beta-amylase (CT-BMY) / 1,4-alpha-D-glucan maltohydrolase identical to beta-
amylase enzyme GI:6065749 from [Arabidopsis thaliana] [At4g17090.1] 
  
 Heat Schock protein 
 Glutathione S-transferase 
 Cytochrome P-450 
 Pathogenesis related protein 
 
 
10.2.1.2 Down-regulated genes in response to 1 mM treatment 
Gene number Description 
At1g77760.1 
nitrate reductase 1 (NR1) identical to SP|P11832 Nitrate reductase 1 (formerly 
EC 1.6.6.1) (NR1){Arabidopsis thaliana} [At1g77760.1] 
At5g04150.1 
basic helix-loop-helix (bHLH) family protein contains Pfam profile: PF00010 
helix-loop-helix DNA-binding domain; PMID: 12679534 [At5g04150.1] 
At5g65010.1 
asparagine synthetase 2 (ASN2) identical to asparagine synthetase (ASN2) 
[Arabidopsis thaliana] GI:3859536 [At5g65010.1] 
At2g26980.4 
CBL-interacting protein kinase 3 (CIPK3) identical to CBL-interacting protein 
kinase 3 [Arabidopsis thaliana] gi|9280638|gb|AAF86507 [At2g26980.4] 
At2g26980.1 
CBL-interacting protein kinase 3 (CIPK3) identical to CBL-interacting protein 
kinase 3 [Arabidopsis thaliana] gi|9280638|gb|AAF86507 [At2g26980.1] 
At5g15500.1 
ankyrin repeat family protein contains Pfam domain, PF00023: Ankyrin repeat 
[At5g15500.1] 
At5g25190.1 
ethylene-responsive element-binding protein, putative ethylene responsive 
element binding protein homolog, Stylosanthes hamata, EMBL:U91857 
[At5g25190.1] 
At1g10550.1 
xyloglucan:xyloglucosyl transferase, putative / xyloglucan endotransglycosylase, 
putative / endo-xyloglucan transferase, putative similar to endoxyloglucan 
transferase related protein EXGT-A3 GI:2154609 from [Arabidopsis thaliana] 
[At1g10550.1] 
At1g22990.1 
heavy-metal-associated domain-containing protein / copper chaperone (CCH)-
related low similarity to copper homeostasis factor [GI:3168840][PMID:9701579]; 
strong similarity to farnesylated protein ATFP7 [GI:4097555]; contains heavy-
metal-associated... 
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At4g37540.1 
LOB domain protein 39 / lateral organ boundaries domain protein 39 (LBD39) 
identical to SP|Q9SZE8 LOB domain protein 39 {Arabidopsis thaliana} 
[At4g37540.1] 
At5g26200.1 
mitochondrial substrate carrier family protein contains Pfam profile: PF00153 
mitochondrial carrier protein [At5g26200.1] 
At4g15690.1 
glutaredoxin family protein contains INTERPRO Domain IPR002109, 
Glutaredoxin (thioltransferase) [At4g15690.1] 
At3g14440.1 
9-cis-epoxycarotenoid dioxygenase, putative / neoxanthin cleavage enzyme, 
putative / carotenoid cleavage dioxygenase, putative similar to 9-cis-
epoxycarotenoid dioxygenase GB:AAF26356 [GI:6715257][Phaseolus vulgaris] 
[At3g14440.1] 
At1g70920.1 
homeobox-leucine zipper protein, putative / HD-ZIP transcription factor, putative 
similar to homeodomain leucine zipper protein GI:5006851 from [Oryza sativa] 
[At1g70920.1] 
At2g18480.1 
mannitol transporter, putative similar to mannitol transporter [Apium graveolens 
var. dulce] GI:12004316; contains Pfam profile PF00083: major facilitator 
superfamily protein [At2g18480.1] 
At5g18050.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) (GI:3043536) [Raphanus sativus] [At5g18050.1] 
At3g03820.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) (GI:3043536) [Raphanus sativus] [At3g03820.1] 
At1g53830.1 
pectinesterase family protein identical to pectinesterase 2 (PME2/ PE 2) 
SP:Q42534 from [Arabidopsis thaliana];contains Pfam profiles: PF01095 
pectinesterase, PF04043 plant invertase/pectin methylesterase inhibitor 
[At1g53830.1] 
At2g21210.1 
auxin-responsive protein, putative similar to small auxin-up regulated protein 
SAUR (GI:3043536) [Raphanus sativus] [At2g21210.1] 
At5g02760.1 
protein phosphatase 2C family protein / PP2C family protein similar to Ser/Thr 
protein phosphatase 2C (PP2C6) (GI:15020818) [Arabidopsis thaliana]; similar 
to protein phosphatase 2C (GI:3608412) [Mesembryanthemum crystallinum]; 
contains Pfam PF00481 :... 
At5g18060.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) GI:3043536 from radish [Raphanus sativus] [At5g18060.1] 
At4g11320.1 
cysteine proteinase, putative contains similarity to cysteine proteinase RD21A 
(thiol protease) GI:435619, SP:P43297 from [Arabidopsis thaliana] 
[At4g11320.1] 
At5g18010.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) (GI:3043536) [Raphanus sativus] [At5g18010.1] 
At3g54830.1 
amino acid transporter family protein belongs to INTERPRO:IPR002422 amino 
acid/polyamine transporter, family II [At3g54830.1] 
At5g50740.1 
copper chaperone (CCH)-related low similarity to copper homeostasis factor 
[GI:3168840][PMID: 9701579]; similar to farnesylated protein ATFP3 
[GI:4097547]; contains Pfam profile PF00403: Heavy-metal-associated domain 
[At5g50740.1] 
At5g52910.1 
timeless family protein contains Pfam domains PF05029: Timeless protein C 
terminal region and PF04821: Timeless protein [At5g52910.1] 
At3g48360.1 
speckle-type POZ protein-related contains Pfam PF00651 : BTB/POZ domain; 
similar to Speckle-type POZ protein (SP:O43791) [Homo sapiens] [At3g48360.1] 
At1g69790.1 
protein kinase, putative similar to protein kinase APK1A [Arabidopsis thaliana] 
SWISS-PROT:Q06548 [At1g69790.1] 
At5g19600.1 
sulfate transporter, putative similar to sulfate transporter [Arabidopsis thaliana] 
GI:2285885; contains Pfam profiles PF00916: Sulfate transporter family, 
PF01740: STAS domain; supporting cDNA gi|14141683|dbj|AB061739.1| 
[At5g19600.1] 
At1g07610.1 
metallothionein-like protein 1C (MT-1C) identical to Metallothionein-like protein 
1C (MT-1C). (SP:Q38804) (Arabidopsis thaliana) [At1g07610.1] 
At1g32560.1 
late embryogenesis abundant group 1 domain-containing protein / LEA group 1 
domain-containing protein contains Pfam domain, PF03760: Late 
embryogenesis abundant (LEA) group 1 [At1g32560.1] 
At5g18020.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) (GI:3043536) [Raphanus sativus] [At5g18020.1] 
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At2g38170.1 
calcium exchanger (CAX1) identical to high affinity calcium antiporter CAX1 
[Arabidopsis thaliana] gi|9256741|gb|AAB05913, except a possible frameshift at 
base 58008. Sequence has been confirmed with 5 sequencing reads.; 
Ca2+:Cation Antiporter (CaCA)... 
At1g74670.1 
gibberellin-responsive protein, putative similar to SP|P46690 Gibberellin-
regulated protein 4 precursor {Arabidopsis thaliana} GASA4; contains Pfam 
profile PF02704: Gibberellin regulated protein [At1g74670.1] 
At5g22940.1 
exostosin family protein contains Pfam profile: PF03016 exostosin family 
[At5g22940.1] 
At1g73330.1 
protease inhibitor, putative (DR4) identical to Dr4 GI:469114 from [Arabidopsis 
thaliana]; contains Pfam profile PF00197: Trypsin and protease inhibitor 
[At1g73330.1] 
At5g18030.1 
auxin-responsive protein, putative similar to auxin-inducible SAUR (Small Auxin 
Up RNAs) (GI:3043536) [Raphanus sativus] [At5g18030.1] 
At2g32100.1 
ovate protein-related contains TIGRFAM TIGR01568 : uncharacterized plant-
specific domain TIGR01568 [At2g32100.1] 
At4g11310.1 
cysteine proteinase, putative contains similarity to cysteine proteinase RD21A 
(thiol protease) GI:435619, SP:P43297 from [Arabidopsis thaliana] 
[At4g11310.1] 
At2g37870.1 
protease inhibitor/seed storage/lipid transfer protein (LTP) family protein 
contains Pfam protease inhibitor/seed storage/LTP family domain PF00234 
[At2g37870.1] 
At5g18080.1 
auxin-responsive protein, putative similar to GP:3043536 SAUR {Raphanus 
sativus} [At5g18080.1] 
At4g14550.1 
auxin-responsive AUX/IAA family protein identical to IAA14 (GI:972931) 
[Arabidopsis thaliana]; similar to SP|Q38825 Auxin-responsive protein IAA7 
(Indoleacetic acid-induced protein 7) {Arabidopsis thaliana} [At4g14550.1] 
At2g42380.1 bZIP transcription factor family protein  [At2g42380.1] 
At5g57560.1 
xyloglucan:xyloglucosyl transferase / xyloglucan endotransglycosylase / endo-
xyloglucan transferase (TCH4) identical to xyloglucan endotransglycosylase 
TCH4 protein GI:886116 [At5g57560.1] 
At5g67420.1 
LOB domain protein 37 / lateral organ boundaries domain protein 37 (LBD37) 
identical to LOB DOMAIN 37 [Arabidopsis thaliana] GI:17227170 [At5g67420.1] 
At1g02205.1 
CER1 protein identical to maize gl1 homolog (glossy1 locus) GI:1209703 and 
CER1 GI:1199467 from [Arabidopsis thaliana] [At1g02205.1] 
At1g58300.1 
heme oxygenase, putative similar to heme oxygenase 4 GI:14485565 from 
[Arabidopsis thaliana] [At1g58300.1] 
At1g03470.1 
kinase interacting family protein similar to kinase interacting protein 1 
(GI:13936326) [Petunia integrifolia] [At1g03470.1] 
At3g19380.1 
U-box domain-containing protein contains similarity to immediate-early fungal 
elicitor protein CMPG1 GI:14582200 [Petroselinum crispum]; contains Pfam 
profile PF04564: U-box domain [At3g19380.1] 
At3g06770.1 
glycoside hydrolase family 28 protein / polygalacturonase (pectinase) family 
protein weak similarity to polygalacturonase [Persea americana] GI:166951; 
contains PF00295: Glycosyl hydrolases family 28 (polygalacturonases) 
[At3g06770.1] 
At5g46690.1 
basic helix-loop-helix (bHLH) family protein contains similarity to bHLH DNA-
binding protein [At5g46690.1] 
At1g29500.1 
auxin-responsive protein, putative similar to auxin-induced protein 6B 
(SP:P33083) [Glycine max] [At1g29500.1] 
At1g20190.1 
expansin, putative (EXP11) similar to GB:U30460 from [Cucumis sativus]; alpha-
expansin gene family, PMID:11641069 [At1g20190.1] 
At5g42200.1 
zinc finger (C3HC4-type RING finger) family protein contains Pfam profile: 
PF00097 zinc finger, C3HC4 type (RING finger) [At5g42200.1] 
At5g20110.1 
dynein light chain, putative similar to SP|O02414 Dynein light chain LC6, 
flagellar outer arm {Anthocidaris crassispina}; contains Pfam profile PF01221: 
Dynein light chain type 1 [At5g20110.1] 
At3g25670.1 
leucine-rich repeat family protein contains leucine rich-repeat (LRR) domains 
Pfam:PF00560, INTERPRO:IPR001611; + [At3g25670.1] 
At1g50280.1 phototropic-responsive NPH3 family protein contains NPH3 family domain, 
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Pfam:PF03000 [At1g50280.1] 
At5g01740.1 
expressed protein wound-inducible protein wun1 protein - Solanum tuberosum, 
PIR:JQ0398 [At5g01740.1] 
At1g29510.1 
auxin-responsive protein, putative similar to auxin-induced protein 6B 
(SP:P33083) [Glycine max] [At1g29510.1] 
At3g07340.1 
basic helix-loop-helix (bHLH) family protein contains Pfam profile: PF00010 
helix-loop-helix DNA-binding domain [At3g07340.1] 
At1g29450.1 
auxin-responsive protein, putative similar to auxin-induced protein 6B 
(SP:P33083) [Glycine max] [At1g29450.1] 
At5g62100.1 
BAG domain-containing protein similar to BAG domain containing proteins 
(At5g07220, At5g52060) [At5g62100.1] 
At4g26790.1 
GDSL-motif lipase/hydrolase family protein similar to family II lipase EXL3 
(GI:15054386), EXL1 (GI:15054382), EXL2 (GI:15054384) [Arabidopsis 
thaliana]; contains Pfam profile PF00657: Lipase/Acylhydrolase with GDSL-like 
motif [At4g26790.1] 
At5g62040.1 
brother of FT and TFL1 protein (BFT) identical to SP|Q9FIT4 BROTHER of FT 
and TFL1 protein {Arabidopsis thaliana}; contains Pfam profile PF01161: 
Phosphatidylethanolamine-binding protein [At5g62040.1] 
At4g02630.1 
protein kinase family protein contains protein kinase domain, Pfam:PF00069; 
contains serine/threonine protein kinase domain, INTERPRO:IPR002290 
[At4g02630.1] 
At2g05070.1 
chlorophyll A-B binding protein / LHCII type II (LHCB2.2) identical to Lhcb2 
protein [Arabidopsis thaliana] GI:4741946; contains Pfam profile PF00504: 
Chlorophyll A-B binding protein [At2g05070.1] 
At3g58120.1 
bZIP transcription factor family protein contains Pfam profile: PF00170 bZIP 
transcription factor ;supported by cDNA gi|15100054|gb|AF401300.1|AF401300 
[At3g58120.1] 
At5g24770.1 
vegetative storage protein 2 (VSP2) identical to SP|O82122 Vegetative storage 
protein 2 precursor {Arabidopsis thaliana}; contains Pfam profile PF03767: HAD 
superfamily (subfamily IIIB) phosphatase [At5g24770.1] 
At2g18050.1 
histone H1-3 (HIS1-3) similar to histone H1 [Lycopersicon pennellii] SWISS-
PROT:P40267; identical to cDNA histone H1-3 (His1-3) GI:1809314, histone H1-
3 [Arabidopsis thaliana] GI:1809305 [At2g18050.1] 
At1g28130.1 
auxin-responsive GH3 family protein similar to auxin-responsive GH3 product 
[Glycine max] GI:18591; contains Pfam profile PF03321: GH3 auxin-responsive 
promoter [At1g28130.1] 
At1g49780.1 
U-box domain-containing protein similar to immediate-early fungal elicitor protein 
CMPG1 [Petroselinum crispum] GI:14582200; contains Pfam profile PF04564: 
U-box domain [At1g49780.1] 
At4g34760.1 
auxin-responsive family protein auxin-induced protein X15, Glycine max, 
PIR2:JQ1097 [At4g34760.1] 
At4g17460.1 
homeobox-leucine zipper protein 1 (HAT1) / HD-ZIP protein 1 identical to 
Homeobox-leucine zipper protein HAT1 (SP:P46600) [Arabidopsis thaliana] 
[At4g17460.1] 
At1g33340.1 
epsin N-terminal homology (ENTH) domain-containing protein / clathrin 
assembly protein-related contains Pfam PF01417: ENTH domain. ENTH (Epsin 
N-terminal homology) domain; similar to clathrin assembly protein AP180 
(GI:6492344) [Xenopus laevis]... 
At1g29460.1 
auxin-responsive protein, putative similar to auxin-induced protein 6B 
(SP:P33083) [Glycine max] [At1g29460.1] 
At3g63450.1 
RNA recognition motif (RRM)-containing protein contains InterPro entry 
IPR000504: RNA-binding region RNP-1 (RNA recognition motif) (RRM) 
[At3g63450.1] 
At4g32280.1 
auxin-responsive AUX/IAA family protein contains Pfam profile: PF02309: 
AUX/IAA family [At4g32280.1] 
At5g43270.1 
squamosa promoter-binding protein-like 2 (SPL2) identical to squamosa 
promoter binding protein-like 2 [Arabidopsis thaliana] GI:5931645; contains 
Pfam profile PF03110: SBP domain [At5g43270.1] 
At5g57660.1 
zinc finger (B-box type) family protein contains Pfam domain, PF00643: B-box 
zinc finger [At5g57660.1] 
At5g29000.1 myb family transcription factor contains Pfam profile: PF00249 myb-like DNA-
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binding domain [At5g29000.1] 
At4g03070.1 
2-oxoglutarate-dependent dioxygenase (AOP1.2) identical to GI:16118887; 
contains PF03171: 2OG-Fe(II) oxygenase superfamily domain [At4g03070.1] 
At1g29440.1 
auxin-responsive family protein similar to auxin-induced protein 6B (SP:P33083) 
[Glycine max] [At1g29440.1] 
At4g39770.1 
trehalose-6-phosphate phosphatase, putative similar to trehalose-6-phosphate 
phosphatase (AtTPPB) [Arabidopsis thaliana] GI:2944180; contains Pfam profile 
PF02358: Trehalose-phosphatase [At4g39770.1] 
At3g28860.1 
multidrug resistance P-glycoprotein, putative similar to mdr-like P-glycoprotein 
GI:3849833 from [Arabidopsis thaliana]; contains Pfam profiles PF00005: ABC 
transporter and PF00664: ABC transporter transmembrane region; identical to 
cDNA MDR-like... 
At4g26100.3 
casein kinase, putative similar to casein kinase I, delta isoform [Arabidopsis 
thaliana] SWISS-PROT:P42158; contains protein kinase domain, Pfam:PF00069 
[At4g26100.3] 
At4g31890.1 
armadillo/beta-catenin repeat family protein contains Pfam profile: PF00514 
armadillo/beta-catenin-like repeat [At4g31890.1] 
At5g65920.1 
U-box domain-containing protein low similarity to immediate-early fungal elicitor 
protein CMPG1 [Petroselinum crispum] GI:14582200; contains Pfam profile 
PF04564: U-box domain [At5g65920.1] 
At4g20820.1 
FAD-binding domain-containing protein similar to SP|P30986 reticuline oxidase 
precursor (Berberine-bridge-forming enzyme) (BBE) (Tetrahydroprotoberberine 
synthase) [Eschscholzia californica]; contains PF01565 FAD binding domain 
[At4g20820.1] 
At1g52830.1 
auxin-responsive protein / indoleacetic acid-induced protein 6 (IAA6) nearly 
identical to SP|Q38824 Auxin-responsive protein IAA6 (Indoleacetic acid-
induced protein 6) {Arabidopsis thaliana} [At1g52830.1] 
At4g13560.1 
late embryogenesis abundant domain-containing protein / LEA domain-
containing protein similar to LEA protein [Cicer arietinum] GI:2909420; contains 
Pfam profile PF02987: Late embryogenesis abundant protein [At4g13560.1] 
At3g27690.1 
chlorophyll A-B binding protein (LHCB2:4) nearly identical to Lhcb2 protein 
[Arabidopsis thaliana] GI:4741950; similar to chlorophyll A-B binding protein 151 
precursor (LHCP) GB:P27518 from [Gossypium hirsutum]; contains Pfam 
PF00504: Chlorophyll A-B... 
At5g24380.1 
transporter, putative similar to iron-phytosiderophore transporter protein yellow 
stripe 1 [Zea mays] GI:10770865; contains Pfam profile PF03169: OPT 
oligopeptide transporter protein [At5g24380.1] 
At1g03300.1 
agenet domain-containing protein contains Pfam PF05641: Agenet domain 
[At1g03300.1] 
At4g39510.1 
cytochrome P450 family protein contains Pfam PF00067: Cytochrome P450; 
similar to Cytochrome P450 86A2 (SP:O23066) [Arabidopsis thaliana] 
[At4g39510.1] 
At1g51940.1 
protein kinase family protein / peptidoglycan-binding LysM domain-containing 
protein contains protein kinases ATP-binding region signature, 
PROSITE:PS00107 [At1g51940.1] 
At1g56600.1 
galactinol synthase, putative similar to galactinol synthase, isoform GolS-1 
GI:5608497 from [Ajuga reptans] [At1g56600.1] 
At5g44260.1 
zinc finger (CCCH-type) family protein contains Pfam domain, PF00642: Zinc 
finger C-x8-C-x5-C-x3-H type (and similar) [At5g44260.1] 
At5g24155.1 
squalene monooxygenase, putative / squalene epoxidase, putative similar to 
SP|O65404 (SE 1,1), SP|O65402 (SE 1,2) [At5g24155.1] 
At3g49620.1 
2-oxoacid-dependent oxidase, putative (DIN11) identical to partial cds of 2-
oxoacid-dependent oxidase (din11) from GI:10834554 [Arabidopsis thaliana]; 
identical to cDNA 2-oxoacid-dependent oxidase (din11) GI:10834553; contains 
Pfam profile PF03171:... 
At3g59060.1 
basic helix-loop-helix (bHLH) family protein contains Pfam profile: PF00010 
helix-loop-helix DNA-binding domain [At3g59060.1] 
  
  Auxin-responsive protein 
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10.2.2 Treatment with 100 μM 22a,b, 65a 
 
10.2.2.1 Up-regulated genes in response to 100 μM treatments 
Gene identifier Description 
At4g15210.2 ATBETA-AMY (BETA-AMYLASE); beta-amylase 
At2g39350.1 ATPase, coupled to transmembrane movement of substances 
At4g15210.1 ATBETA-AMY (BETA-AMYLASE); beta-amylase 
At2g02990.1 RNS1 (RIBONUCLEASE 1); endoribonuclease 
At1g76930.1 ATEXT4 (extensin 4) 
At5g57560.1 
TCH4 (TOUCH 4); hydrolase, acting on glycosyl bonds / hydrolase, hydrolyzing 
O-glycosyl compounds 
At1g70920.1 DNA binding / transcription factor 
At5g59310.1 LTP4 (LIPID TRANSFER PROTEIN 4); lipid binding 
At1g19610.1 LCR78/PDF1.4 
At2g23130.1 AGP17 (ARABINOGALACTAN PROTEIN 17) 
At2g16440.1 
ATP binding / DNA binding / DNA-dependent ATPase/ nucleoside-
triphosphatase/ nucleotide binding 
At2g23130.2 AGP17 (ARABINOGALACTAN PROTEIN 17) 
At4g38400.1 ATEXLA2 (ARABIDOPSIS THALIANA EXPANSIN-LIKE A2) 
At1g35140.1 PHI-1 (PHOSPHATE-INDUCED 1) 
At5g39550.1 protein binding / ubiquitin-protein ligase/ zinc ion binding 
At3g59220.1 PRN (PIRIN); calmodulin binding 
At3g23730.1 
hydrolase, acting on glycosyl bonds / hydrolase, hydrolyzing O-glycosyl 
compounds 
At5g24080.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At5g24770.1 VSP2 (VEGETATIVE STORAGE PROTEIN 2); acid phosphatase 
At5g24780.1 VSP1 (VEGETATIVE STORAGE PROTEIN 1); acid phosphatase 




At1g73325.1 endopeptidase inhibitor 
At5g23530.1 catalytic 
At3g14740.1 protein binding / zinc ion binding 
At5g41040.1 transferase 
AI996914 CORI3 (CORONATINE INDUCED 1); transaminase 
At2g25820.1 transcription factor 
At3g54810.1 transcription factor 
At1g10585.1 transcription factor 
At3g50060.1 DNA binding / transcription factor 
At4g00180.1 YAB3; transcription factor 
At1g12210.1 RFL1 (RPS5-LIKE 1); ATP binding 
At2g43510.1 ATTI1 
At5g43420.1 protein binding / ubiquitin-protein ligase/ zinc ion binding 
At1g71000.1 heat shock protein binding / unfolded protein binding 
At4g16590.1 ATCSLA01; glucosyltransferase/ transferase, transferring glycosyl groups 
At1g76650.1 calcium ion binding 
At4g11280.1 
ACS6 (1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (ACC) SYNTHASE 
6) 
At3g05890.1 RCI2B (RARE-COLD-INDUCIBLE 2B) 
At5g46050.1 transporter 
At5g26010.1 catalytic/ protein phosphatase type 2C 
At5g61390.1 exonuclease 
At1g65450.1 transferase 
At2g43840.1 UDP-glycosyltransferase/ transferase, transferring hexosyl groups 
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At2g42800.1 protein binding 
At5g05810.1 protein binding / ubiquitin-protein ligase/ zinc ion binding 
At5g41120.1 catalytic 
At1g15165.1 ubiquitin-protein ligase 
At3g48350.1 cysteine-type endopeptidase/ cysteine-type peptidase 
At5g42100.2 hydrolase, hydrolyzing O-glycosyl compounds 
At3g48570.1 protein translocase 
At1g33770.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At1g04760.1 ATVAMP726 
At4g18170.1 WRKY28; transcription factor 
At1g17250.1 protein binding / protein kinase 
At4g29900.1 ACA10; calcium-transporting ATPase/ calmodulin binding 
At4g19520.1 ATP binding / transmembrane receptor 
At1g53140.1 ATP binding / GTP binding / GTPase 
At4g01575.1 serine-type endopeptidase inhibitor 
At4g26100.3 CK1; casein kinase I/ kinase 
At5g18860.1 hydrolase 
At4g11320.1 cysteine-type endopeptidase/ cysteine-type peptidase 
At2g22730.1 carbohydrate transporter/ sugar porter/ transporter 
At1g44318.1 porphobilinogen synthase 
At1g47510.1 hydrolase/ inositol or phosphatidylinositol phosphatase 
At5g45820.1 CIPK20 (CBL-INTERACTING PROTEIN KINASE 20); kinase 
At4g30980.1 DNA binding / transcription factor 
At1g68795.1 CLE12 (CLAVATA3/ESR-RELATED 12); receptor binding 
At4g37260.1 MYB73; DNA binding / transcription factor 
At5g07660.1 ATP binding 
At5g10080.1 pepsin A 
At2g30560.1 ATP binding 
At5g67300.1 DNA binding / transcription factor 
At5g39840.1 
ATP binding / ATP-dependent RNA helicase/ ATP-dependent helicase/ helicase/ 
nucleic acid binding 
At1g19940.1 hydrolase, hydrolyzing O-glycosyl compounds 
At4g19230.1 CYP707A1; heme binding / iron ion binding / monooxygenase/ oxygen binding 
At5g64520.1 XRCC2 
At5g47435.2 
formyltetrahydrofolate deformylase/ hydroxymethyl-, formyl- and related 
transferase 
BP575077 
VHA-A; ATP binding / hydrogen-transporting ATP synthase, rotational 
mechanism / hydrogen-transporting ATPase, rotational mech 
At1g52030.1 MBP2 (MYROSINASE-BINDING PROTEIN 2) 
At3g62590.1 triacylglycerol lipase 
At1g26770.1 ATEXPA10 (ARABIDOPSIS THALIANA EXPANSIN A10) 
At5g61890.1 DNA binding / transcription factor 
BP667723 ELP (ECTOPIC DEPOSITION OF LIGNIN IN PITH); chitinase 
At3g10910.1 protein binding / ubiquitin-protein ligase/ zinc ion binding 
At1g57980.1 purine transporter 
At4g22753.1 SMO1-3 (STEROL 4-ALPHA METHYL OXIDASE); catalytic 
BX822209 JKHR07A9 snoRNA, complete sequence 
At2g19990.1 PR-1-LIKE (PATHOGENESIS-RELATED PROTEIN-1-LIKE) 
At1g25510.1 aspartic-type endopeptidase/ pepsin A 
At5g40942.1 ribonucleoside-diphosphate reductase 
At1g70090.1 
transferase, transferring glycosyl groups / transferase, transferring hexosyl 
groups 
At4g01500.1 transcription factor 
At1g16410.2 CYP79F1 (SUPERSHOOT 1) 
At3g50970.1 XERO2 
At3g49160.1 pyruvate kinase 
At1g58300.1 oxidoreductase 
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10.2.2.2 Down-regulated genes in response to 100 μM treatments 
Gene identifier Description 
At5g65080.1 MAF5 (MADS AFFECTING FLOWERING 5 VARIANT I); transcription factor 
At2g41240.1 DNA binding / transcription factor 
At2g45220.1 enzyme inhibitor/ pectinesterase 
At5g22890.1 transcription factor 
At3g04280.1 
ARR22 (ARABIDOPSIS RESPONSE REGULATOR 22); transcription regulator/ 
two-component response regulator 
At5g07450.1 cyclin-dependent protein kinase 
At5g36150.1 ATPEN3; catalytic 
At3g56970.1 ORG2; DNA binding / transcription factor 
AV540967 
CPK5 (CALMODULIN-DOMAIN PROTEIN KINASE 5); ATP binding / calcium 
ion binding / calcium- and calmodulin-dependent protein kinase 
At5g15220.1 structural constituent of ribosome 
At2g23830.1 structural molecule 
At2g31083.1 CLE7 (CLAVATA3/ESR-RELATED 7); receptor binding 
At1g23700.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At1g68940.1 ubiquitin-protein ligase 
At3g09930.1 carboxylic ester hydrolase/ hydrolase, acting on ester bonds / lipase 
At5g17750.1 ATP binding / ATPase/ nucleoside-triphosphatase/ nucleotide binding 
At5g23020.1 MAM-L (METHYLTHIOALKYMALATE SYNTHASE-LIKE) 
At3g22231.1 PCC1 (PATHOGEN AND CIRCADIAN CONTROLLED 1) 
At1g16980.1 ATTPS2; transferase, transferring glycosyl groups 
At1g67090.1 ribulose-bisphosphate carboxylase 
At1g10480.1 
ZFP5 (ZINC FINGER PROTEIN 5); nucleic acid binding / transcription factor/ 
zinc ion binding 
At2g25810.1 water channel 
At2g28960.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At1g15820.1 LHCB6; chlorophyll binding 
At3g17150.1 enzyme inhibitor/ pectinesterase/ pectinesterase inhibitor 
At1g69930.1 ATGSTU11; glutathione transferase 
At3g49760.1 DNA binding / transcription factor 
At5g34870.1 nucleic acid binding 
At5g58010.1 DNA binding / transcription factor 
At5g38000.1 oxidoreductase/ zinc ion binding 
At5g10140.1 FLC (FLOWERING LOCUS C); transcription factor 
At5g38420.1 ribulose-bisphosphate carboxylase 
At1g12805.1 nucleotide binding 
At4g34380.1 nucleotide binding 
At3g45690.1 transporter 
At3g26120.1 RNA binding / nucleic acid binding 
At2g03160.1 ASK19; ubiquitin-protein ligase 
At1g59780.1 ATP binding 
At1g29910.1 CAB3 (CHLOROPHYLL A/B BINDING PROTEIN 3); chlorophyll binding 
At2g26490.1 nucleotide binding 
At5g65100.1 transcription factor 
At5g04150.1 DNA binding / transcription factor 
At2g34420.1 LHB1B2 
At5g38410.1 ribulose-bisphosphate carboxylase 
BX836788 CLV1 (CLAVATA 1); ATP binding / kinase/ protein serine/threonine kinase 
At5g24530.1 
oxidoreductase, acting on paired donors, with incorporation or reduction of 
molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom 
each of oxygen into both donors 
At1g51790.1 kinase 
At2g41090.1 calcium ion binding 
At2g34430.1 LHB1B1; chlorophyll binding 
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At4g23515.1 transmembrane receptor 
At1g64720.1 CP5 
AV523348 EMB2734; lyase 
At2g02850.1 ARPN (PLANTACYANIN); copper ion binding / electron transporter 
At1g61520.1 LHCA3*1; chlorophyll binding 
At3g54890.1 LHCA1; chlorophyll binding 
At5g45380.1 solute:sodium symporter/ urea transporter 
At1g21250.1 WAK1 (CELL WALL-ASSOCIATED KINASE); kinase 
At2g39730.2 RCA (RUBISCO ACTIVASE) 
At3g45540.1 ubiquitin-protein ligase/ zinc ion binding 
At5g54610.1 protein binding 
At2g47130.1 oxidoreductase 
At2g30730.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At5g60830.1 DNA binding / transcription factor 
At1g52940.1 hydrolase/ protein serine/threonine phosphatase 
At5g52170.1 DNA binding / transcription factor 
At1g23020.1 ferric-chelate reductase/ oxidoreductase 
At5g10760.1 pepsin A 
At4g14400.1 ACD6 (ACCELERATED CELL DEATH 6); protein binding 
At5g11920.1 hydrolase, hydrolyzing O-glycosyl compounds 
At2g31500.1 
CPK24; ATP binding / calcium ion binding / calcium- and calmodulin-dependent 
protein kinase/ kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At3g04530.1 PPCK2 (PHOSPHOENOLPYRUVATE CARBOXYLASE KINASE 2); kinase 
At1g03980.1 glutathione gamma-glutamylcysteinyltransferase 
At1g53420.1 ATP binding / kinase/ protein serine/threonine kinase 
At1g06680.1 PSBP (OXYGEN-EVOLVING ENHANCER PROTEIN 2); calcium ion binding 
At1g57830.1 transmembrane receptor 
AV518576 ALDH3F1; aldehyde dehydrogenase/ oxidoreductase 
At3g56710.1 SIB1 (SIGMA FACTOR BINDING PROTEIN 1); binding 
At5g66570.1 PSBO-1 (OXYGEN-EVOLVING ENHANCER 33) 
At5g01900.1 WRKY62; transcription factor 
At4g25480.1 
DREB1A (DEHYDRATION RESPONSE ELEMENT B1A); DNA binding / 
transcription factor/ transcriptional activator 
At1g74350.1 RNA binding / RNA-directed DNA polymerase 
At5g55460.1 lipid binding 
At2g23240.1 zinc ion binding 
At1g35710.1 
ATP binding / protein kinase/ protein serine/threonine kinase/ protein-tyrosine 
kinase 
AV537449 CHS (CHALCONE SYNTHASE); naringenin-chalcone synthase 
At5g65070.1 MAF4 (MADS AFFECTING FLOWERING 4); transcription factor 
At2g46430.1 
ATCNGC3 (CYCLIC NUCLEOTIDE GATED CHANNEL 3); calmodulin binding / 
cyclic nucleotide binding / ion channel 
At1g10620.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At4g13480.1 DNA binding / transcription factor 
At1g55060.1 UBQ12 (UBIQUITIN 12) 
At5g39020.1 
ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-
tyrosine kinase 
At2g46440.1 ATCNGC11; calmodulin binding / cyclic nucleotide binding / ion channel 
At3g25820.1 ATTPS-CIN; myrcene/(E)-beta-ocimene synthase 
AY090988 3'-5' exonuclease/ nucleic acid binding 
At3g14210.1 carboxylic ester hydrolase/ hydrolase, acting on ester bonds 
At1g49860.1 ATGSTF14; glutathione transferase 
At3g46070.1 nucleic acid binding / transcription factor/ zinc ion binding 
At5g38430.1 ribulose-bisphosphate carboxylase 
At5g54770.1 THI1 (THIAZOLE REQUIRING) 
At3g63480.1 ATP binding / microtubule motor 
 
